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ABSTRACT
Before 1995, the frequencies of mycobacterial and fungal bloodstream infections (BSI) in 
human immunodeficiency virus (HIV)-infected populations in sub-Saharan Africa and 
Southeast Asia were unknown. Therefore, a prospective survey of febrile (oral temperature 
>38°C or axillary temperature >37.5°C) adult patients who presented to sentinel teaching 
hospitals in Tanzania (1995), Thailand (1997), and Malawi (1997 dry season and 1998 wet 
season) was conducted. The objectives were to (I) determine the aetiology, prevalence, and 
clinical correlates of BSL and (ii) characterise the role played by HIV infection. After 
informed consent, a detailed history was recorded for each patient followed by physical 
examination. Next, blood was cultured for bacteria, mycobacteria, and fungi, and tested for 
HIV and malaria. Data were collected for 517 patients in Tanzania, 246 in Thailand, and 471 
in Malawi. Respective BSI, HIV, and malaria parasitaemia rates were: Tanzania: 28%, 55%, 
9.5%; Thailand: 48%, 74%, 0; Malawi dry season: 30%, 74%, 4%; Malawi wet season: 28%, 
73%, 31%. The most frequently isolated bloodstream pathogens were Mycobacterium 
tuberculosis (MTB) and non-typhi Salmonella species (NTS) in Tanzania; MTB and 
Cryptococcus neoformans in Thailand; MTB and Streptococcus pneumoniae during Malawi 
dry season; and MTB and NTS during Malawi wet season. In each country, HIV-infected 
patients were significantly  more likely to acquire BSI; all patients with mycobacteraemia 
were HIV-infected. The Malawi f ind ings are the first description of seasonal variation in the 
occurrence of S. pneumoniae and NTS bacteraemias. Logistic regression models yielded 
predictors of BSI in Thailand (HTV infection, chronic diarrhoea, lymphadenopathy, or 
splenomegaly) and Malawi (HIV infection, chronic fever, oral candidiasis, or acute 
diarrhoea). In populations with high prevalence rates of HIV infection, MTB has become the
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foremost cause of documented BSI. Similar season- and country-specific surveys, performed 
periodically in HIV-endemic regions will provide data on the aetiology and predictors of 
BSI, and facilitate empirical therapy of febrile illnesses.
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CHAPTER 1 
OVERVIEW
The presence o f  living microorganisms in blood has substantial clinical importance. From 
the diagnostic standpoint, a positive blood culture yielding a clinically important 
microorganism represents either a failure o f  host defences to contain an infection at its 
primary focus or failure o f  the physician to effectively eradicate, drain, excise, or otherwise 
remove that focus o f  infection. (Reller, 1997).
Blood is a very special juice. (Goethe, 1749-1823)
Pathogens normally regarded as ‘non-opportunistic’ have been well documented as causes of 
systemic infections in human immunodeficiency virus type 1 (HlV-l)-infected patients in 
industrialized countries [Schrager, 1988; Krumholz et al., 1989]. The presence of an 
infection in the bloodstream of an individual is an indication of the failure of the host’s 
defences to contain an infection at its primary site, or may also be the result of the failure of 
a health professional to properly diagnose or treat the focus of infection. Delay or inability 
to diagnose a bloodstream infection may lead to significant morbidity or mortality. The 
misdiagnosis of bloodstream infections is common in the developing world due to shortage 
of skilled personnel, lack of training facilities, shortage of medical supplies, and or the 
inappropriate use of available resources.
For hospitals in less-industrialized countries, infectious diseases remain the leading 
cause of death [Hinman, 1998; Mabey et al., 2004]. Thus, it is essential that clinicians in 
these countries be provided reliable information regarding the most likely pathogens that are
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associated with commonly diagnosed infections, and the susceptibilities of these pathogens 
to available antimicrobials. Without effective microbiology services this is not possible and 
decisions to treat infections often have to be based on presumptive diagnoses. Unfortunately, 
development, implementation, or enhancements of basic microbiology services have not 
been priorities in many less-industrialized countries, particularly in sub-Saharan Africa. In 
these regions, where many laboratories lack resources, skilled personnel, and diagnostic 
microbiology services, or where available resources are inappropriately utilized, the nature of 
various infections in adult inpatient populations remains largely unknown, and the limited 
available data on the prevalence, aetiology, and epidemiology of putative infections may 
result in empiric therapeutic options that are either blind or misdirected.
In 1976, before the onset of the HIV-1 pandemic in sub-Saharan Africa, investigators in 
Ibadan, Nigeria, demonstrated that Salmonella species, Klebsiella pneumoniae, and 
Pseudomonas aeruginosa were the predominant causes of community-acquired bacteraemia 
in hospitalized adult patients [Alausa et al., 1977]. Although community-acquired 
bacteraemia, especially those caused by Gram-positive organisms, had already been shown 
to be common in HIV-1-seropositive patients in the United States [Eng et al., 1986;
Krumholz et al., 1989; Simberkoff et al., 1984; Wimbrey et al., 1986], very little research 
had been done before 1995 to fully characterize the aetiology and epidemiology of 
bloodstream infections in adult inpatients in Africa or Asia, especially among those patients 
with HIV-1 infection.
Although at the start o f the 1990s human immunodeficiency virus (HIV) disease was 
already considered an epidemic in sub-Saharan Africa [Lucas et al., 1993], underlying causes 
of attributable mortality had not been characterised by representative studies. In 1991,
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consecutive adult medical admissions to a large city hospital in Cote d’Ivoire were studied 
and a sample of patients whose deaths were attributable to HIV infection were further 
characterised and analysed through autopsies [Lucas et al., 1993]. Of 5401 adult admissions 
who were evaluated, 50% were HIV-positive; 38% of these HIV-positive patients died. 
Among 294 autopsies, including 24% of the HIV-positive deaths in hospital, tuberculosis, 
bacteraemia, and cerebral toxoplasmosis were the underlying causes of 53% of deaths. 
Tuberculosis was seen in 54% of cadavers with acquired immune deficiency syndrome 
(AIDS)-defining pathology. In addition, bacteraemia was associated with 16% of deaths in 
HTV-1-positive patients, in general, and with 7% of deaths among patients with AIDS- 
defining disease [Lucas et al., 1993]. Because Gram stain rather than blood culture was used 
to make the diagnoses of bacteraemia, the lack of bloodstream isolates meant that 
antimicrobial susceptibility testing o f bloodstream pathogens could not be done. The 
predominant bloodstream pathogens ascertained by this method were Gram-negative bacilli. 
The study, by nature of its design, suffered from selection bias in that death (and by 
inference autopsies) would have occurred mainly in patients with advanced HTV disease.
The major impact of this study, however, was to highlight the importance of bacteraemia and 
disseminated tuberculosis as the two major underlying pathologies associated with mortality 
in adult HIV-infected patients in sub-Saharan Africa. The clinical and public health 
relevance of these findings are underscored by the fact that these two infections are either 
preventable or treatable.
One of the first major studies o f bloodstream infections in an HIV-1-endemic region in 
Africa was conducted during 1988-1989 in the largest hospital in Nairobi, Kenya [Gilks et 
al., 1990a]. In this study, consecutive adult patients admitted to the medical service in the
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Kenyatta National Hospital were recruited over six months. Following informed consent 
from study patients, a full medical history, and a physical examination, blood was drawn for 
culture and HIV-1 testing. The patients were followed up while they remained in hospital. 
Blood was cultured specifically for bacteria but not for mycobacteria or fungi. Of 506 
patients recruited over the study period, 95 (19%) were positive for HIV-1 antibody and the 
overall bacteraemia rate was 10.1%. The prevalence rate of bacteraemia was 26% among 
HIV-1-positive patients versus 6% among those patients without HIV-1 infection. 
Streptococcus pneumoniae and Salmonella typhimurium were the leading causes of 
bloodstream infections in the study population, accounting for 68% of the bloodstream 
pathogens. Moreover, S. pneumoniae and S. typhimurium were responsible for 25% of all 
the HIV-1-related medical admissions. Ciyptococcus neoformans was isolated from only 
one blood culture. The Nairobi study also demonstrated that the mortality rate among HIV- 
1 -infected patients, who had culture proven bacteraemia, was significantly higher than the 
rate for study-patients who were not HIV-1-infected (58% vs. 32%) [Gilks et al., 1990a].
Although the Nairobi bacteraemia study yielded important results, there were a few 
limitations [Gilks et al., 1990a]. First, although 19.2% of the study-population had received 
antimicrobials in the previous 24 hours before blood was drawn for culture, the investigators 
speculated but did not conclusively demonstrate any effect of this factor on the bloodstream 
infection rate. Second, because the study protocol did not utilize a strict case-defmition for 
the selection of study-patients, blood cultures almost certainly were obtained for patients 
who did not require this investigation in the first place; this probably led to an 
underestimation of die true bloodstream infection rate.. Third, the investigators did not 
specifically seek to delineate the frequency of mycobacterial or fungal bloodstream
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infections in their study population. And fourth, although that study spanned the 1988 dry 
season and the 1989 wet season, the design of the study did not enable the investigators to 
demonstrate seasonal variation in the incidence and prevalence of community-acquired 
bloodstream infections.
During 1987-1992, the prevalence of bacteraemia in febrile patients aged >8 years was 
studied in hospitals in Ghana and Kenya. The findings, published in 1995, confirmed the 
predominance of Salmonella, Klebsiella, and Enterobacter species among bloodstream 
pathogens [Petit et al., 1995]. However, there were major flaws in the study design. First, 
although the authors indicated that the study population consisted of paediatric and adult 
patients, the authors neither indicated the age breakdown of the study populations, nor 
stratified their main findings by age. In fact, from the design of the study, it was obvious that 
the authors had concluded, a priori, that the epidemiology and clinical characteristics of 
bacteraemias would be similar in paediatric and adult patients—an incorrect presumption. 
Secondly, the authors made another presumption that the epidemiology of bacteraemias 
would be similar in two different African countries—this is not necessarily so. Thirdly, the 
authors included post-operative patients in their study patient population during the conduct 
of the study; the relevance of doing this was not clear in their published paper and rendered a 
selection bias that was not acknowledged in the discussion (e.g., postoperatively, patients 
may develop fever associated with the actual surgical procedure, anaesthetics, surgical site 
infection, respiratory tract infection, or basal atelectasis). And fourthly, the researchers 
cultured blood only for bacteria and not for mycobacteria despite the existing evidence that 
the latter pathogen was associated with significant morbidity and mortality in HIV-infected 
patients in Africa [Lucas et al., 1993].
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In 1989, investigators in Rwanda sought to investigate and compare the occurrence of 
bacteraemia, fungaemia, and parasitaemia in newly hospitalized patients using fever (oral 
temperature >38°Celsius) as the case definition for patient recruitment [Taelman et al.,
1990]. O f 271 patients who met the fever case definition, 163 (60%) were positive for HTV- 
1 antibody. The Rwanda investigators reported a bloodstream infection rate of 55%. This 
rate, however, included the rate of bloodbome malaria parasites, which the investigators had 
classified as bloodstream pathogens (note: one could have both bacteraemia and parasitaemia 
at the same time). When the malaria parasitaemia rate was excluded from the analysis (this 
additional analysis had to be done by the reader and was not part of the published abstract), 
the true bacteraemia rate was estimated to be approximately 29%. The Rwanda authors 
concluded that Plasmodium species constituted the most common bloodbome pathogen in 
febrile African adults, regardless of their HIV-1 status. Notwithstanding this biased 
inference, the overall results of the Rwanda study confirmed the predominance of S. 
pneumoniae, non-typhi Salmonella species, and C. neoformans as commonly seen 
bloodstream pathogens in HIV-1-seropositive patients with fever. These data, presented at 
an international meeting as an abstract in 1990 [Taelman et al., 1990], were never published 
in the peer-reviewed medical literature.
During 1991, subsequent to the Rwanda study, investigators from the Centers for 
Disease Control and Prevention (CDC) in Atlanta conducted a study to determine the 
frequency of nonmalarial bloodbome pathogens and ascertain the predictors of septicaemia 
and death among adults admitted to the infectious disease ward of a large hospital in 
Abidjan, Cote d ’Ivoire [Vugia et al., 1993]. This study was comparable to the Nairobi study 
[Gilks et al., 1990a] in that all newly admitted patients, regardless of symptoms, were
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recruited, and clinical and demographic parameters (e.g., age, sex, medical history, 
symptoms, vital signs including oral temperature, and whether the patient was discharged or 
died) were identical. The laboratory methods for the Abidjan study included HIV-1 testing 
and blood cultures. The blood culture methods included the Septi-Chek™ (Roche 
Diagnostic Systems, Montclair, NJ) blood culture bottle for detection of bacteraemia, Trans- 
Isolate medium for Neisseria meningitidis, S. pneumoniae, and Haemophilus influenzae, and 
the BACTEC 13A (Johnston Laboratories, Towson, MD) for recovery of mycobacteria. Of 
the 319 study-patients that were enrolled, 201 (63%) were positive for HIV-1 antibody and 
85 (27%) had positive blood cultures. O f these 85 positive cultures, 31 (36%) were deemed 
bacterial contaminants. Thus, the true bloodstream infection rate was significantly lower 
than the published rate (54/319 [17%] vs. 85/319 [27%]; P <0.01). Gram-negative 
organisms were the predominant bloodstream pathogens with Salmonella species most 
numerous. Ten (3.1%) study patients had mycobacteraemia (eight M tuberculosis complex 
and two unidentified mycobacterial species): and eight (2.5%) had fungaemia, predominantly
C. neoformans. The latter finding was consistent with reports that fungal infections 
associated with AIDS in Central Africa were largely due to Ciyptococcus species [Desmet et 
al., 1989; Swinne et al., 1989]. Only four patients had S. pneumoniae bacteraemia although 
previous studies had shown that 5. pneumoniae is an important bloodstream pathogen in 
HIV-1-infected patients [Gilks et a l- 1990a: bimberkoff et al., 1984; Witt et al., 1987]. The 
paucity of S. pneumoniae in Cote d'Ivoire might have been a reflection of geographic or 
seasonal variation (that study was conducted during a 4-week period during the height of the 
Cote d ’Ivoire wet season). O f note, neither N. meningitidis nor H  influenzae were isolated 
from Cote d’Ivoire patients. In addition, HIV-infected patients were significantly more
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likely to acquire bacteraemia, mycobacteraemia, or fungaemia. The most sensitive indicators 
of the presence of bloodstream pathogens in Cote dTvoire patients were an oral temperature 
>38°C or an absolute lymphocyte count <1000 cells/mm3.
Although studies of bloodstream infections in HTV-1-infected children in sub-Saharan 
Africa have demonstrated significant mortality in these patients, most of these studies have 
focused solely on isolating bacteria rather than other opportunistic pathogens, such as 
mycobacteria or fungi [Wolf et al., 1995; Nathoo et al., 1996; Walsh et al., 2000; Mulholland 
et al., 1999; Westwood et al., 2000; WHO Young Infants Study Group, 1999].
Gram-negative bloodstream pathogens are common and often predominate, representing 
74% of the organisms isolated in a Kenyan study [Musoke et al., 2000]. This predominance 
of Gram-negative pathogens was observed by Archibald et al. in a study of bloodstream 
infections in a bacille Calmette-Guerin-vaccinated paediatric population in Malawi, where 
non-typhi Salmonella spp. were the predomonant bloodstream pathogen while Gram-positive 
microorganisms, fungi, and mycobacteria were uncommon in HIV-infected children 
[Archibald et al., 2003a]. Gram-negative organisms can be highly invasive and thus are 
disproportionately important causes of morbidity and mortality [Mulholland et al., 1999; 
Musoke et al., 2000].
The organisms causing bloodstream infections in children vary and depend on the region 
in which the study is conducted, the study population selected, and the microbiological 
techniques used [Mabey et al., 1987; Walsh et al., 2000; Nathoo et al.. 1996; Berkowitz,
1984; Hui et al., 1997; Mulholland et al., 1999; Lehmann et al.. 1999: Gatchalian et al., 1999; 
Westwood et al., 2000; Stauffer & Fischer, 2004]. In sub-Saharan Africa, regional 
differences have also been documented for the frequency and importance of various
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microorganisms that cause bloodstream infections in paediatric populations [Walsh et al., 
2000; Westwood et al., 2000; Nathoo et al., 1996; O'Dempsey et al., 1994]. In addition, it is 
possible that the frequency of these microorganisms may be dependent on seasons as has 
been documented for paediatric patients in The Gambia [Mabey et al., 1987], southern 
Malawi [Graham et al., 2000] and in Kenya [Musoke et al., 2000]. Way back in 1987, 
Mabey et al. demonstrated the seasonal occurrence of Salmonella bacteraemia among 
paediatric patients in The Gambia. More recently, the results of a pilot study of two 
paediatric inpatient populations in Malawi during each of the 1998 wet and dry seasons 
indicated that Gram-negative pathogens are the predominant cause of bloodstream infection 
in both seasons and that Gram-positive organisms, such as Staphylococcus aureus and 
Streptococcus spp., are relatively uncommon in this patient population in central Malawi 
[Archibald et al., 2003b]. The possibility of geographic variation is underscored by the 
results o f a prospective review of all positive paediatric blood culture results from another 
Malawi hospital over a one-year period, which showed one-quarter of bacteremic episodes 
were caused by S. pneumoniae [Walsh et al., 2000].
With rising rates of HTV-1 infection and concomitant tuberculosis in human 
populations in developing countries, the probable occurrence of mycobacteraemia in 
susceptible paediatric populations also needs to be addressed. There are several reasons why 
only bacteraemia rather then mycobacteraemia or fungaemia has been sought or 
comprehensively studied in paediatric populations in sub-Saharan Africa. First, although 
early detection and treatment of bloodstream infection in children generally may improve 
patient outcomes, routine screening for bloodstream infections among children in 
less-developed countries might not be feasible because of the unavailability of the financial
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or trained personnel necessary to offer or maintain such services. Second, culturing blood 
simultaneously for bacteria, mycobacteria, and fungi, using conventional methods, often 
requires drawing >25 ml of blood from adult patients. Drawing such relatively large blood 
volumes might be impractical, inappropriate or unethical for blood culture research activities 
involving infants or children, especially those who are very sick, immunocompromised, 
malnourished, or severely anemic. Third, because of cultural reasons, parents may be 
reluctant for their children to part with the seemingly large volumes of blood that are 
necessary when culturing for these groups of pathogens. Fourth, due to the difficulty of 
drawing blood aseptically from paediatric populations, especially those with malnutrition or 
small, fragile veins, and low levels of circulating organisms in the bloodstream of children, 
sensitive methods are needed that can comprehensively detect fungaemia, bacteraemia and 
mycobacteraemia. In developing countries, hospital personnel, equipment, and finances are 
limited, often preventing routine performance of blood cultures [WHO Young Infants Study 
Group, 1999]. For all these reasons, these studies in Tanzania, Malawi, and Thailand did not 
seek to characterize the epidemiology of bacteraemia, mycobacteraemia and fungaemia in 
HIV-1-infected paediatric patients. To date, these three categories of bloodstream infections 
remain uncharacterized for paediatric patients in most most HIV-endemic region in Africa 
and southeast Asia.
In the United States and other developed countries- M. tuberculosis bloodstream 
infection had been recognised and reported both in HIV-l-seropositive [Barnes et al., 1987; 
Reimer 1984; Bouza et al., 1993: Shafer et al., 1991] and HIV-1-seronegative patients 
[Kiehn et al., 1985]. In fact, M. tuberculosis bloodstream infections had been reported in 
15-56 % of HIV-1-infected patients clinically suspected to have extra pulmonary
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tuberculosis [Barnes et al., 1987; Bouza et a l, 1993; Shafer et al., 1991; Kramer et al., 1990; 
Barber et al., 1990; Shafer et al., 1989]. In Brazil, researchers demonstrated that M. 
tuberculosis bloodstream infection is a frequent event in patients with AIDS and suspected 
disseminated mycobacterial disease [Grinsztejn et al., 1997]. Although the association 
between HIV-1 infection and tuberculosis had been well documented in Africa [Gilks et al., 
1990b; Nunn et al., 1990; Nunn et al., 1992; DeCock et al., 1992], few blood culture studies 
that included methodology for detection of mycobacteraemia (i.e., disseminated tuberculosis) 
had been performed there [Kiehn, et al., 1985]. By 1991, M. tuberculosis bloodstream 
infections among HIV-affected patients in Africa was still considered relatively novel 
enough to warrant being written up as a single case report [Kamamfu et al., 1991].
In Western Europe and North America, M. tuberculosis bloodstream infection are 
relatively less common than Mycobacterium avium complex bloodstream infection. Most 
major studies showed that the latter pathogen is more frequently observed in patients with 
advanced HIV-1 infection [Askgaard et al., 1992; Bames et al., 1988; Macher et al., 1983; 
Reimer 1994. In contrast, M. avium complex bloodstream infection appeared to be relatively 
uncommon in sub-Saharan Africa [Gilks et al., 1990b; Okello et al. 1990]. Researchers in 
sub-Saharan Africa, who attempted to culture blood specifically for mycobacteria, isolated 
M. tuberculosis in relatively small numbers only [Gilks et al., 1990b; Morrissey et al., 1992; 
Vugia et al., 1993]. The first published report of disseminated M. avium complex infection 
occurring in patients with advanced HIV-1 infection in sub-Saharan Africa was based on a 
study of patients with advanced HIV infection in Kenya [Gilks et al.. 1995]: among 14 
patients with mycobacteraemia, three (21 %) were due to M. avium complex and 11 (79 %)
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to M. tuberculosis. Thus, M. avium complex, too, appeared to be uncommon [Gilks et al., 
1995] or absent [Morrissey et al., 1992] in HIV-1-infected individuals in these regions.
M. tuberculosis infection is an increasing worldwide public health threat. 
Approximately one-third of the world’s population is infected and M  tuberculosis is now 
responsible for as many as 3 million deaths annually [World Health Organization, 1998]. 
The burden of active tuberculosis is spread disproportionately among two key regions of the 
less-developed world: Southeast Asia and sub-Saharan Africa. Of approximately 40 million 
episodes of active tuberculosis that were estimated to have occurred worldwide in young 
adults between 1990 and the year 2000, over 28 million occurred in Southeast Asia with 
another 9 million estimated for sub-Saharan Africa [World Health Organization, 1998].
The HIV-1 pandemic has contributed to the increased spread and mortality from 
tuberculosis; HIV-1-infected patients are 30 times more likely to develop active tuberculosis 
and become infectious [World Health Organization, 1998]. Of approximately 20 million 
persons with HIV/AIDS estimated in the world in 1997, over 5 million were diagnosed in 
Southeast Asia and 14 million in sub-Saharan Africa [Fox, 1998]. In these regions, where 
both HIV and tuberculosis infections are prevalent, the hospital setting may play an 
important role in the spread of M. tuberculosis.
Preventing nosocomial transmission of M. tuberculosis requires the early clinical 
recognition of patients with active disease so that isolation precautions may be taken and 
therapy promptly initiated [Centers for Disease Control and Prevention, 1994]. However, 
recognition of tuberculosis may be difficult in HIV-1-infected patients; such patients 
frequently present with atypical signs and symptoms and are susceptible to a wide variety of 
other pulmonary infections that may mimic tuberculosis and obfuscate the diagnosis [Elliott
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et al., 1993; Gilks et al., 1990b; Kramer et al., 1990; Modilevsky et al., 1989; Shafer et al.,
1991]. Although simple diagnostic tests, such as chest radiographs [Barnes et al., 1988] and 
sputum smears [Modilevsky et al., 1989], may assist in the recognition of active disease in 
hospitalized patients, resources for performing such diagnostic tests are limited in many parts 
of the less-developed world.
Mycobacteraemia is a key event in the pathogenesis of tuberculosis and may frequently 
be detected in HIV-1-infected patients with active tuberculosis [Barnes & Arevalo, 1987; 
Barber et al., 1990; Bouza et al., 1993; Grinsztejn et al., 1997]. However, clinicians in these 
regions frequently do not suspect underlying mycobacteraemia (a surrogate marker for 
disseminated tuberculosis) and therefore may not request appropriate diagnostic tests. In 
addition, lack of or inappropriate use of clinical microbiology resources in hospitals in the 
less-developed world, or the absence of clinical algorithms for making the decision to obtain 
M. tuberculosis blood cultures from patients suspected to have disseminated tuberculosis can 
contribute to low detection rates of mycobacteraemia.
Therefore, by 1995, the epidemiologic, clinical, and microbiology features of 
bloodstream infections caused by bacteria and fungi still remained largely unstudied and 
uncharacterised in sub-Saharan Africa and Southeast Asia—areas of the world with 
relatively high rates of HIV infection. Moreover, the prevalence and clinical significance of 
mycobacteraemia (i.e., disseminated tuberculosis) in these regions was unknown. To 
address this lack of data on bloodstream infections in patients from these parts of the world, 
the blood culture study upon which this thesis is based wras designed and implemented. The 
importance of studying bloodstream infections and the role of blood cultures are highlighted 
and delineated in the following chapters of this thesis.
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CHAPTER 2
ROLE OF BLOOD CULTURES IN DETECTING BLOODSTREAM INFECTIONS
A bloodstream infection is defined as the detection of a clinically significant 
microorganism in the blood. Patients with bloodstream infection may be asymptomatic or 
symptomatic. Septicaemia is a serious systemic infection characterised by the presence of 
microorganisms or bacterial products in the bloodstream, together with clinical evidence of a 
systemic response to infection. Thus, for the clinician, a blood culture is one of the most 
important microbiological examinations that could be requested for a patient, and the 
discovery of living microorganisms in a patient's blood has great diagnostic and prognostic 
importance.
The main portal o f entry of bacteria into the bloodstream from extravascular sites is the 
lymphatic system. With intravascular infections bacteria enter the blood directly. This 
occurs, for example, with infective endocarditis (acute and subacute), suppurative 
thrombophlebitis, and infected intravenous or intra-arterial catheters (intravenous fluids, 
hyperalimentation, dialysis cannulae, and pressure monitors). There are multiple 
mechanisms for clearing bacteria from the blood; their efficiency depends in part on the 
microorganism. The liver and spleen play major roles in removal of microorganisms. 
Capsules and other virulence factors delay clearance, whereas specific antibody promotes 
removal. Ordinarily a sudden influx of bacteria is cleared from the blood over minutes to 
hours, except with overwhelming infections or an intravascular focus of infection. The level 
of microorganisms in an infection represents the balance between bacterial multiplication, 
invasion of the bloodstream, and the efficiency of the reticuloendothelial system in removing 
bacteria. The great prognostic importance of bacteraemia stems from its usefulness as index
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of failure of the host to localize the infectious process in the extravascular tissues or failure 
of the physician to remove, drain, or treat an infected focus.
There are three clinical patterns of bacteraemia: transient, intermittent, and continuous. 
Recognition of the settings in which different types of bacteraemia are likely to occur is 
helpful in planning a schedule for diagnostic studies and in interpreting results of blood 
cultures. Transient (minutes to hours) bacteraemia occurs following manipulation of 
infected tissues (e.g., abscesses, furuncles, and surgical procedures); instrumentation of 
contaminated mucosal surfaces (e.g., dental procedures, cystoscopy, and sigmoidoscopy); 
and the onset o f bacterial pneumonia, arthritis, osteomyelitis, and meningitis [Everett et al.,
1977]. Intermittent bacteraemia occurs most commonly with undrained, occult abscesses 
within the abdomen or elsewhere. Continuous bacteraemia is a cardinal feature of bacterial 
endocarditis, both acute and chronic, as well as suppurative thrombophlebitis and infected 
aneurysms. This pattern also occurs in the first few weeks of typhoid fever and brucellosis; 
however, compared with endocarditis, very few bacteria per ml of blood are found with these 
diseases.
There are no specific signs o f bloodstream infections or septicaemia, and signs that are 
present in early septicaemia may be either minimal and/or subtle an may be easily missed 
with a cursory examination or if the diagnosis of underlying bloodstream infection or 
septicaemia are not considered. Although the most common clinical features of a 
bloodstream infection include fever (body temperature >37.8°C [100°F] orally or >38.2°C 
[100.8°F] rectally). up to 20% of patients with positive blood cultures are afebrile, 
particularly the elderly, neonates, the immunosuppressed, and the debilitated. An early 
clinical sign o f septicaemia is relative hypotension which may be difficult to interpret if the
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patient’s baseline blood pressure is unknown. Notwithstanding these limitations, an elevated 
body temperature has been shown to be a significant predictor of bloodstream infections. A 
seminal study conducted at Duke University found that patients with a body temperature 
>40°C were significantly more likely to have positive blood cultures that were clinically 
significant {Bacillus species, coagulase-negative Staphylococcus species, diphtheroids, or 
Micrococcus species were invariably found to be contaminants) than patients whose 
temperatures were normal or only slightly elevated [Weinstein et al., 1997].
The number of organisms present in blood is often low (<1 organism /ml) and cannot 
be predicted in advance. Thus, low volumes of blood yield fewer positive cultures than 
cultures of larger volumes. As the volume of blood sampled increases from 2 to 20 ml, the 
diagnostic yield increases by 30 to 50%. Studies of sequential blood cultures from 
bacteraemic patients without endocarditis have yielded 80 to 90% positive results on the first 
culture, 90 to 95% with two cultures, and 99% in at least one of a series of three cultures 
[Weinstein et al., 1983]. Transient bacteraemia is usually not detected, because organisms 
are cleared before the appearance of any clinical findings suggesting sepsis. Intermittent 
bacteraemia presents the greatest challenge because fever spikes generally occur after, rather 
than during, the bacteraemia. Little is known about the periodicity of bloodstream invasion, 
except that the bacteraemia is more likely to be present and sustained in the early acute 
stages of infection. It is generally not useful to collect blood cultures while the patient is 
receiving antimicrobials.
Since the normal bacterial flora of the skin may be inadvertently inoculated into blood 
culture bottles, to avoid problems in interpretation of positive cultures the risk of 
contamination of blood cultures during collection must be reduced to a minimum, ideally
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less than 3% [Reller et al., 1982]. Published data suggest that blood culture contamination is 
minimized when the venipuncture site is cleansed with 70% alcohol followed by 1-2% 
tincture of iodine or povidone-iodine [Calfee & Farr, 2002]; other data suggest that skin 
disinfection with tincture of iodine is associated with lower blood culture contamination rates 
[Strand et al, 1993; Little et al., 1999]. For patients in Tanzania and Thailand, the 
venipuncture site was disinfected with 70% alcohol followed by povidone-iodine; for 
Malawi patients, skin disinfection was carried out with 70% alcohol followed by 1-2% 
tincture o f iodine. For maximum effectiveness, the disinfectant should be allowed to dry (1- 
2 minutes) before blood is aspirated. Each sample of blood (minimum of 10 ml from adults 
and 0.5-5 ml from infants and children) should be obtained by a separate venipuncture. Most 
often two blood cultures suffice [Weinstein et al., 1983]; more may be required for certain 
suspected diagnoses, such as bacterial endocarditis. Multiple bottles filled from a single 
venipuncture should be interpreted as a single blood culture.
Even with the most exacting techniques of collection and processing, contamination of 
blood cultures occurs occasionally. Bacterial growth in blood cultures first detected beyond 
72 hours o f incubation is more commonly associated with contamination than with true 
bacteraemia; however, prior exposure of the patient to antimicrobials may also delay 
recognition o f positive cultures. Recovery of Propionibacterium acnes, Corynebacterium 
species, Bacillus species, and Staphylococcus epidermidis nearly always means 
contamination, unless these bacteria are present in multiple positive blood cultures obtained 
by independent venipunctures [Weinstein et al., 1983; Weinstein et al., 1997].
Thus, no investigation is more important for accurate diagnosis and therapy of septic 
patients than blood cultures. Without an isolated microorganism therapy remains empirical
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and antimicrobial susceptibility testing is impossible. A pair of blood cultures, each with an 
adequate volume of blood, obtained from separate venipunctures should enable detection of 
most episodes of bacteraemias and fungaemias in clinical patients.
Primary infections, such as pneumonia, urinary tract infections, or gastrointestinal 
infections, often result in bloodstream infection and may cause fever. Thus, the management 
of febrile inpatients may be greatly assisted by the detection of bloodstream infections. On 
the other hand, although fever is one of the most common clinical features associated with 
bloodstream infections, it is related to a variety of diseases and infections and therefore does 
not have adequate specificity on its own for predicting the presence of an underlying 
bloodstream infection. Because of the limitations in the provision of microbiology services 
in less-developed settings, and the lack of specificity of fever, it may be useful to be able to 
predict the presence of bloodstream infections from the clinical features of the illness. 
Moreover, since blood is a normally sterile site, blood cultures, properly performed, have a 
high predictive value positive for bloodstream infections.
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CHAPTER 3 
MATERIAL AND METHODS
This project was designed to meet the challenge of comprehensively defining the role of 
emerging pathogens that cause bloodstream infections in febrile hospitalized patients in three 
countries with relatively high endemic rates of HIV infection—Tanzania, Malawi, and 
Thailand—through the conduct of cross-sectional studies with clinical, epidemiologic, and 
microbiologic components. The studies were conducted in sentinel hospitals in each of these 
countries. Sentinel hospitals tend to be large institutions (usually >500 beds) that are the 
main teaching centres for medicine, surgery, nursing, and laboratory science; they commonly 
house specialized intensive care units (ICU), surgery, haemodialysis, or units for invasive 
medical procedures; they have problems with hospital infections and antimicrobial-drug 
resistance; they are associated with microbiology laboratories that are often reference centres 
with the ability and capacity to conduct various microbiologic tests using scrupulous, 
quality-controlled methods; and they usually are government affiliated and have very close 
links with the respective ministry of health.
O b j e c t iv e s
The overall objectives of the study in each of the three countries were as follows :
(i) To determine the prevalence, aetiology, and clinical outcome of bloodstream infections 
caused by bacteria, mycobacteria, and fungi in febrile, hospitalized adult patients.
(ii) To determine the prevalence of HIV-1 infection in febrile, adults admitted to hospital.
(iii) To ascertain clinical predictors for bloodstream infection (e.g., enlarged lymph nodes, 
family history of cough) in this patient population.
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(iv) To determine risk factors for bloodstream infection (e.g., HIV-1 infection, Bacille 
Calmette Guerin [BCG], or nutritional status) in this patient population.
(v) To determine the effect of seasonal variation on the prevalence and aetiology of 
bloodstream infection.
(vi) To determine the frequency of occult mycobacteraemia and its influence on mortality. 
S t u d y  d e s ig n
At sentinel hospitals in Tanzania, Thailand, and Malawi, adult patients with fever were 
nonselectively recruited and enrolled in the study following informed consent. After 
documentation of clinical and epidemiologic data, study-patients underwent a comprehensive 
physical examination. Blood was then drawn from patients and cultured. These blood 
cultures were processed on site using previously pilot-tested, simple and cost-beneficial 
methods that could be continued at the study hospitals after the completion of the study. The 
requirements for microbiologic processing of blood cultures was a laboratory with an 
incubator, centrifuge, and a refrigerator. During the conduct of the study, local technicians 
and doctors were trained in microbiologic methods and it was expected that surveillance of 
bloodstream infections at the study sites would be continued through the initiative of the 
local investigators at each of the study hospitals. The project was conducted first in 
Tanzania (Appendix A), then Thailand (Appendix B), and finally in Malawi (Appendix C). 
The study was completed at each site before it was initiated at another site.
The study protocol was comprised of two integrated components:
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(i) Clinical/epidemiologic component: This component involved the study of all adult 
patients who presented to hospital with fever and were admitted to the inpatient medical 
service or were followed up in the outpatient clinic. All clinical, epidemiologic, and 
outcome data were recorded in a standardized assessment form specifically developed for 
this purpose (Appendix D).
(ii) Microbiology component: In this component, blood was drawn from study-patients and 
cultured for bacteria, mycobacteria, and fungi. Several blood culture systems were used with 
inbuilt redundancy for quality assurance. These systems included commercially prepared 
biphasic (broth/agar) systems for aerobic bacterial blood cultures and mycobacterial blood 
cultures, respectively. A lysis-centrifugation system was used in parallel for isolation of 
mycobacteria, yeasts, and fungi. In Malawi, an additional blood culture system that recovers 
mycobacteria, bacteria, and fungi from just five ml of blood was introduced. The relative 
utility of each blood culture system for detection of bacteraemia, mycobacteraemia, and 
fungaemia was assessed. The frequency of malaria parasitaemia was ascertained and 
documented, where appropriate. HTV-1 testing was performed on each study patient 
following pre-test counselling and patient consent. After the results of HIV-1 status became 
available, the results were made available to each patient with post-test counselling. This 
was carried out by the patient's physician or a full-time counsellor.
The integrated data were analysed to (i) establish prevalence rates of bloodstream infections, 
HIV infection, and malaria: (ii) determine associations between clinical and microbiologic 
variables and bloodstream infections; and (iii) evaluate the effect of acquiring a bloodstream 
infection on patient outcome (i.e., discharge from hospital or death).
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P a t ie n t  e n r o l l m e n t  a n d  c l in ic a l  d a t a  c o l l e c t io n
This was a cross-sectional study of adult patients with fever admitted to the medical wards of 
sentinel hospitals in three countries—Tanzania, Thailand, and Malawi. In Tanzania and 
Malawi, the minimum age of admission to the adult medical wards was 14 years; in 
Thailand, 15 years. Patients were enrolled in the study if they were febrile on admission or if 
they developed a fever within 12 hours o f admission. Fever was defined as an oral 
temperature >38.0° Celsius or an axillary temperature >37.5° Celsius. An individual was 
enrolled once and only one set (i.e., one peripheral blood draw) of blood cultures was drawn 
at the time of admission to the study. Blood cultures were not drawn each time a study- 
patient developed a fever.
S a m p l e  s iz e
The sample size was based on whether or not the true prevalence of bloodstream infections 
in a random sample of febrile patients is 25%. This rate was an estimate of the bacteraemia 
rates in Kenya, Rwanda, and Cote d’Ivoire (10%—24%) [Gilks et al., 1990a; Taelman et al., 
1990; Vugia et al., 1993]. However, because these rates did not reflect the frequency of 
mycobacteraemia or fungaemia, the true bloodstream infection rate was thought likely to be 
>25%. The population at each of the urban study sites was >1 million. If the true rate is 
0.25, then by accepting deviations of 0.25 ± 0.05, the calculated confidence interval of the 
prevalence rate is 0.30-0.20. To ensure that the true proportion of bloodstream infections in 
the population will have a 95% probability of falling between 0.20 and 0.30, the sample size
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was calculated as follows: sample size = 1.96 x 1.96 [0.25(1- 0.25)] / (0.05) (0.05) = 288. 
The percentile of the standard normal distribution for a 95% confidence interval =1.96.
Thus, at each study site, it was projected that approximately 300 febrile adult patients would 
have to be recruited and enrolled to correctly estimate the bloodstream infection prevalence 
rate.
E t h ic a l  c o n c e r n s  a n d  in f o r m e d  c o n s e n t
Participation was voluntary and all patients were informed that they were free to refuse 
participation or withdraw participation after enrollment in the study without consequence to 
their medical management or care. If a patient was unconscious or otherwise unable to 
communicate, the next of kin was asked to provide informed consent. The next of kin was 
informed that he/she was free to refuse to give consent for participation of the patient in the 
study without consequence to the quality of medical management or care. If a patient was 
unconscious and there was no next-of-kin, blood cultures were performed on the patient only 
if the clinician taking care of the patient at the study hospital made such a request on the 
grounds that the results might assist in the medical management of the patient; these 
unconscious patients with no next-of-kin, however, were not be entered into the study. The 
investigator saw every patient and explained the informed consent form (Appendix E) to 
each patient or guardian at the initial clinical assessment. The protocol for the studies was 
approved by the Institutional Review Boards (IRB) at CDC, Atlanta, Georgia, USA and by 
the Ministries of Health of Tanzania, Thailand, and Malawi.
C o n f id e n t ia l it y
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To protect the privacy of patients participating in the study, clinical information and results 
of bloods tests and blood cultures were kept in the medical records maintained in the hospital 
wards. Hard copies of data collection taken to the collaboration field site were kept in a 
locked room when not in use. Names were removed from all data collection forms. A 
hospital administrator kept the linkage code between the patient and laboratory results.
HIV-1 TESTING
Patients were advised that HIV-1 testing is voluntary and confidential. They were educated 
about the increased risk of serious tuberculosis disease in individuals who are co-infected 
with HIV-1 and M. tuberculosis. All patients were offered pre- and post-test counselling.
M e d ic a l  m a n a g e m e n t
All decisions regarding patients' medical management and follow-up were made by the 
physicians responsible for their care at the participating hospital. Clinicians were promptly 
advised by the investigator about positive blood cultures and the identities of organisms.
C o m p l ic a t io n s  o f  v e n ip u n c t u r e
All study-patients were advised that (i) venipuncture is a common diagnostic procedure 
which aids medical management; (ii) obtaining a blood culture by needlestick puncture and 
withdrawing blood is a routine medical procedure; (iii) possible complications may include 
bruising at the site of needle puncture and/or bleeding.
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CHAPTER 4 
DETAILED STUDY METHODS
The studies were conducted in Tanzania (1995), Thailand (1997), and Malawi (1997 dry 
season and 1998 wet season). The first study in Tanzania established the methodology for 
the subsequent Thailand and Malawi phases by demonstrating the feasibility and utility of 
the proposed microbiologic methods in a less-developed country, and enabling the data 
collection form to be field tested and refined. This resulted in a short, user-friendly, but 
comprehensive standardized questionnaire that addressed relevant epidemiologic and clinical 
variables for the respective study populations. The detailed methods used to conduct the 
studies in each of the countries follow:
D a r  e s  S a la a m , T a n z a n ia  
Patients, site, and study period
In Tanzania, the sentinel hospital selected for the study was Muhimbili Medical Centre 
(MMC), which has >3,000 beds, and is the largest hospital as well as the main medical 
referral centre in Tanzania. There are on average 25 admissions to the medical service per 
day; over 50% of these patients are febrile. For each 24-hour period from February 18 
through April 16, 1995 (study period), all febrile adults (>15 years) admitted to the adult 
Medical Unit in the Mwaisela Block at MMC were seen by the principal investigator. After 
informed consent, a detailed history was obtained and a physical examination performed. 
Before antimicrobial treatment was commenced, 25 ml of venous blood was drawn for 
culture, HIV-1 serology, and malaria parasitaemia testing, after skin cleaning with povidone- 
iodine and isopropyl alcohol. HIV-1 enzyme-linked immunosorbent assay (ELISA) tests
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were repeated on patients with one positive result and confirmed by Western blot at Duke 
University Medical Center. The ward was notified as soon as an organism was isolated from 
the blood and again when the organism was identified. Doctors and other ward staff were 
given advice on antimicrobial regimens when appropriate.
Laboratory
Blood cultures. After blood was drawn up into the syringe, the needle was discarded in a 
sharps collection box and replaced with a clean needle before inoculation into the blood 
culture bottles and lysis centrifugation tubes. Following cleansing of the bottle cap rubber 
diaphragm with 70% alcohol, 10 ml of venous blood were inoculated at the bedside into a 
Septi-Chek™ biphasic bacterial (SC-B) blood culture bottle (Becton Dickinson 
Microbiology Systems [BDMS], Cockeysville, MD) to which an agar slide paddle (BDMS) 
was attached in the laboratory. The The blood culture bottle was then momentarily inverted 
so that the contents covered the agar paddle. An additional 10 ml of blood was added to an 
ISOLATOR 10 (Isolator) tube (Wampole Laboratories, Cranbury, NJ ) for lysis and 
centrifugation within 8 hours of venesection. To further minimize the risk of contamination, 
the rubber stopper of the Isolator tube was cleaned with 70% alcohol before inoculation with 
blood, immediately after centrifugation, and also before the bung was accessed with the 
pipette for lysis-centrifugation concentrate withdrawal. A one-ml aliquot of the lysis- 
centrifugation concentrate was inoculated into a Septi-Chek™ AFB (SC-AFB) biphasic 
mycobacteria blood culture bottle (BDMS) containing Middlebrook 7H9 broth, to which 
acid-fast bacilli (AFB) culture supplement (BDMS) was added, and to which an AFB agar 
paddle (BDMS) was attached in the laboratory.
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The remainder of the lysis centrifugation concentrate was inoculated onto Middlebrook 
7H11, heated blood (chocolate), and Inhibitory Mold Agar (IMA) slants (BDMS). The 
bacterial and mycobacterial blood culture bottles and agar slants were incubated aerobically 
at 35°C. The SC-B blood culture bottles were examined twice for signs of growth in the first 
24 hours following incubation, then daily for the next seven days. Broth from bottles that 
remained clear after seven days were terminally subcultured onto sheep blood agar plates. 
Preliminary identification of organisms was made in Tanzania using standard microbiologic 
tests. If an enteric organism was suspected on initial microbiologic analysis, a standardized 
inoculum of the organism was incubated in the BBL®Crystal™ Enteric/Nonfermenter 
Identification System (BDMS) for identification according to recommended procedures. All 
bacterial and fungal isolates were suspended in trypticase soy broth with calf serum and 
frozen to -70°C. The SC-AFB blood culture bottles were inverted and rotated daily to cover 
the agar paddles during the first week, and then once weekly for 8 weeks or until growth was 
observed. Mycobacterial isolates were frozen to -70°C in freezing media (7H9 broth with 
10 % sucrose) and also stored on Middlebrook 7H11 agar slants. All frozen isolates were 
transported to the Clinical Microbiology Laboratory, Duke University Medical Centre, where 
the identities of all bacteria, mycobacteria, and fungi isolates were confirmed. M. 
tuberculosis complex and M. avium complex were identified using AccuPROBE (Gen-Probe, 
San Diego, CA) DNA probes and biochemical tests.
DNA fingerprinting ofM. tuberculosis isolates. M. tuberculosis isolates were characterized 
by Restriction Fragment Length Polymorphism (RFLP) assays, which are based on 
polymorphisms generated by variabilities in both the copy numbers and the chromosomal
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positions of DNA IS6110 elements in M. tuberculosis complex isolates. The assay used in 
these studies was a standardized methodology based on testing for repetitive DNA Y&6110 
elements in M. tuberculosis complex [van Embden et al., 1993]. The standardized technique 
encompasses the following: growth of M. tuberculosis, extraction of DNA, restriction 
endonuclease digestion, Southern blotting, and probing for the insertion sequence element 
[van Embden et al., 1993]. The standardized RFLP technique used to characterize the M. 
tuberculosis strains isolated in Tanzania, Malawi and Thailand were identical to that 
described and published by van Embden et al. [van Embden et al., 1993].
Malaria. Blood films were prepared for a control group of 150 afebrile trauma patients in the 
main MMC orthopaedic ward; these control-patients had been admitted for trauma, did not 
have clinical manifestations of sepsis, and were matched for age and sex with randomly 
selected patients from the febrile study group. For each study patient, one thick and two thin 
blood smears were stained with Fields stain and examined quantitatively for malaria parasites.
HIV-1 serology. Serum samples were labelled with a randomly generated code number 
together with the age and sex of the patient. Sera were assayed in batches by ELISA 
(Vironostika® HIV-1 Microelisa System, Organon Teknika Corporation, Durham, NC ) for 
HIV-1 antibody. Each positive test was repeated using the same type of ELISA test kit and 
then confirmed by Western blot analysis at Duke University Medical Center. The code was 
then broken and the ELISA and Western blot results correlated with patients' study records.
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Antimicrobial susceptibility testing. Antimicrobial susceptibility tests and interpretations 
were performed at Duke University Medical Centre, according to the recommendations and 
guidelines proposed by the National Committee for Clinical Laboratory Standards (NCCLS) 
[National Committee for Clinical Laboratory Procedures, 1997a & 1997b]. The antimicrobial 
panel chosen for testing included affordable drugs readily available to patients hospitalized at 
MMC. Susceptibilities of gram-negative organisms to the selected antimicrobials were tested 
using the Microscan® Walkaway (Baxter Diagnostics Inc. Deerfield, IL). Other 
susceptibilities were tested using disk diffusion procedures (Kirby-Bauer test). The E-test® 
(AB BIODISK, Culver City, CA) was used to test the susceptibility of S. pneumoniae to 
penicillin. Susceptibility testing of M. tuberculosis isolates was performed using the 
BACTEC radiometric method (Becton Dickinson Diagnostics Instrument Systems, Sparks, 
MD).
B a n g k o k ,  T h a i l a n d  
Patients, site, and study period
The study protocol was identical as for Tanzania and was conducted at Bamrasnaradura 
Hospital, a 500-bed hospital located in the northern part of Bangkok, Thailand. This hospital 
is one of the largest infectious diseases hospitals in the region and is a major referral centre 
for HIV-infected patients. Typically, during November through April, there are 
approximately 10 admissions to the adult medical service per day and more than half of these 
patients tend to have fever. The hospital microbiology facilities included an automated blood 
culture system that was adequate for bacterial cultures but did not accommodate 
mycobacterial blood cultures, and was insensitive for the detection of fungaemia.
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For each 24-hour period from February 11 through April 12, 1997 (study period), all 
adult (>15 years) patients who met the fever case definition on admission to the medical 
service at Bamrasnaradura Hospital were seen and evaluated by the principal investigator. 
Following informed consent, a detailed history was obtained through a translator, after which 
a comprehensive physical examination was performed. Data obtained included age, sex, 
medical history of acute and chronic symptoms, antimicrobial therapy before hospital 
admission, clinical findings, hospital course, and outcome (e.g., discharged or died). Fever 
and diarrhoea were deemed chronic if present >1 month; chronic weight loss was defined as 
weight loss >10% of usual body weight. Data were entered on standardized forms.
Additional diagnostic tests, such as chest radiographs, sputum smears for AFB, and complete 
blood counts were requested when deemed appropriate by the attending physician.
Laboratory
The blood culture methods, malaria smear preparation, and all isolation, processing, 
identification, and confirmatory methods used in Thailand were identical to those used in 
Tanzania. Aliquots (1 ml) of the Isolator concentrate were inoculated into the SC-AFB blood 
culture bottles and onto solid media. The identities of uncommon Mycobacterium species 
(e.g., Mycobacterium simiae and mycobacteria strains of the SAV Group*) were confirmed 
using high performance liquid chromatography (HPLC).
* Mycobacterium organisms that resemble M. avium complex by conventional biochemical tests 
but have high-performance liquid chromatography profiles that are more consistent with M. 
simiae.
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HIV-1 serology. Serum samples were assayed in batches using two ELISA kits: (1)
Enzygnost anti-HIV V2 Plus (Behring AG, Marburg, Germany) and (2) ACCESS HIV lA 
(Sanofi Diagnostics Pasteur S.A., Mames-LA Coquette, France). HIV ELISA tests were 
repeated if the first test was positive.
L il o n g w e , M a l a w i  (d r y  a n d  w e t  s e a s o n s )
Patients, site, and study period
Lilongwe Central Hospital (LCH) is the largest government regional medical centre in central 
Malawi. It has approximately 500 beds and provides services to a patient catchment area of 
230,000 citizens, regardless of their ability to pay. During the dry season, there are 
approximately 4-8 admissions to the medical service per day and about 50% of these patients 
have febrile illnesses. Fevers in adult LCH patients are most often attributed to malaria, 
tuberculosis, diarrhoea, sepsis, or HIV-1 infection. LCH clinicians estimate that 30%-40% of 
febrile, adult patients receive antimicrobials or antimalarials before admission to hospital. At 
LCH, <1 % of newly admitted adult patients with fever have blood cultures performed. All 
patients who present to LCH are triaged in the medical outpatient department where the 
decision is made either to admit or follow-up the patient in the outpatient department.
Patients diagnosed with M. tuberculosis disease are referred to a separate sanatorium 
affiliated with LCH for appropriate treatment and follow-up.
The microbiology facilities at LCH were limited to only Gram stains routinely 
performed on specimens submitted to the hospital laboratory and the preparation and 
examination of blood smears for malaria. Thus, many of the above clinical diagnoses (e.g., 
tuberculosis, diarrhoea, sepsis) were never confirmed by laboratory testing. Cultures of
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cerebrospinal fluid and occasional blood cultures for selected patients are performed at the 
Community Health Sciences Unit laboratory (run and administered by the Malawi Ministry of 
Health), located approximately one mile from the hospital.
For each 24-hour period from August 20 through September 16, 1997 (study period and 
height of the dry season in Malawi), all patients who met the fever case definition on 
presentation or admission to LCH were evaluated. Recruitment methods, informed consent, 
data collection, and laboratory studies were similar to Tanzania and Thailand. Additional data 
collected included whether patients were admitted to the wards or managed as outpatients, 
and whether patients admitted to hospital for therapy survived. Fever and diarrhoea were 
deemed chronic if present >1 month; cachexia was defined as weight loss >10% of usual body 
weight. Additional diagnostic tests, such as chest radiographs, sputum smears for AFB, and 
blood counts were requested when deemed appropriate by clinicians.
To ascertain whether the prevalence of bloodstream infections varied by season, the 
study was repeated at LCH during March 22-May 6, 1998 (study period and height of the 
Malawi wet season). The clinical and epidemiologic components of this study were identical 
to those used during the dry season.
Laboratory
The laboratory protocol in Malawi was essentially similar to that used in Tanzania and 
Thailand except for two differences: (i) XA ml (instead of 1 ml) aliquots of the lysis- 
centrifugation concentrate were inoculated into broth and onto solid media, and (ii) a novel 
but simple microbiologic method for culturing blood comprehensively for bacteria, 
mycobacteria, and fungi was introduced in the protocol to be used in parallel with the
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previous microbiologic methods piloted and used in Tanzania and Thailand. This new blood 
culture method consisted of inoculation of 5 ml of blood into BACTEC™ MYCO/F LYTIC 
(MFL) blood culture bottles (BDMS).
To ascertain the utility of various blood culture methods that could be adapted for 
selected use at the Malawi study site after completion of the study, the blood culture methods 
used during the wet season varied slightly from those used during the dry season. During the 
Malawi dry season, one MFL blood culture bottle was used; during the wet season, 
inoculation of blood into the SC-B bottle was discontinued and replaced by inoculation of five 
ml of blood into each of a pair of MFL bottles.
The MFL bottles were read for evidence of growth using a hand-held ultraviolet (X =
365 nanometre) lamp to detect fluorescence of the indicator at the bottom of the bottle. All 
MFL bottles were examined for signs of growth twice in the first 24 hours following 
incubation, daily for the next 7 days, then once weekly for a total of 8 weeks.
Malaria smears. For both wet and dry seasons, thick smears were prepared from the blood of 
each patient enrolled in the study. Smears were stained using a modified Wright stain and 
examined for the presence of any malaria parasites under the microscope. Malaria smear 
results were correlated with results obtained using the Parasight F (BDMS) on a subset of 
enrolled patients to confirm results from microscopy. In addition, smears were prepared from 
the blood of a randomly selected control group of adult patients who were attending the 
outpatient department for minor trauma, did not have fever, and were deemed unlikely to have 
an underlying infection.
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HIV-1 serology. Serum samples were assayed in batches using the SUDS HIV 1&2 enzyme- 
linked immunosorbent assay (ELISA) test kits (Murex Diagnostics Inc., Norcross, GA). 
Positive HIV ELISA results were repeated on site using same type of ELISA kit. Serum 
samples underwent confirmatory ELISA assays at Duke University Medical Center using 
another ELISA test kit (Vironostika® HIV-1 Microelisa System, Organon Teknika 
Corporation, Durham, NC ) for HIV-1 antibody. All serum samples underwent further 
confirmatory Western blot testing at the Centers for Disease Control and Prevention.
Antimicrobial susceptibility testing. The susceptibility testing methods were similar to those 
used for the organisms isolated in Tanzania and Thailand, and were performed by the same 
personnel at Duke University Medical Centre.
Seasons and rainfall. In Malawi, the wet season is the period between December and April; 
the dry season runs from May through November. Records with details of the daily levels of 
rainfall in Lilongwe during 1997 and 1998 were obtained from a local agricultural company. 
These rainfall data were obtained from daily on-site measurements taken at a fixed location 
within 5 kilometres of LCH.
S t a t is t ic a l  a n a l y s e s
All clinical and epidemiology data and results from blood cultures, malaria smears, and HIV- 
1 serology were recorded in standardized forms. These data were then entered into a 
computer database and analysed using Epi Info computer software (Version 6.02) [Dean et 
al., 1996]. The Chi Square test with Mantel Haenszel and Yates's correction and Fisher's
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exact test, where appropriate, were used to compare categorical variables. Continuous 
variables were compared using the Wilcoxon two-sample test. Relative risks (RR), odds 
ratios (OR), and 95% confidence intervals were calculated. The calculation of the population 
sample size for the Tanzania study was based on the documented prevalence rate of 
bloodstream infections in Kenya [Gilks et al., 1990a], and Cote d’Ivoire [Vugia et al., 1993]. 
The sample size for Thailand and Malawi were calculated using the rates ascertained in the 
Tanzania study. Multivariate analysis and logistic regression were performed using the PC 
SAS statistical software [SAS Institute Inc., Cary NC]. The McNemar modification of the 
Chi Square test and, where appropriate, Yates’s correction for small numbers of observations 
was used to compare the various blood culture systems utilized for detection of bacteraemia, 
mycobacteraemia, and fungaemia.
B l o o d  c u l t u r e  c o n t a m in a n t s
During the conduct of the studies, each blood culture that was positive for bacteria or fungi 
was evaluated by the principal investigator. Isolates such as Bacillus species, coagulase- 
negative Staphylococcus species, diphtheroids, or Micrococcus species were deemed 
contaminants based on published data [Weinstein et al., 1983].
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CHAPTER 5 
RESULTS
D a r  e s  S a l a a m , T a n z a n ia
Over the study period (60 days), 1,425 patients >15 years were consecutively admitted to the 
MMC medical service. Of these, 517 (36%) met the study criteria and were enrolled into the 
study. No patient refused enrollment into the study. There were 280 (54%) males. The 
median age of the study population was 38 (range 15-95) years. Over the study period, 15 
patients died within the first 6 hours of admission before the investigator was notified or 
blood could be drawn. One hundred and forty-five (28%) patients had a bloodstream 
infection. One hundred and fifty-five clinically important organisms were isolated (Table 1). 
Of the 517 study patients, 282 (55%) were HIV-1 seropositive and of the 145 patients with 
bloodstream infection, 118 (81%) were HTV-1 seropositive. HIV-1-positive patients were 
significantly more likely than HIV-1-negative patients to have a bloodstream infection (RR = 
3.6; 95% Cl = 2.5-5.3; P <0.0001). Ten patients had polymicrobial (i.e., >1 pathogen) 
bloodstream infections; 8 (80%) of these 10 patients were HTV-1- infected.
Sixty-one (42%) of the 145 patients with bloodstream infection had mycobacteraemia. 
The median time to isolation of mycobacterial species using the lysis-centrifugation system 
followed by inoculation into biphasic media wras 25 days. Biochemical and gene probing 
techniques identified one of the mycobacterial isolates as M. avium complex; the remaining 
60 (98%) were M. tuberculosis complex. RFLP analysis of M. tuberculosis complex isolates 
demonstrated 45 different fingerprint designations among the 60 isolates. Fifty-nine (97%) of 
the 61 patients with mycobacteraemia were HIV-1-seropositive (the M. avium complex isolate 
was also from an HIV-1-infected patient).
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M. tuberculosis complex was the most frequently isolated pathogen (43%) followed by 
non-typhi Salmonella species (20%); Table 2 shows the six most frequently isolated 
organisms. These six organisms alone or in combination accounted for 135 (87%) of the 155 
pathogens isolated. Of the 29 non-typhi Salmonella species isolates, 14 were Salmonella 
enteritidis, ten were Salmonella typhimurium, and five belonged to other Salmonella sero- 
groups. There were four Shigella species isolates: three Shigella flexneri and one S. 
dysenteriae. The three S. flexneri infections occurred in HIV-positive patients; the patient 
with S. dysenteriae was HIV-negative.
The isolation rate for non -typhi Salmonella species was significantly higher in the HIV- 
1-seropositive patients than in the seronegative patients (P <0.01) (Table 1). S. typhi was 
isolated once, from one patient who was HIV-1 negative. There was no difference in the 
prevalence of S. pneumoniae bloodstream infection among HIV-1-positive and HIV-1- 
negative patients. However, the infections due to other Streptococcus species (two group G 
and one group A) all occurred in HIV-1-positive patients. All 10 C. neoformans isolates were 
from HIV-1-positive patients.
Chapter 5: Page 47
Table 1. Bloodstream pathogens in 
Dar es Salaam, Tanzania.
HIV-l-positive and -negative patients,
Pathogen HIV status Relative Risk P-value
Positive
(n=282)
Negative
(n=235)
/o V.1 )
Enter obacteriaceae
Citrobacter freundii 0 1 t
Escherichia coli 7 5 1.2 (0.4-3.6) NS §
non-typhi Salmonella 23 6 3.2 (1.3-7.7) <0.00001
Salmonella typhi 0 1 t
Shigella dysenteriae 0 1 t
Shigella flexneri 3 0 t
Other Gram-negative bacilli
Acinetobacter Iwoffi 1 0 t
Alcaligenes xylosoxidans 1 0 t
Burkholderia cepacia 1 0 t
Pseudomonas aeruginosa 0 0 f
Serratia plymuthica 0 1 t
Stenotrophomonas maltophilia 1 0 t
Gram-positive organisms
Enterococcus casseliflavus 0 1 f
Staphylococcus aureus 5 8 0.5 (0.2-1.6) NS
Streptococcus pneumoniae 6 5 1.0 (0.3-3.2) NS
Streptococcus Group A 1 0 t
Streptococcus Group G 2 0 t
Yeasts
Candida lusitaniae 0 1 t
Cryptococcus neoformans 10 0 Undefined 0.002
Histoplasma capsulatum 1 0 f
Mycobacteria
Mycobacterium tuberculosis 57 J 15.8(5.0-50.0) <0.00001
Mycobacterium avium complex 0 1 f
<0.00001Total number of patients with 118 27 3.6 (2.5-5.3)
blood pathouenst
* Cl: confidence interval 
t  Numbers too small to calculate a test statistic 
§ NS: not significant
$ Ten patients had two organisms isolated from their blood: one with Shigella flexneri and M.
tuberculosis, two with Salmonella sp. and M. tuberculosis. one with Salmonella typhimurium and 
S. aureus, one with Burkholderia cepacia and Salmonella sp., two with Salmonella sp. and S. 
pneumoniae, one with Citrobacter freundii and Serratia plymuthica, one with Salmonella sp. and 
C. neoformans, and one with group A Streptococcus sp. and E. coli.
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Table 2. The organisms most frequently isolated from 145 positive blood cultures.
Organism Number (% of all positive blood cultures)
Mycobacterium tuberculosis 60 (43)
Non-typhi Salmonella species 29 (20)
Staphylococcus aureus 13(9)
Escherichia coli 12 (8.4)
Streptococcus pneumoniae 11 (7.7)
Cryptococcus neoformans 10(6.5)
Note: These six organisms alone or in combination accounted for 135 (87%) of all pathogens 
isolated.
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Seven (1.3%) of the 517 blood cultures yielded organisms that were considered 
contaminants (three Staphylococcus epidermidis, two diphtheroids, one Micrococcus sp., one 
Bacillus cereus). There was no significant difference between the contamination rates of the 
blood cultures taken from the HIV-1-seropositive (1.8%) and -seronegative (0.9 %) patients. 
Moreover, there was no significant difference between the contamination rates of blood 
cultures that yielded significant growth and those that were truly negative.
Forty-nine (9.5%) of 517 study patients had malaria parasitaemia; there was no 
significant difference when compared to the parasitaemia rate (8%) in the afebrile control 
group. Five (10.2%) of these 49 patients with parasitaemia also had bloodstream infections 
caused by non-typhi Salmonellae spp. Twenty (41%) of the 49 patients with malaria 
parasitaemia were HIV-1 positive, suggesting that febrile HIV-1-negative patients were more 
likely than HIV-1-positive patients to have a positive malaria blood film on admission (P 
<0.05).
Antimicrobial susceptibility tests suggested that chloramphenicol was the most effective 
of the available antimicrobials against S. aureus and S. pneumoniae. Four (40%) of 11 S. 
pneumoniae isolates were resistant to penicillin (i.e., minimum inhibitory concentrations >2 
pg/mL) [National Committee for Clinical Laboratory Procedures, 1997a]. Against 
Salmonella species, chloramphenicol was also the most effective antimicrobial. Fifty-seven 
(95%) of 60 M. tuberculosis isolates were susceptible to ethambutol, isoniazid, rifampicin, 
and streptomycin; two (3.3 %) were resistant to isoniazid and streptomycin and one (1.7%) 
was resistant to isoniazid only.
The median age of the 60 patients with M. tuberculosis bloodstream infection was 35 
(range 15-65) years. At presentation, 37 (62%) of these patients gave a history of one or more
Chapter 5: Page 50
family members with chronic cough, shortness of breath, haemoptysis, chronic symptoms 
(i.e., cough, diarrhoea, or weight loss > 1 month), or had clinical signs of pleural effusion, or 
pulmonary consolidation on physical examination. Only 10 (17%) individuals with 
mycobacteraemia had sputum smears examined for AFB; the results of these sputum smears 
were not available. Moreover, the prevalence of chronic symptoms, pleural effusion, 
consolidation, and lymphadenopathy were similar in patients with and without M. 
tuberculosis bloodstream infection. There were no symptoms or signs that were predictive of 
the presence of mycobacteraemia. Twenty-three (38%) of sixty patients with M. tuberculosis 
bloodstream infection had no respiratory symptoms or physical signs suggestive of underlying 
pulmonary pathology. Chest radiographs were not available for the majority of these patients. 
Twenty-seven (45%) of the 60 patients with M. tuberculosis bloodstream infection died 
before discharge from hospital.
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B a n g k o k , T h a il a n d
During the study period, 246 patients met the study entry criteria. One hundred and seventy- 
one (69.5%) were male. The median age of the study population was 32 (range: 15-87) years. 
One hundred and nineteen (48%) patients had bloodstream infection; 19 (16%) of these had 
polymicrobial (>1 pathogen) bloodstream infection. One hundred and thirty-three clinically 
important organisms were isolated from patients (Table 3). Of the 246 study patients, 182 
(74%) were HIV-1-seropositive; of the 119 patients with bloodstream infection, 114 (96%) 
were HIV-1-seropositive.
The most frequently isolated bloodstream pathogens were C. neoformans (n=30), M. 
tuberculosis (n=27), M. avium complex (n=24), non-typhi Salmonella (n=16), S. aureus 
(n=7), Histoplasma capsulatum (n=4), Penicillium marneffei (n=4), Candida species (n=2), 
M. scrofulaceum (n=2), M. simiae (n=2), and SAV group mycobacteria (n=2). Two blood 
cultures grew coagulase-negative staphylococcus yielding an overall blood culture 
contamination rate of 0.8%. RFLP analysis of M. tuberculosis isolates demonstrated 25 
different electrophoretic band patterns among the 27 M. tuberculosis isolates.
HIV-1-positive patients were significantly more likely than HIV-1-negative patients to 
have bloodstream infection (RR: 8; 95% confidence interval: 3.4 -18.7; P <0.00001). The 
frequency of bacteraemia was greater among HIV-1-positive than HIV-1-negative patients 
(31/182 vs. 5/64, P = 0.07), although this difference did not reach statistical significance. 
Further, HIV-1-positive patients were more likely than HIV-1-negative patients to have 
mycobacteraemia (57/182 vs. 0/64; P <0.0001), fungaemia (38/182 vs. 2/64; P <0.001), or 
polymicrobial bloodstream infection (19/182 vs. 0/64; P = 0.002).
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Table 3. Distribution of pathogens causing bloodstream infections, Bamrasnaradura 
Hospital, Bangkok, Thailand, February-April, 1997.
Pathogen Patients 
HIV-positive HIV-negative 
(n = 182) (n = 64)
P-value
Enterobacteriaceae
Escherichia coli 1 2 NS*
Klebsiella pneumoniae 1 0 NS
non-typhi Salmonella spp. 16 0 <0.05
Other gram-negative bacilli
Acinetobacter johnsonii 1 0 NS
CDCf Group 03 0 1 NS
Pseudomonas aeruginosa 1 0 NS
Pseudomonas stutzeri 1 0 NS
Gram-positive organisms
Staphylococcus aureus 7 0 NS
Streptococcus pneumoniae 0 2 NS
Streptococcus Group A 1 0 NS
Nocardia sp. 1 0 NS
Rhodococcus equi 1 0 NS
Yeasts
Candida parapsilosis 1 0 NS
Cryptococcus laurentii 1 0 NS
Cryptococcus neoformans 30 0 <0.001
Histoplasma capsulatum 4 0 NS
Penicillium marnejfei 4 0 NS
Mycobacteria
Mycobacterium avium complex 24 0 <0.01
Mycobacterium scrofulaceum 2 0 NS
Mycobacterium simiae 2 0 NS
Mycobacterium sp. (SAV)§ 2 0 NS
Mycobacterium tuberculosis 27 0 <0.01
Total number of patients with blood 114 5 <0.000001
pathogens i
* NS: not significant
t  CDC: Centres for Disease Control and Prevention
§ SAY: Mycobacterium organisms that resemble M. avium complex by conventional 
biochemical tests but have high-performance liquid chromatography profiles that are 
more consistent with M. simiae.
J >one organism was isolated from blood of 19 patients
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When patients were stratified by age, those aged 20-38 years were more likely than other age 
groups to have a bloodstream infection (P <0.05), a likely reflection of higher incidence rates 
of HTV-1 infection in this age group. In addition, patients who received antimicrobial therapy 
before hospital admission were more likely to have a bacteraemia versus patients who had not 
received antimicrobials (P <0.05). However, receipt of antimicrobials before admission was 
not associated with the presence or absence of mycobacteraemia or fungaemia.
Inpatient mortality was significantly higher in patients with bloodstream infection than 
in those without bloodstream infection (37/108 vs. 19/124; P <0.001). On stratification by 
type of bloodstream infection, 43% of patients with bacteraemia, 40% of those with 
fungaemia, and 26% of those with mycobacteraemia died before hospital discharge.
Next, using logistic regression analysis, clinical predictors were ascertained for 
bacteraemia, mycobacteraemia, or fungaemia. Febrile, HIV-1-infected patients presenting 
with chronic diarrhoea, chills and rigors, an absolute lymphocyte count < 1,200/mm3, and a 
total white blood cell count > 13,000/mm3 or <4,000/mm3 had a 91% estimated probability of 
having a bloodstream infection caused by any pathogen. Febrile, HTV-1-infected patients 
presenting with lymphadenopathy and an abnormal white blood cell count >13,000/mm3 or 
<4,000/mm3 had a 50% estimated probability of having a bloodstream infection caused by 
Mycobacterium species. Any febrile patient with a history of chronic diarrhoea alone had a 
71% estimated probability of having bacteraemia. A febrile, HIV-1-infected patient with a 
history o f  chronic diarrhoea and findings o f  splenomegaly and oral candidiasis on physical 
examination had a an 81% estimated probability of having a polymicrobial bloodstream 
infection.
Of 46 patients with fever and chronic diarrhoea, 31 (67%) had bloodstream infection.
Chapter 5: Page 54
Of these 31 patients, 6 (19%) had bacteraemia only, 7 (23%) had fungaemia only, 10 (32 %) 
had mycobacteraemia only, and 8 (26%) had polymicrobial bloodstream infection. Similarly, 
of 125 patients with fever, lymphadenopathy, and HIV-1 infection, 76 (61%) had bloodstream 
infection. Of these 76 patients, 10 (13%) had bacteraemia, 15 (20%) had fungaemia, 37 
(49%) had mycobacteraemia, and 14 (18%) had polymicrobial bloodstream infection.
Several pathogens demonstrated significant antimicrobial resistance. All six S. 
typhimurium isolates were resistant to both ampicillin and trimethoprim/sulphamethoxazole 
(TMP/SMZ); three (50%) of the S. kunzendorf isolates were resistant to ampicillin but not to 
TMP/SMZ. All three S. enteritidis isolates were susceptible to both ampicillin and 
TMP/SMZ; all sixteen Salmonella species isolates were susceptible to ceftriaxone and 
ciprofloxacin. All seven S. aureus isolates were resistant to penicillin; two (29%) were 
resistant to erythromycin and one was methicillin-resistant but susceptible to vancomycin and 
clindamycin. Of the 27 M. tuberculosis isolates, seven (26 %) were resistant to isoniazid; 
eight (30%), to rifampicin; six (22%) to both isoniazid and rifampicin; six (22%) to 
streptomycin; and four (15%) to isoniazid, rifampicin, ethambutol, and streptomycin. No M. 
tuberculosis isolate was resistant to pyrazinamide.
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M a l a w i (d r y  s e a s o n )
During the study period, approximately 375 adult patients, who presented to LCH, were 
assessed in the LCH outpatient department; 233 (62%) met the case definition of fever and 
were admitted to the study. The median age of all patients in the study cohort was 31 (range: 
18-64) years; 128 (55%) patients were male. The median body temperature was 38.8°C 
(range: 37.5^-0.9°C). One hundred and thirty-two (57%) patients were admitted to LCH for 
further evaluation and therapy; 101 (43 %) patients were followed up and managed in the 
outpatient clinic. A clinical diagnosis of malaria was made in 114 (49%) patients at the initial 
evaluation. The clinical characteristics of all study-patients are summarized in Table 4.
Study patients managed as inpatients and outpatients were similar for median body 
temperature at presentation, and for rates of HIV-1 infection, bloodstream infection, and 
malaria parasitaemia. However, compared to study-patients who were followed up as 
outpatients, those who were admitted had a significantly higher median age (32 vs. 29 years;
P <0.01), pulse rate (110 vs. 100 beats per minute; P <0.001), or respiratory rate (32 vs. 26 
breaths per minute; P <0.001), a lower median systolic blood pressure (110 mm Hg vs. 120 
mm Hg.; P <0.001), and were more likely to be female (68/132 vs. 37/101; P <0.05), or to 
have altered mental status (25/132 vs. 2/101; P <0.01). Study-patients managed as outpatients 
were significantly more likely to be male, or to have acute symptoms of chills (63/101 vs. 
39/132; P <0.01) or cough (49/101 vs. 35/132; P <0.01).
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Table 4. Characteristics of study patients, Lilongwe Central Hospital, Malawi, 
August-September 1997.
Characteristics Positive blood cultures
Clinical feature 
present
Clinical 
feature absent
P-value
Previous antibacterial therapy 42/112 28/121 <0.05
Previous antituberculosis therapy 10/23 60/210 NS*
Acute symptoms (<1 week)
Chills 23/102 47/131 NS
Cough 21/84 49/149 NS
Diarrhoea 6/23 64/210 NS
Skin lesions 0/4 70/229 NS
Chronic symptoms (>1 month)
Fever 29/75 41/158 <0.05
Cough 23/60 47/173 0.07
Diarrhoea 3/12 67/221 NS
Skin lesions 4/8 66/225 NS
Cachexia 32/84 38/149 NS
Oral thrush 10/19 60/214 <0.05
Lymphadenopathy 7/25 63/208 NS
Hepatomegaly 4/13 66/220 NS
Splenomegaly 3/10 67/223 NS
Varicella zoster scar 11/19 59/214 <0.01
Bacille Calmette-Guerin scar 54/195 16/38 NS
Abnormal chest physical findings 30/102 40/131 NS
Abnormal central nervous system 
physical findings
15/27 55/206 <0.01
Positive serology for HIV-1 infection 62/173 8/60 0.001
*NS: not significant
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Seventy (30%) study-patients had bloodstream infection caused by bacteria, 
mycobacteria, or fungi and 173 (74%) were HIV-1-infected (Table 5). The rate of malaria 
parasitaemia among study-patients was not significantly different from the rate in the afebrile 
control-patient group (9/233 [4%] vs. 3/45 [7%], P = NS). Seventy-five pathogens were 
isolated from the 70 patients with documented bloodstream infection; three patients had 
polymicrobial bloodstream infection (Table 5). S. pneumoniae was the most common 
bloodstream pathogen, representing 34% of all isolated pathogens; M. tuberculosis was the 
second most common pathogen, representing 29% of all isolated pathogens (Table 6). In 
addition, there was one M. avium complex, one M. simiae, one M bovis, and two 
Mycobacterium species in the SAV group {Mycobacterium spp. that resemble M. avium 
complex by conventional biochemical tests but have HPLC profiles that are more consistent 
with M. simiae). C. neoformans was isolated from the bloodstream of only five patients.
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Table 5. Relationship between HIV-1 status and patients with bloodstream infection 
(BSI)
Pathogen HIV-1 Status Relative Risk 
(95% Cl*)
P-value
Positive Negative
(N = 173) (N = 60)
Any BSI 62 (36%) 8(13%) 2.7 (1.4-5.3) <0.01
Mycobacteria 24 (14%) 0 Undefined <0.01
Bacteria 33 (19%) 8 (13%) 1.4 (0.7-2.9) NS
Fungi 5 (3%) 0 Undefined NS
Polymicrobial BSIf 3 (2%) 0 Undefined NS
* Cl: 95% confidence interval
f  Two patients each had two organisms (S. pneumoniae and non-typhi salmonella spp.) and 
one patient had three organisms (S. pneumoniae, non-typhi Salmonella spp. and M 
tuberculosis) isolated from their bloodstream.
i
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Table 6. Distribution of bloodstream pathogens by patient HIV-1 status
Pathogen HIV status Relative Risk P-value
Positive Negative (Cl*)
(n = 173) (n = 60)
Streptococcus pneumoniae 21 (12%) 4 (7 %) 1.8 (0.7-5.1) NS f
Mycobacterium tuberculosis 20 (12 %) 0 Undefined <0.01
Salmonella spp.§ 12 (7 %) 1 (2 %) 4.2 (0.6-31.3) NS
Gram-negative bacilli J 4 (2 %) 2 (3 %) 0.7 (0.1-3.7) NS
Cryptococcus neoformans 5 (3 %) 0 Undefined NS
Gram-positive cocci ^ 3 (2 %) 0 Undefined NS
Mycobacterium simiae!SAV group 2 (1 %) 0 Undefined NS
Mycobacterium avium complex 1 (0.5 %) 0 Undefined NS
Mycobacterium bovis 1 (0.5 %) 0 Undefined NS
* Cl: 95% confidence interval 
f  NS: not significant
§ Includes eight S. typhimurium, three S. enteriditis, and two S. typhi 
J Includes three E. coli, two Klebsiella spp., and one Brucella spp. 
f  Includes one S. pyogenes, one S. sanguis, and one Rhodococcus equi
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Antimicrobial use before attending LCH was common among the 233 study-patients: 94 
(40%) reported taking antimalarials; 21 (9%) were already on antituberculosis therapy while 
111 (48%) patients reported taking some form of antibacterial therapy. Patients already 
receiving antibacterial therapy (but not anti-tuberculosis or antifungal therapy) were more 
likely than those without such a history to have a bloodstream infection caused by 
Mycobacterium species (20/114 vs. 4/119, RR: 5.4; 95% confidence interval: 1.8-14.0; P 
<0.001). The presence or absence of bacteraemia or fungaemia was not associated with any 
previous antimicrobial therapy.
On univariate analysis, patients with HIV-1 infection were significantly more likely than 
those without HIV-1 infection to have bloodstream infection caused by any pathogen or 
mycobacteraemia (Table 5). When the analyses were stratified by pathogen, M. tuberculosis 
bloodstream infection was more frequently seen in HIV-1-positive than in HIV-1-negative 
patients (P <0.01); this was not so for other bloodstream pathogens (Table 6).
There was no significant difference in the rate of mycobacteraemia in patients with BCG 
scars vs. the rate in those without (19/195 vs. 5/38; P = NS). Although patients with 
pulmonary consolidation on physical examination were about three times more likely than 
patients without consolidation to have S. pneumoniae bloodstream infection (RR: 2.8; 95% 
confidence interval: 1.2-8.0; P = 0.07), possibly because of the small numbers, this 
association was not statistically significant at the 0.05 level.
Logistic regression analysis highlighted several physical signs that were independently 
associated with bloodstream infection (Table 7). Rates of positive blood cultures were 100% 
(5/5) for those patients with all three independent risk factors (HIV-1 infection, altered mental 
status, and herpes zoster scar), 47% (15/32) for those with two of these risk factors, 32 %
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(43/138) for those with one risk factor, and 12% (7/58) for patients with none of the three risk 
factors. Moreover, having one or more of HIV-1 infection, altered mental status, or herpes 
zoster scar was 90% (63/70) sensitive but only 31% (51/163) specific in predicting 
bloodstream infections.
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Table 7. Independent clinical predictors of bloodstream infections (BSI) in febrile 
adults
Type of BSI Clinical predictor Odds Ratio (Cl*) P-value
Any BSI HIV infection 2.1 (1.4-7.2) <0 .01
Altered mental status 3.5 (1.5-8.2) <0.01
Herpes zoster scar 2.8(1.0-8.0) <0.05
Mycobacteraemiaf Pleural effusion 4.5(1.1-18.1) <0.05
Oral candidiasis 4.4(1.3-15.6) <0.05
Chronic fever 8.7(1.1-25.8) <0.001
Bacteraemia Pulmonary consolidation 2.7 (0.95-8.3) 0.06
Fungaemia Altered mental status 13.5 (2.1-85.0) <0.01
* Cl: 95% confidence interval.
t  Only HIV-1-positive patients had mycobacteraemia; there was no mycobacteraemia among HIV- 
1 -negative patients
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Mycobacteraemia rates were 59% (10/17) for those patients with three independent risk factors 
(pleural effusion, oral candidiasis, or chronic fever), 17% (10/58) for those with two risk 
factors, 4% (4/110) for patients with one risk factor, and 0% (0/48) for patients with no risk 
factors; all patients with mycobacteraemia were HIV-1-positive (Table 7). Having >1 of these 
mycobacteraemia risk factors was 100% (24/24) sensitive and 25% (52/209) specific in 
predicting mycobacteraemia.
Bacteraemia rates were 33% (5/15) for patients with pulmonary consolidation and 17% 
(37/218) for those without. Rates of fungaemia were 11% (3/27) for patients with altered 
mental status and 1% (2/206) for those without this clinical feature.
Outcome data (death or discharge from hospital) were available for 131 (99%) of the 
132 study patients that were admitted to the medical service for therapy. Of these 131 
patients, 27 (21%) died during hospitalization. Patients with HIV-1 infection were as likely to 
die during hospitalization as patients without HIV-1 infection (24/102 vs. 3/29, RR: 2.3; 95% 
confidence interval: 0.7-7.0; P = NS). On multivariate analysis, predictors of inpatient 
mortality included presence of any bloodstream infection (OR: 3.5; 95 % confidence interval: 
1.4-10.0; P = 0.01) or altered mental status (OR: 6.6; 95 % confidence interval: 2.4-18.7; P 
< 0 .001).
Radiographs and sputum smears were obtained from a significant number of patients. Of 
21 patients with M. tuberculosis bloodstream infection, 15 (71%) were inpatients. Eleven 
(73%) of the 15 hospitalized patients with M. tuberculosis bloodstream infection had no test 
result (i.e., chest radiograph or sputum smear) or previous therapy to suggest active 
tuberculosis at the time of admission. Chest radiographs performed for five patients with M.
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tuberculosis bloodstream infection were abnormal; sputum smears prepared for three of these 
five patients were negative for AFB.
Of the 25 S. pneumoniae isolates, 8 (32%) had intermediate resistance to penicillin 
(minimum inhibitory concentration: 0.1-2.0 mg/ml); all blood isolates were fully susceptible to 
third-generation cephalosporins and chloramphenicol. Although the frequency of penicillin 
resistance among S. pneumoniae isolated from study-patients who reported exposure to 
antimicrobial agents before admission to the hospital was similar to that in patients who 
reported no exposure (3/11 vs. 5/14; P = NS), the small numbers of penicillin-resistant S. 
pneumoniae isolates do not have sufficient power to enable any specific conclusions regarding 
the relationship between exposure to antimicrobial agents and the prevalence of penicillin- 
resistant S. pneumoniae. All M. tuberculosis isolates were susceptible to isoniazid and 
rifampicin; one isolate was streptomycin-resistant and one was pyrazinamide-resistant. All 
eight S. typhimurium isolates were resistant to gentamicin and TMP/SMX but susceptible to 
chloramphenicol, the principal antimicrobials available for treating gram-negative infections in 
LCH.
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M a l a w i  R e s u l t s  (W e t  s e a s o n )
During the wet season study period, 238 consecutive, febrile adults were enrolled in the study. 
The median axillary temperature was 38.9°C (range 37.5-42°C). The median age of study- 
patients was 29 (range: 14-61) years; 137 (58%) patients were female. Comprehensive clinical 
characteristics were available for 229 study-patients and are presented in Table 8.
Sixty-seven (28%) study-patients had bloodstream infection; only one of these 
bloodstream infections was polymicrobial (i.e., >1 pathogen isolated). Non-typhi Salmonella 
species, M. tuberculosis, or C. neoformans were the three most common bloodstream 
pathogens, representing 41%, 19%, and 9% of all isolated pathogens, respectively. Only one 
S. pneumoniae was isolated. These results were different compared to those reported for the 
1997 dry season (Table 9).
Of the 238 study-patients, 173 (73%) were HIV-1-positive; of the 67 patients with 
bloodstream infection, 55 (82%) were HIV-1-positive. Malaria smears were prepared for 231 
study-patients and 73 afebrile, outpatient adult attendees. The rate of malaria parasitaemia was 
significantly higher in the study-patient group than in the afebrile group from the outpatients 
clinic (72/231 [31%] vs. 10/73 [14%], RR: 2.3; 95% confidence interval: 1.2 - 4.2; P <0.01). 
Malaria was the presumptive diagnosis made by clinicians in 114 (48%) study-patients. Of 
these 114 patients, 64 (56%) were presumptively treated for malaria despite having negative 
blood smears. Of these 64 patients, 22 (34%) had bloodstream infection; all but one (S. 
pneumoniae) of these bloodstream pathogens were gram-negative bacteria.
Patients with HIV-1 infection were significantly more likely than those without HIV-1 
infection to have M. tuberculosis bloodstream infection (Table 10); risk of bacteraemia or 
fungaemia were not associated with patient HIV-1 status. There was no significant association
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between the presence of BCG scars and M. tuberculosis bloodstream infection. Logistic 
regression analysis confirmed that oral candidiasis, chronic fever, and acute diarrhoea were 
independently associated with bloodstream infection (Table 11).
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Table 8. Clinical characteristics of study-patients (N=238), Lilongwe Central 
Hospital, Malawi, March-May, 1998
Characteristic Frequency 
n (%)
History of previous antibacterial therapy 78 (33)
History of previous antituberculosis therapy 21(9)
History of previous antimalarial therapy 96 (40)
Family history of cough 28(12)
Acute symptoms (<1 week)
Chills 78 (33)
Cough 117(49)
Shortness of breath 100 (42)
Diarrhoea 78 (33)
Skin lesions 10(4)
Chronic symptoms (>1 month)
Fever 90 (38)
Cough 69 (29)
Diarrhoea 16(7)
Skin lesions 8(3)
Cachexia 92 (39)
Physical findings
Oral thrush 43 (18)
Jaundice 6(3)
Lymphadenopathy 22 (9)
Hepatomegaly 15(6)
Splenomegaly 15(6)
BCG scar present 166 (70)
Abnormal chest physical findings 78 (33)
Abnormal central nervous system findings 47 (20)
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Table 9. Distribution of bloodstream pathogens, Lilongwe Central Hospital,
Malawi: wet season vs. dry season______________________________________
Season
Pathogen Wet 
n (%)
Dry
n (%)
P-value
Non-typhi Salmonella spp. 28 (41) 11(15) <0.001
Mycobacterium tuberculosis 13(19) 19(26) NS*
Cryptococcus neoformans 6(9) 4 (5.5) NS
Escherichia coli 3(4) 3(4) NS
Salmonella typhi 3(4) 2(3) NS
Staphylococcus aureus 2(3) 0 NS
Acinetobacter Iwoffi 2(3) 0 NS
Other fungi f 2(3) 0 NS
Streptococcus pneumoniae 1 (1.5) 24 (33) <0.0001
Proteus mirabilis 1 (1.5) 0 NS
Rhodococcus equi 1 (1.5) 0 NS
Other Mycobacterium spp. 0 4 (5.5) NS
* NS: not significant
f  One Cryptococcus laurentii and one Candida tropicalis.
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Table 10. Relationship between HIV-1 status and bloodstream infection (BSI), 
Lilongwe Central Hospital, Malawi, March-May 1998
Pathogen HIV-1 Status Relative Risk (Cl)* P-value
Any BSI
Positive 
N=173 (%)
56 (32)
Negative 
N=65 (%)
12(18) 1.7 (1.0-3.0) 0.04
Mycobacteria 13(8) 0(0) Undefined 0.01
Bacteria 36(21) 10(15) 1.4 (0.7-2.6) NSf
Fungi 7(4) 2(3) 1.3 (0.3-6.2) NS
* Cl = 95% confidence interval 
f NS: not significant
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Table 11. Independent clinical predictors of bloodstream infections (BSI) in febrile 
adults, Lilongwe Central Hospital, Malawi, March-May 1998
Type of BSI Clinical predictor Odds Ratio (Cl*) P-value
Any BSI (N=67) Chronic fever 3.1 (1.6-6.0) <0.001
Oral candidiasis 2.3 (1.1-4.8) 0.03
Acute diarrhoea 2.2 (1.1—4.1) 0.02
Mycobacteraemiaf (N=13) Chronic cough 16.4 (2.0-139) 0.01
Family history of cough 5.9(1.4-24.5) 0.01
Bacteraemia (N=45) Chronic vomiting 8.5(1.8-40) 0.007
Acute diarrhoea 2.7(1.3-6.0) 0.009
Jaundice 7.8(1.2-51.7) 0.03
Temperature >38.9 C 2.9(1.3-6.5) 0.007
Fungaemia (N=9) Chronic cough 7.4(1.2-44.2) 0.03
Neck rigidity 17.1 (2.8-105) 0.002
Herpes zoster infection 29.1 (1.6-542) 0.02
* Cl = 95% confidence interval
t  All patients with mycobacteraemia were HIV-1-positive
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Bloodstream infections were found in 37% (51/137) of patients with >1 of these clinical 
features vs. 15% (16/101) of patients without. Thus the predictive positive value for 
bloodstream infection in patients having >1 of these clinical features was 37%. When the 
analyses were stratified by specific types of bloodstream infection, HIV-1 infection, history of 
chronic cough, or a family history of cough emerged as independent risk factors for 
mycobacteraemia (Table 11).
A history of use of antimicrobial, antituberculosis, or antimalarial agents before hospital 
admission was available for 221 study-patients. For the week preceding hospital admission, 
antimicrobial use was documented in 78 (35%) of these patients. Preadmission use of 
antimalarial and antituberculosis agents were documented in 96 (43%) and 21 (10%) of 
patients, respectively. There was no association between being on any of these therapies on 
admission and presence or absence of mycobacteraemia, bacteraemia, or fungaemia.
Outcome data (death or discharge from hospital) were available for 199 (84%) of the 238 
study patients. The overall inpatient mortality rate in these patients was 24% (47/199). 
Inpatient mortality was significantly higher in patients with bloodstream infection than in 
those without bloodstream infection (22/53 [42%] vs. 25/146 [17%]; P <0.001). When 
stratified by type of bloodstream infection, 37% of patients with bacteraemia, 36% of those 
with mycobacteraemia. and 71% of those with fungaemia died in hospital. Although patients 
with HIV-1 infection were more likely to die during hospitalization than patients without HIV- 
1 infection (42/148 [28%] vs. 5/51 [10%], RR: 2.9; 95% confidence interval: 1.2 - 6.9; P 
<0.01), on multivariate analysis, independent predictors of inpatient mortality were presence 
of any bloodstream infection (OR: 3.2; 95% confidence interval: 1.4 - 7.3; P <0.001), altered
Chapter 5: Page 72
mental status (OR: 4.3; 95% confidence interval: 1.8-9.8; P = 0.0001), or chronic symptoms 
(OR: 2.7; 95% confidence interval: 1.1 - 6.3; P <0.05).
Of the 28 non-typhi Salmonella species that were isolated during the wet season, 15 
(53%) were S. typhimurium, four (14%) S. enteritidis, and nine (32%) were other serotypes.
All non-typhi Salmonella species and Salmonella typhi isolates were susceptible to 
chloramphenicol and ciprofloxacin. However, among the non-typhi Salmonella species 
isolates, there was 64% resistance to TMP/SMZ and 73% resistance to ampicillin. Resistance 
to TMP/SMZ and ampicillin among non -typhi Salmonella species isolates were not associated 
with exposure to antibacterial agents before admission to the hospital. All 13 M. tuberculosis 
isolates were susceptible to ethambutol, isoniazid, pyrazinamide, rifampicin, and streptomycin.
The mean monthly rainfall in the 1998 Malawi wet season during which this study was 
conducted was 118 mm/month. In contrast, the mean monthly rainfall during the 1997 dry 
season period was <1 mm/month.
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CHAPTER 6 
SUBSIDIARY STUDIES AND ANALYSES 
U n r e c o g n i s e d  ( o c c u l t )  m y c o b a c t e r a e m ia
Background. The clinical and public health importance of M. tuberculosis bloodstream 
infections was highlighted in the overview to this thesis (Chapter 1) and has been underscored 
by the results from the current study showing M. tuberculosis as one of the predominant 
bloodstream pathogens in HIV-infected patients in Tanzania, Thailand, and Malawi. During 
the conduct of the current study, it was noted that several of the patients who had 
mycobacteraemia had neither symptoms nor signs that would have suggested underlying M. 
tuberculosis infection. To add clarity to this observation, subsets of the data from Thailand 
and the Malawi dry season were selected and analysed. Patients were selected for this 
subsidiary analysis if they satisfied the following conditions: (i) their blood cultures yielded 
growth of M. tuberculosis only; (ii) they were not taking any form of anti-tuberculosis therapy 
before admission; (iii) there were no symptoms or clinical signs to suggest underlying active 
tuberculosis infection that would have substantiated further investigation for tuberculosis 
infection; and (iv) no abnormal chest radiographs or positive sputum smears were documented 
on or before the day of admission for those patients who perchance had these investigations 
performed. The objectives of these analyses were to: (i) compare and contrast the prevalence 
rates of M. tuberculosis bloodstream infection among febrile, hospitalized adult patients from 
two HIV-endemic countries; (ii) determine whether active tuberculosis in patients with 
mycobacteraemia is, in practice, frequently unrecognised; (iii) ascertain clinical predictors for 
M. tuberculosis bloodstream infection; and (iv) characterize factors associated with the under­
recognition of active tubercular disease in patients with mycobacteraemia.
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Case definition. A case of unrecognised, active disease was defined as a blood culture positive 
for M. tuberculosis in any adult patient who was not already receiving anti-tuberculosis 
therapy on or before the day of admission and who had neither an abnormal chest radiogram 
nor positive sputum smear on or before the day of admission.
Results. A  total of 344 patients (216 in Thailand and 128 in Malawi) were included in this 
analysis (Table 12). The median age of patients was 33 (range: 18-87) years. Sixty-two 
percent were male; a greater percentage of patients enrolled in Thailand (68%) than Malawi 
(48%) was male. Of the 344 patients, 255 (74%) were HIV-1-infected; 34 (10%) had M. 
tuberculosis bloodstream infection.
Clinical predictors of M. tuberculosis bloodstream infection included the presence of 
HIV-1 infection, lymphadenopathy, or chronic (>1 month duration) cough, fever, or weight 
loss (defined as >10% loss in body weight) (Table 13). When the analysis was limited to 
patients who were HIV-1-infected, oral thrush, chronic cough, fever, or weight loss remained 
significantly associated with M. tuberculosis bloodstream infection; lymphadenopathy was no 
longer significantly associated with mycobacteraemia.
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Table 12. Baseline characteristics of study-patients, Thailand and Malawi
Characteristic Overall
N=344
Thailand
N=216
Malawi
N=128
P-value
Median age/years (range) 33 (18-87) 33 (18-87) 33 (18-64) NS*
Male 208 (61%) 146 (68%) 62 (48%) <0.001
HIV-1-infected 255 (74%) 154 (71%) 101 (79%) NS
M. tuberculosis bloodstream 
infection
34(10%) 20 (9%) 14(11%) NS
* NS: not significant
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Table 13. Clinical predictors of M. tuberculosis bacteraemia in febrile hospital 
inpatients
Mycobacteraemia (%) Relative Risk 
95% Cl*
P-value
Clinical predictor Present Absent
All patients
HIV-1 infection 34/255 (13) 0/89 (0) Undefined 0.0006
Oral thrush 14/56 (25) 20/286 (7) 3.6 (1.9-6.6) <0.0001
Lymphadenopathy 20/133 (16) 14/210(7) 2.3 (1.2-4.3) 0.01
Chronic cough 19/113 (16) 15/230 (7) 2.6(1.6-4.9) 0.003
Chronic fever 26/143 (18) 8/200 (4) 4.6 (2.1-9.8) 0.0001
Chronic weight loss 26/162(16) 8/181 (4) 3.6(1.7-7.8) 0.0003
HIV-infected patients
Oral thrush 14/56 (25) 20/197(10) 2.5 (1.3-4.6) 0.004
Lymphadenopathy 20/129 (16) 14/125(11) 1.4 (0.7-2.6) 0.3
Chronic cough 19/102(19) 9/113 (8) 2.3 (1.1^1.9) 0.02
Chronic fever 26/136(19) 2/79 (3) 7.5 (1.8-31) 0.0015
Chronic weight loss 26/155(17) 2/60 (3) 5.0(1.2-20.6) 0.016
*CI: confidence interval
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Of the 34 patients with M. tuberculosis bloodstream infection, five were already receiving 
anti-tuberculosis therapy at the time of admission (Figure 1). Of the remaining 29 patients, 13 
(45%) had either abnormal chest radiographs (eight patients) or positive AFB sputum smears 
(five patients) on or before the day of admission. Thus, 16 (55%) patients with M. 
tuberculosis bloodstream infection met the case-definition of unrecognised active disease. Of 
these, 13 (81%) had acute or chronic cough; three subsequently had chest radiographs (all 
were normal); and none had preparation and microscopic examination of sputum smears for 
AFB.
Overall, febrile patients at the infectious disease hospital (Thailand) were more likely 
than patients at the general hospital (Malawi) to have been on antituberculosis therapy, to have 
had a recent chest radiograph, or to have had an AFB sputum smear performed on or before 
the day of admission (Table 14). Febrile patients with M. tuberculosis bloodstream infection 
at the general hospital, where chest radiography and sputum testing was less frequent, were 
more likely than patients at the infectious disease hospital to meet the case definition for 
unrecognised active disease (10/14 vs. 6/20, RR: 2.4, 95% confidence interval 1.1-5.0; P 
<0.04). M. tuberculosis blood culture isolates from the infectious disease hospital in Thailand 
were significantly more resistant to available antituberculosis drugs than isolates from the 
general hospital in Malawi (Table 15).
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Figure 1. Unrecognised active disease among patients with M. tuberculosis 
bacteraemia
348 patients screened
344 enrolled
4 declined to participate
310 without M. tuberculosis 
bacteraemia
34 with M 
tuberculosis
5 already on therapy
13 patients with abnormal chest 
radiograph or sputum smear
X
16 with unrecognised active disease
Chapter 6: Page 79
Table 14. Therapy and diagnostic testing on or before the day of admission
Thailand (n=216) Malawi (n=128) P-value
Anti-tuberculosis therapy 40 (18%) 15(12%) 0.13
Chest radiograph 109 (50%) 16 (13%) <0.0001
Sputum smear 42(19%) 5 (4%) < 0.0001
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Table 15. Antimicrobial resistance among M. tuberculosis isolates from blood 
Thailand and Malawi
I,
Antituberculosis Drug Number of resistant isolates P-value
Thailand (n=20) Malawi (n=14)
Rifampicin 6 (30%) 0 0.03
Isoniazid 5 (25%) 0 0.06
All other drugs 5 (25%) 2 (14%) 0.7
Multidrug resistant* 5 (25%) 0 0.06
* Resistant to at least isoniazid and rifampicin
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C o m p a r is o n  o f  b l o o d  c u l t u r e  m e t h o d s
Backgj'ound. The results of studies conducted in Tanzania, Thailand, and Malawi suggest that 
the detection and characterization of bloodstream infections in HIV-1-endemic countries 
necessitate the culturing of blood for bacteria, mycobacteria, and fungi. This endeavour is 
made particularly difficult for the following reasons: (i) extensive technician time required to 
process multiple media and stages (including quality control) to identify the various 
pathogens; (ii) inadequate microbiology resources or laboratory capacity for processing blood 
cultures; and (iii) lack of trained staff determined by prohibitive costs for the services of 
skilled personnel, materials, or laboratory equipment.
In Tanzania and Thailand, where there are high prevalence rates of HIV-1 infection, 
blood was cultured for bacteria, mycobacteria, and fungi using three blood culture systems 
simultaneously: (i) the Septi-Chek™ biphasic bacterial blood culture bottle (SC-B); (ii) the 
ISOLATOR™ 10 (Isolator) lysis-centrifugation system; and (iii) the Septi-Chek™ AFB 
biphasic mycobacteria blood culture bottle (SC-AFB) containing Middlebrook 7H9 broth. 
Although using three blood culture systems in parallel would be expected to increase the 
recovery rate for bacteria, fungi, and mycobacteria, the drawbacks include the relatively large 
volume (20 to 25 ml) of blood required for recovery of these three groups of pathogens, and 
increased time, effort, and resources needed for processing.
Recently, the MFL blood culture bottle was introduced and licensed for use in the United 
States to detect mycobacteraemia [Waite et al., 1998]. Each MFL bottle contains 40 ml of 
non-selective culture medium (supplemented Middlebrook 7H9 and brain heart infusion 
broth), specific proteins and sugars, saponin (a blood lysing agent), and added oxygen and 
carbon dioxide. At the bottom of each bottle, there is a sensor that can detect decreases in
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oxygen concentration resulting from growth of microorganisms. Growth of microorganisms 
may be detected in the automated BACTEC 9000 series systems, or manually by shining the 
ultraviolet light of a Wood’s lamp on the sensor at the bottom of the bottle; the resulting 
fluorescence is growth-dependent and is proportional to the decrease in oxygen in the bottle.
Methods. In this analysis of the blood culture methods used in Malawi, the MFL blood culture 
system was compared with the SC-B, the SC-AFB, and the Isolator systems for yield of 
microorganisms (i.e., bacteria, mycobacteria, and fungi). The dry and wet seasons are termed 
study periods I and II, respectively. Clinical and epidemiology details and results are 
described in earlier chapters.
Results. A total of 486 single blood cultures (251 in period I and 235 in period II) were 
obtained from adult patients admitted to LCH with fever during both study periods combined. 
Non-typhi Salmonella species, S. pneumoniae, and M. tuberculosis were the most common 
bloodstream infection isolates. For study periods I and II combined, a total of 8 (1.6%) blood 
cultures yielded organisms that were considered contaminants, including coagulase-negative 
Staphylococcus species, diphtheroids, and Micrococcus species. Four of these contaminants 
grew in an MFL or SC-B bottle, and four only on the Middlebrook 7H11 agar. For 
contaminated blood culture bottles, contamination occurred in just four (0.8%) of the 486 
blood cultures obtained.
Detection o f  bacteraemia (study period I). During this study period, the growth of bacteria in 
251 blood cultures was assessed using three blood culture systems (MFL, SC-B bottle, and
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Isolator concentrate on chocolate agar). From these 251 blood cultures, 44 bacterial pathogens 
grew in one or more of the three systems (Table 16). Overall, the MFL system had a bacteria 
recovery rate that was similar to that of the Isolator concentrate inoculated on chocolate agar 
(34/44 vs. 27/44, P = NS). However, the MFL bottle had a higher bacteria recovery rate than 
the SC-B bottle (34/44 vs. 24/44; P <0.05).
Detection o f bacteraemia (study period II). During this study period, only the MFL bottle was 
used to detect bacteraemia. The SC-B bottle and inoculation of the Isolator concentrate on 
chocolate agar were discontinued because their significantly lower diagnostic yield for bacteria 
did not warrant collection of an extra 10 ml of blood for the former, or the extra work involved 
in the latter. Of the 235 MFL bottles inoculated during this period, 45 (19%) yielded bacterial 
growth.
Detection o f mycobacteraemia (study periods I  and II combined). The growth of mycobacteria 
was assessed in 486 cultures in each of three systems (MFL, the Isolator concentrate 
inoculated into the SC-AFB bottle, and the Isolator concentrate on Middlebrook 7H11 agar). 
From these 486 blood cultures, 37 mycobacterial species were detected by one or more of the 
three systems. The MFL bottle and the Isolator concentrate in the SC-AFB bottle had similar 
rates of detection of mycobacteria (30/37 vs. 29/37, P = NS). However, the MFL bottle had a 
higher rate of isolation of mycobacteria than did the Isolator concentrate on Middlebrook 
7H11 agar slants (30/37 vs.15/37, P = 0.002) (Table 17).
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Detection offungaemia (study period I). The MFL system had a higher fungal recovery rate 
than did the SC-B bottle (3/5 vs. 0/5, P = NS) or the Isolator concentrate on chocolate agar (3/5 
vs. 1/5, P = NS); this difference did not reach statistical significance.
Detection o f fungaemia (study periods I  and 11 combined). The MFL system had a lower 
fungal recovery rate than the Isolator concentrate on IMA (6/13 vs. 10/13, P = NS); this 
difference, however, did not reach statistical significance.
Time o f recoveiy (bacterial and fungal isolates). During study period I, the reading intervals 
of the SC-B, MFL, and the Isolator concentrate on chocolate agar systems for the detection of 
bacteraemia, during the first week, were similar. The median time to detect bacteria and fungi 
was one (range: 1-4) day for the MFL system, one (range: 1-3) day for the SC-B system, and 
two (range: 1-3) days for the Isolator concentrate on chocolate agar. The median time for 
detecting fungi by culturing the Isolator concentrate on IMA was 3.5 (range: 3-10) days.
Time o f recovery (mycobacterial isolates). Although the reading interval for mycobacteraemia 
in MFL, SC-AFB, and Middlebrook 7H11 agar cultures were similar during the initial 
microbiolog}7 work-up in Malawi, growth during shipment of these cultures to the United 
States might have occurred so relative times of detection could not be assessed accurately.
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Table 16. Bacterial pathogens isolated from blood cultures, Lilongwe Central Hospital, Malawi, during study 
period 1 (1997).
Pathogens
Number of bacterial isolates recovered by:
All
systems
MFL*
bottle
Septi-Chek
bottle
Isolator concentrate 
on chocolate agar
Streptococcus pneumoniae 24 19 17 20
Salmonella spp.f 13 9 4 5
Enterobacteriaceae § 5 5 2 1
Other Gram-positive cocci;]: 2 1 1 1
* MFL: MYCO/F LYTIC bottle
f Eight S. typhimurium, three S. enteritidis, and two S. typhi 
§ Three Escherichia coli, and two Klebsiella spp.
J One Streptococcus pyogenes isolate and one Streptococcus sanguis isolate.
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Table 17. Mycobacterial species isolated from blood cultures, Lilongwe Central Hospital, Malawi, {luring 
study 1997 dry season (study period I) and 1998 wet season (study period II)
No. of mycobacterial isolates recovered by:
Pathogens All
systems
MFL*
bottle
Isolator concentrate 
in Septi-Chek AFB 
bottle
Isolator concentrate 
on Middlebrook 7H11 
agar
Mycobacterium tuberculosis 33 27 25 13
Mycobacterium simiae/SAVf 2 2 2 1
Mycobacterium bovis 1 0 1 0
Mycobacterium avium complex 1 1 1 1
* MFL: MYCO/F LYTIC bottle
t  SAV: Mycobacterial species of the SAV group resemble M. avium complex by conventional biochemical tests, including a 
negative niacin reaction (true M. simiae have positive niacin reactions), but have high-performance liquid chromatography profiles 
that are consistent with M. simiae.
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UTILITY OF NUMBER OF BLOOD CULTURE BOTTLES IN THE RECOVERY OF BLOODSTREAM 
PATHOGENS
Background. The rationale for inoculating two blood culture bottles with blood drawn either 
from a single venipuncture and divided, or from separate distinct blood draws, is based on the 
evidence that the likelihood of recovery of bloodstream pathogens is increased if larger 
volumes of blood are cultured [Hall et al., 1976; Ilstrup & Washington, 1983; Plorde et al., 
1985; Tenney et al., 1982]. Weinstein and colleagues argued that, using conventional manual 
methods, a single set (i.e., one blood draw) of blood cultures will generally detect 91% of 
bacteraemia while two sets would detect >99% cases of bacteraemia [Weinstein et al., 1983].
The current studies in Tanzania, Thailand and Malawi have established that (i) in less- 
developed countries, where HIV-1 infection is prevalent, valid characterization of bloodstream 
infections in hospitalized adults necessitate culturing blood for mycobacteria, bacteria, and 
fungi; and (ii) culturing blood for the three groups of pathogens using conventional blood 
culture methods requires drawing up to 30 ml of blood from patients. However, limited blood 
culture supplies or microbiology capacity in less-developed countries often preclude obtaining 
>1 blood culture per patient, inoculating >1 bottle per blood draw, or culturing simultaneously 
for bacteria, mycobacteria, and fungi. Also, as mentioned earlier, patients from many of these 
countries do not like parting with the large volumes of blood that are necessary for culturing 
these three groups of pathogens.
The analysis in the previous chapter showed that 5ml of blood inoculated into one MFL 
blood culture bottle was a convenient method for culturing blood for bacteria, mycobacteria, 
and fungi and was as good as or superior to alternative, conventional blood culture systems. It
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was suggested that the MFL bottle may be a useful tool for studying bloodstream infections in 
less-developed settings, where blood cultures already are part of a microbiology service 
repertoire or where existing resources limit blood culture service; or the MFL bottle may be 
used for conducting prevalence surveys of bloodstream infections.
Although inoculation of two MFL bottles has potential clinical benefit, it may be 
economically unsustainable if recommended for routine blood culture service in less- 
developed countries with limited resources. Therefore, further analyses of the Malawi data 
from the wet season were executed to determine the utility of inoculating blood from one draw 
consecutively into two MFL bottles for detection of bacteraemia, mycobacteraemia, and 
fungaemia in febrile, adult inpatients.
Results. During this study period, 228 study-patients had single blood draws inoculated into 
two MFL blood culture bottles; 56 (24.6%) of these study-patients had clinically significant 
bloodstream infections: 41 bacteria, 12 mycobacteria, and 3 fungi. Salmonella species and M. 
tuberculosis were the two most common isolates. Fifty-one (91%) of the 56 positive cultures 
were positive in both bottles. Of the 228 MFL pairs, 51 (22%) were both positive, 170 (75%) 
were both negative, and 5 (3%) had discordant results. Two (0.9%) of the 228 pairs of blood 
cultures yielded coagulase-negative Staphylococcus species that were considered skin 
contaminants and therefore were not included in the data analysis. The results are summarized 
in Table 18.
Chapter 6: Page 89
Table 18. Comparison of paired MYCO/F LYTIC (MFL) bottles for recovery of
bacteria, mycobacteria, and fungi
Organism and 
result for first 
MFL bottle*
Result for second MFL bottle*
Positive Negative
Bacteria
Positive 38 3
Negative 0 170
Mycobacteria
Positive 11 0
Negative 1 170
Fungi
Positive 2 1
Negative 0 170
* The data represent numbers of bottles; none of the differences were statistically significant.
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T h e  E m e r g e n c e  o f  M y c o b a c t e r i u m  s i m i a e  a n d  S i m i a e -A  v iu m  (SAV) G r o u p  
B l o o d s t r e a m  I n f e c t i o n s  in  p e r s o n s  w i t h  t h e  a c q u ir e d  im m u n o d e f ic ie n c y
SYNDROME— THAILAND AND MALAWI
Background. Persons with HIV-1 infection and AIDS are susceptible to disseminated 
mycobacterial infections involving blood, bone marrow, and multiple organs [Shafer et al., 
1991; Grinsztejn et al., 1997]. In the United States, most such infections are caused by 
Mycobacterium avium or M. intracellulare (referred to collectively as M. avium complex). In 
less-developed nations where HIV-1 is endemic, M. tuberculosis is as or more prevalent than 
Mycobacterium avium complex [see previous chapters]. Accurate identification of 
mycobacterial species causing these infections is important for directing appropriate therapy, 
because different mycobacterial species are not uniformly susceptible to all antituberculosis 
agents.
Other mycobacterial species that have been reported to cause disseminated infection in 
HIV-infected persons include M. simiae and simiae-avium (SAV) group mycobacteria. SAV 
group organisms share characteristics of M avium and M  simiae [Tortoli et al., 1997]. 
Disseminated infection with M. simiae has been reported in HIV-infected persons [Koeck et 
al., 1996; Levy-Frebault et al., 1987; Munier et al., 1993; Torres et al., 1991]. Within the SAV 
group, one distinct species, M. triplex, has recently been characterized [Floyd et al., 1996]. 
Subsequently, two case reports of disseminated infection caused by M. triplex have been 
reported: (i) an HIV-1-positive adult male patient in Italy [Cingolani et al., 2000] and (ii) a 13- 
year-old female patient who underwent a liver transplant in the United States [Hoff et al., 
2001].
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In the present study, four patients (two from Bangkok, Thailand and two from Lilongwe, 
Malawi) were found to have bloodstream infections caused by SAV group mycobacteria
Bangkok, Thailand
Patient 1, a 32 year-old-man, presented with fever, chronic cachexia, and diarrhoea of three 
month’s duration. Physical examination revealed oral candidiasis and lymphadenopathy. The 
liver and spleen were not enlarged.
Patient 2, a 36-year old man, presented with fever, cachexia, and cough and shortness of breath 
of one week’s duration. Physical examination revealed lymphadenopathy. The liver and 
spleen were not enlarged. Additional laboratory studies revealed marked anaemia and positive 
cerebrospinal fluid cryptococcal antigen.
Both Thailand patients were HIV-1-positive. Neither was receiving antiretroviral or 
antimycobacterial therapy at time of presentation. Both patients were treated with broad- 
spectrum antimicrobials for possible underlying bacterial infection and were discharged alive 
from the hospital.
Lilongwe, Malawi
Patient 3, a 28-year-old man, presented with chronic fever and cough of seven months 
duration. A physical exam revealed cachexia and skin lesions consistent with Kaposi’s 
sarcoma. No lymphadenopathy or liver or spleen enlargement was noted.
Chapter 6: Page 92
Patient 4, a 36-year-old man, presented with fever, chronic cough and a five-month history of 
diarrhoea. Physical examination revealed oral candidiasis. There was no lymphadenopathy; 
liver and spleen were not enlarged.
Both Malawi patients were HIV-1-positive. Neither was receiving antiretroviral or 
antimycobacterial therapy at the time of presentation. Both were treated with penicillin and 
chloramphenicol for presumed underlying bacterial infection, and were discharged alive from 
the hospital.
Susceptibility testing o f SA V Group mycobacteria. All four isolates were available for 
susceptibility testing. All were resistant to all first-line drugs used for treating M. tuberculosis 
infection (isoniazid, rifampicin, and pyrazinamide) and to alternative drugs used for treating 
multidrug-resistant tuberculosis (MDRTB).
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CHAPTER 7 
SUMMARY
D a r  e s  S a l a a m , T a n z a n ia
This was a prospective study of 517 febrile (axillary temperature 37.5°C) adults (>15 years) 
who were admitted consecutively to the largest teaching hospital in Tanzania. One hundred 
and forty-five (28 %) patients had bloodstream infections. Of these 145 patients, 118 (81 %) 
were HIV-1-infected. HIV-1-positive were more likely than HIV-1-negative patients to have 
bloodstream infection (118/282 vs. 27/235; P <0.0001). The three most frequently isolated 
pathogens were M. tuberculosis 60 (39 %), non-typhi Salmonella species 29 (19 %), and 
Staphylococcus aureus 13 (8.3 %). The malaria parasitaemia rate was similar to that of an 
afebrile control group of patients (9.4 % vs. 8 %). In this patient population with high 
prevalence of HIV-1 infection, M. tuberculosis has become the foremost cause of documented, 
community-acquired bloodstream infections.
B a n g k o k , T h a il a n d
This was a study of 246 consecutive febrile patients admitted to a teaching hospital in 
Bangkok. One hundred and nineteen (48%) had bloodstream infections; 182 (74%) patients 
were HIV-1-infected. The two most common pathogens were C. neoformans (n=30) and M. 
tuberculosis (n=27). HIV-1-positive patients were more likely than HIV-negative patients to 
have mycobacteraemia (57/182 vs. 0/64; P <0.0001), fungaemia (38/182 vs. 2/64; P <0.001), 
or polymicrobial bloodstream infection (19/182 vs. 0/64; P <0.002). Mortality was higher 
among patients with bloodstream infection versus those without (P <0.001). Independent
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clinical predictors for bloodstream infections included HIV infection, chronic diarrhoea, 
lymphadenopathy, or splenomegaly.
L il o n g w e , M a l a w i  (d r y  se a s o n )
Of 233 patients who presented to a Malawi teaching hospital during the 1997 dry season, 173 
(74%) were HIV-1-infected and 70 (30%) had bloodstream infections. The two most 
commonly isolated pathogens were S. pneumoniae (n= 25; 34 %) and M. tuberculosis (n= 21; 
29 %). Nine (4 %) patients had malaria parasitaemia. Bloodstream infections were more 
likely in HIV-1 positive than HIV-1-negative patients (62/173 vs. 8/60; P <0.01). Independent 
clinical predictors of bloodstream infections included HIV-1 infection and altered mental 
status. Mortality was higher among patients with than in those without bloodstream infections 
(P <0.001).
L il o n g w e , M a l a w i (w e t  se a so n )
Of 238 patients presented to the same Malawi teaching hospital during the 1998 wet season, 
173 (73%) were HIV-positive and 67 (28%) had bloodstream infection. The predominant wet 
season bloodstream infection pathogens were non-typhi Salmonella species (41%), M. 
tuberculosis (19%), and Ciyptococcus neoformans (9%). (cf., the predominant dry season 
pathogen was S. pneumoniae). As predicted by earlier data, mycobacteraemia was more likely 
in HIV-positive than HIV-negative patients (13/173 vs. 0/65; P <0.05). A logistic regression 
model yielded clinical predictors of bloodstream infection that included chronic fever, oral 
candidiasis, or acute diarrhoea. Thus, the spectrum of pathogens causing bloodstream 
infection in febrile hospitalized patients may vary by season.
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U n r e c o g n is e d  (o c c u l t ) m y c o b a c t e r a e m ia
To determine whether M. tuberculosis bloodstream infections frequently go unrecognised, a 
comparative analysis of a subset of the Thailand and Malawi data was carried out. Of 344 
patients, 255 (74%) were HTV-1-infected, median age was 33 (range 18-87) years, 208 (61%) 
were male. Thirty-four (10%) patients had M. tuberculosis bloodstream infection and 5 of 
these were already on antituberculosis therapy. Only HTV-1-infected patients had M 
tuberculosis bloodstream infection. Of the 29 patients with M. tuberculosis bloodstream 
infection not already receiving antituberculosis therapy, 13 (45%) had an abnormal chest 
radiograph or a positive sputum smear. Sixteen (55%) patients had no additional diagnostic 
test results to indicate M. tuberculosis infection; 13 (81%) of these had cough. Thailand 
patients were more likely than Malawi patients to have chest radiographs or sputum smears 
performed (114/216 vs. 16/128; P <0.0001); patients with M. tuberculosis mycobacteraemia in 
Thailand were more likely than those in Malawi to have received therapy or to have had 
additional diagnostic tests for the diagnosis of tuberculosis (14/20 vs. 4/14; P <0.05). Thus, in 
regions of the less-developed world, where both M. tuberculosis and HIV infections are 
prevalent, disseminated M. tuberculosis infection may frequently go unrecognised.
M ic r o b io l o g y — c o m p a r is o n  o f  b l o o d  c u l t u r e  m e t h o d s  
During two study periods (study period I [1997] and study period II [1998]), blood from 
patients in Malawi was cultured using the BACTEC™ MYCO/F LYTIC (MFL), 
ISOLATOR™ 10 (Isolator), Septi-Chek™ AFB (SC-AFB), and Septi-Chek™ bacteria (SC-B) 
systems. During study period I, 251 blood cultures yielded 44 bacterial isolates. For 
bacteraemia, the MFL was similar to the Isolator concentrate on chocolate agar (34/44 vs.
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27/44, P = NS), but more sensitive than the SC-B bottle (34/44 vs. 24/44, P = 0.05). For both 
study periods combined, 486 blood cultures yielded 37 mycobacterial and 13 fungal isolates. 
For mycobacteraemia, the MFL and Isolator concentrate in the SC-AFB bottle were similar 
(30/37 vs. 29/37, P = NS); the MFL bottle was more sensitive than the concentrate on 
Middlebrook agar (30/37 vs. 15/37, P = 0.002). For fungaemia, the MFL bottle was as 
sensitive as the SC-B bottle or Isolator concentrate on chocolate or IMA slants. Thus, the 
MFL bottle, inoculated with just 5 ml of blood and examined under ultraviolet light, provides a 
sensitive and uncomplicated method for comprehensive detection of bloodstream infections in 
less-developed countries.
M ic r o b io l o g y — o n e  v e r s u s  t w o  b l o o d  c u l t u r e  b o t t l e s  f o r  p a t h o g e n  r e c o v e r y  
Inoculation of one bottle would be expected to reduce the sensitivity of MFL bloodstream 
pathogen detection. To ascertain the degree of this loss of sensitivity, blood was drawn from 
each of 228 febrile, adult inpatients in Malawi and 5 ml were inoculated into each of two MFL 
bottles. Of 228 paired bottles, 51 (22%) were both positive, 172 (75%) were both negative, 
and 5 (3%) were discordant. Eleven (92%) of 12 patients with mycobacteraemia and 38 (92%) 
of 41 patients with bacteraemia would have been detected had only one MFL bottle been 
inoculated. Thus, a second MFL bottle does not significantly increase diagnostic sensitivity.
N e w  e m e r g in g  b l o o d s t r e a m  p a t h o g e n s— SAV G r o u p  m y c o b a c t e r ia
Four patients (two from the Thailand study and two from the Malawi study) were found to 
have bloodstream infections caused by the SAV Group mycobacteria. These mycobacteria 
have the biochemical profile of M. avium complex but the HPLC properties of M. simiae, and
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are generally resistant to all first-line drugs used for treating M. tuberculosis. Patients with 
SAV mycobacterial infections may go unrecognised and presumed to be infected with 
multidrug-resistant M. tuberculosis.
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CHAPTER 8 
DISCUSSION
T a n z a n ia
The results of this study indicate that the prevalence of bloodstream infection among febrile 
adults admitted to the largest referral hospital in Tanzania was 28% and that M. tuberculosis 
complex was the most common cause of community-acquired bloodstream infection. Non- 
typhi Salmonella species were the second most frequent bloodstream pathogen, followed by S. 
aureus, E. coli, S. pneumoniae, and C. neoformans, respectively. Moreover, 55% of febrile 
adult admissions to this hospital were HIV-1-seropositive. The finding that M. tuberculosis 
was the most common bloodstream pathogen was unexpected, especially as previous studies in 
the Ivory coast, Rwanda, and Kenya had suggested otherwise, i.e., that non-typhi Salmonella 
species and S. pneumoniae were the predominant cause of bloodstream infection in sub- 
Saharan Africa [Gilks et al., 1990a Taelman et al., 1990; Vugia et al., 1993]. The 
heterogeneity of strains of M. tuberculosis demonstrated by RFLP suggests that the findings of 
this study were neither a result of an outbreak of M. tuberculosis bloodstream infection at 
MMC, nor due to inadvertent contamination of specimens in the microbiology laboratory.
A 1995 report from Nairobi had previously documented mycobacteraemia in 14 patients 
with advanced HIV infection. Of these 14 cases of mycobacteraemia, three (21 %) were due 
to M. avium complex (the first published report of disseminated M. avium complex infection in 
HIV-1-infected patients in sub-Saharan Africa); the other 11 (79 %) cases were caused by M. 
tuberculosis [Gilks et al., 1995]. The current study supports the finding that M. avium 
complex bloodstream infections are relatively uncommon in HIV-infected patients in 
Tanzania.
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The SC-B bacteria biphasic blood culture system has been previously used in Africa to 
investigate non-mycobacterial bacteraemia [Vugia et al., 1993]. Although this system does not 
require specialized equipment, which would be impractical anyway in a country with limited 
resources, it is expensive relative to lysis-centrifugation. Mattar et al used lysis-centrifugation 
and inoculated concentrate onto various media selective for mycobacteria, including 7H9 
broth, and demonstrated that the lysis-centrifugation technique is easy to perform and has a 
relatively high yield of AFB [Mattar et al., 1992].
The current study is the first in Africa in which the concentrate from lysis-centrifugation 
was inoculated directly into a biphasic bottle containing media selective for AFB, and 
confirms previous findings that liquid media enhance the recovery of small numbers of 
mycobacteria from clinical specimens [Sewell et al., 1993]. The SC-AFB bottle is a biphasic 
system that combines a paddle containing Middlebrook 7H11, modified egg-based, and 
chocolate solid media with a bottle containing 20 ml Middlebrook 7H9 broth and an internal 
CCf source. This mycobacteria culture system was chosen because it has been shown to have 
significantly greater sensitivity, compared with conventional solid media, for the recovery of 
all mycobacteria from clinical specimens [D’Amato et al., 1991; Giger et al., 1990].
Wasilauskas and Morrell demonstrated that the lysing anticoagulant in the Isolator tube 
inhibited the growth of M. avium complex [Wasilauskas and Morrell, 1994]; Doem and 
colleagues subsequently reported optimum recovery of M. avium complex from blood using a 
small volume of Isolator concentrate (0.2 ml) to inoculate the BACTEC 12B broth [Doem et 
al., 1994]. In the current study, 1 ml of concentrate was inoculated into the SC-AFB bottle. 
Although this likely optimized the overall recovery of mycobacteria, M. avium complex and 
M. tuberculosis yield might have been improved further by using a smaller Isolator
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concentrate inoculation volume. A study comparing the yield of M. tuberculosis from blood 
cultures using large and small Isolator concentrate volumes inoculated into a mycobacterial 
biphasic system has not yet been done.
The overall rate of blood culture contamination in the current study was low (1.3%).
True positive blood cultures were no more or less likely than negative cultures to have a 
contaminant. This was achieved by ensuring that high aseptic standards were maintained 
before and during venipuncture, using both alcohol and povodine iodine for skin cleansing and 
allowing the skin to dry properly before venesection, and by scrupulous cleaning of the rubber 
diaphragms of blood culture bottles and Isolator tubes with isopropyl alcohol before 
inoculation with blood or other sterile solutions during every stage of microbiologic 
processing and analysis. Three of the organisms considered contaminants were identified only 
on terminal subculturing of clear blood culture broth onto sheep blood plates, after seven days 
of incubation. Since these three organisms were most likely introduced into the inocula at the 
time of terminal subculturing and not at the initial venipuncture, the true contamination rate 
was almost certainly lower than the observed rate of 1.3%.
Without microbiology facilities and appropriate blood cultures, the prevalence of 
bloodstream infection in the febrile Tanzanian study population would not have been 
determined. While the prevalence of bloodstream infection has probably been underestimated 
in febrile adults, malaria parasitaemia may be overestimated as the underlying cause of fever. 
Tanzania already has an established mycobacteria reference laboratory. Thus, it might be 
more practical to develop existing blood culture facilities, particularly to detect 
mycobacteraemia and fungaemia. Surveillance in this area is vital especially as the current 
study has demonstrated that 95% of M. tuberculosis isolates remain sensitive to ethambutol,
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isoniazid, rifampicin, and streptomycin.
Limited resources restrict the availability of antimicrobials in Tanzania and other sub- 
Saharan countries. Thus, identification of organisms isolated from blood cultures and 
antimicrobial susceptibility testing should promote appropriate antimicrobial prescribing. In 
the current study, 40% of S. pneumoniae isolates were resistant to penicillin and susceptibility 
testing suggested that chloramphenicol would have been the antimicrobial of choice for an 
infection caused by this pathogen. On the other hand, the number of bacterial isolates 
(including S. pneumoniae) tested for susceptibility to available antimicrobials were too small 
to enable specific conclusions regarding optimal choice of agents for specific infections in 
patients, or to enable reasonable estimation of the prevalence of antimicrobial-resistant 
organisms in the community. Susceptibility testing of isolates to panels of antimicrobials used 
for routine antimicrobial susceptibility testing in the United States were not carried out largely 
because many of these agents are not routinely available in most sub-Saharan countries, 
including Tanzania.
Although 37 (62%) of 60 patients with mycobacteraemia had pulmonary disease by 
history and physical examination, sputum smears for mycobacteria were available for only 10 
(17%) of these individuals. Moreover, many patients did not obtain chest radiographs during 
their hospital stay for various reasons which included lack of clear clinical indication, inability 
of the patient to pay for a film, lack of trained hospital personnel, broken radiology machines, 
an overwhelmed radiology department, or death of the patient before a radiograph could be 
obtained. It is possible that many of the 23 patients with mycobacteraemia who exhibited no 
clinical evidence of pulmonary disease had occult pulmonary tuberculosis. However, because 
many of these patients did not have chest radiographs on admission for the various reasons
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mentioned, the true number of patients with occult M. tuberculosis pulmonary or extra- 
pulmonary disease remains unknown. A mortality rate of 45% among study patients with 
mycobacteraemia suggests that further research needs to be conducted to determine the extent 
of occult M. tuberculosis disease in sub-Saharan Africa.
Based on the results of this study, the following were recommended: (i) establish basic 
facilities to rapidly identify AFB, common Gram-positive and -negative pathogens and their 
susceptibilities to available antimicrobials; (ii) expand microbiology capabilities to include 
lysis-centrifugation, which I demonstrated to be feasible and within the capabilities of the 
microbiologic staff at MMC; and (iii) encourage and train clinicians to actively seek 
mycobacterial infection in febrile patients clinically suspected to have HIV-1 infection. As 
has been the case in the United States for many years, it might be more appropriate to integrate 
mycobacteriology and bacteriology services rather than maintain them as separate entities as is 
the case in so many countries in Africa. This study suggests that providing basic microbiology 
laboratory facilities in sub-Saharan Africa will have significant impact on patient care.
The results from this Tanzania study suggest that (i) in less-developed countries with 
high prevalence rates of HIV infection, febrile adults should be evaluated for a wide spectrum 
of infectious agents, including mycobacteria, fungi, and bacteria; (ii) there is a need to expand 
the capability of laboratories in these countries to diagnose a wide range of emerging 
pathogens: and (iii) these data may help change policies for prophylactic or empirical 
antimicrobial therapy of febrile HIV-1-infected patients.
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T h a il a n d
The data from the Thailand study phase indicate that the prevalence of bloodstream infection 
among febrile adults admitted to a large infectious diseases hospital in Bangkok, Thailand, was 
48% and that C. neoformans, M. tuberculosis, and M. avium complex were the three pathogens 
most commonly isolated from the bloodstream of these patients. In addition, certain fungi (H. 
capsulatum and P. marneffei) and mycobacteria (M simiae, M. scrofulaceum, and 
mycobacteria of the SAV group) emerged as important causes of bloodstream infection in this 
patient population. Three-quarters of adults with fever hospitalized at this Bangkok hospital 
and 96% of patients with bloodstream infection were HIV-1-seropositive. Multivariate 
analysis suggested specific clinical parameters that were strongly predictive for bacteraemia, 
mycobacteraemia, and fungaemia. Approximately one-quarter of M. tuberculosis isolates 
showed multidrug resistance.
Previously, the association between HIV-1 infection and tuberculosis had been described 
for HIV-l-endemic regions in Africa [Gilks et al., 1990b; Nunn et al., 1990; Nunn et al.,
1992; De Cock et al., 1992] and in Brazil, where 19 (58%) of 33 HIV-1-infected patients with 
a final diagnosis of tuberculosis had M. tuberculosis bloodstream infection [Grinsztejn et al.,
1997]. The data from the current Thailand study and from the previous Tanzania phase have 
now clearly established the predominance and importance of M tuberculosis bloodstream 
infections in febrile HIV-1-infected adult patients in these countries. Thus, it is imperative 
that laboratories with adequate resources in areas of the world with high HIV-1 prevalence 
rates use methods that enhance recovery of M. tuberculosis, so these infections can be 
diagnosed early and appropriately.
The findings of the Tanzania phase of the current study and of work in Kenya [Gilks et
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al., 1995] had suggested that while M. tuberculosis bloodstream infections are common in 
febrile adult HIV-1-infected patients, M. avium complex bloodstream infections remain 
relatively uncommon. The data from the current Thailand study suggest that, unlike these sub- 
Saharan studies, C. neoformans, M. tuberculosis, or M. avium complex bloodstream infections 
are relatively common in similar patient populations in Bangkok. That the prevalence rate of 
M. avium complex bloodstream infection in Bangkok is so different from the rates in similar 
patient populations in HIV-1-endemic regions in sub-Saharan Africa underscores the variation 
in the epidemiology of bloodstream infection in different countries and the importance of 
capacity building so that regional reference laboratories can culture blood (and other 
specimens) comprehensively for bacteria, mycobacteria, and fungi. In addition, these results 
demonstrate the inherent risk of extrapolating data from one HIV-1-endemic region of the 
world to another for the implementation of clinical or public health policies.
The multivariate analyses provide a statistical model that highlights which febrile 
hospitalized adults in a large Bangkok hospital are at greatest risk of bloodstream infection and 
should be strongly considered for blood culture or empiric antimicrobial therapy. The results 
suggest that (i) any adult HIV-1-infected patient presenting with chronic diarrhoea, chills and 
rigors, and an absolute lymphocyte count under 1200/mnT would have >90% probability of 
having a bloodstream infection; (ii) any adult patient with fever and a histoiy of chronic 
diarrhoea should be considered for bacterial blood cultures, at the very least; and (iii) patients 
with lymphadenopathy, an abnormal white blood cell count, and clinically suspected to be 
HIV 1-infected, should be considered for further microbiological investigation, where 
appropriate, and if comprehensive laboratory resources and services are available. If blood 
culture services are unavailable, empirical therapy alone may be appropriately based on these
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probabilities. Development and use of such algorithms, after discussion between 
microbiologists, clinicians, and epidemiologists, might facilitate better use of scarce laboratory 
resources and improve patient outcome.
In some countries or regions, empirical antimicrobial therapeutic decisions may be based 
on limited laboratory results. Importantly, bloodstream infection prevalence rates vary by 
country, and clinical predictors for bloodstream infection might vary from setting to setting. 
This precludes direct extrapolation of data from one country to another, and clinical algorithms 
developed for one specific site or country might not be universally applicable to other sites. 
Hence, countries that wish to implement public health policy should conduct appropriate 
bloodstream infection studies within their own setting or exercise care when extrapolating data 
from other sources. Cohort-based microbiologic studies, such as the present study, could 
guide appropriate empirical antimicrobial therapy.
RFLP analysis of the M. tuberculosis isolates in the current Thailand study demonstrated 
a heterogeneity of strains suggesting that the findings were neither a result of an outbreak of 
M. tuberculosis infection among hospitalized patients, nor a result of inadvertent 
contamination in the microbiology laboratory. As for Tanzania, a decision to treat coagulase- 
negative staphylococcus as a contaminant was based on the results of studies that 
demonstrated the clinical non-significance of these organisms as causes of bloodstream 
infections in the absence of invasive devices [Weinstein et al., 1997]. None of the patients 
enrolled in the current study had in situ intravascular devices at the time blood was drawn for 
culture. Thus, even if a substantial number of blood cultures had yielded growth of coagulase- 
negative staphylococcus, their clinical significance as true bloodstream pathogens would still 
have remained doubtful. The current findings also demonstrate that when blood cultures are
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obtained by trained personnel using appropriate skin preparation, and specimens are handled 
appropriately in the laboratory, contamination is a relatively infrequent event (i.e., <1 %).
In Thailand, all S. typhimurium isolates were resistant to ampicillin and TMP/SMZ and 
22% of M. tuberculosis isolates showed multidrug resistance. These results demonstrate the 
value of antimicrobial susceptibility information in the clinical selection of antimicrobial 
therapeutic regimens and underscore the importance of surveillance of antimicrobial resistance 
among pathogens that commonly cause bloodstream infection in HIV-1-endemic less- 
developed countries.
C. neoformans was the most common pathogen causing bloodstream infections in the 
Thailand study population; four patients had bloodstream infection due to P. marneffei, which 
is one of the most common pathogens causing opportunistic infections in HIV-1-infected 
patients in northern Thailand [Vanittanakom et al., 1997; Chariyalertsak et al., 1996]. The 
prevalence of P. marneffei infections among HIV-1-infected patients from areas outside the 
northern regions appears to be considerably lower [Chariyalertsak et al., 1996], and may be 
due to the fact that the HIV-1 epidemic has been most severe in the northern provinces of 
Thailand [Weniger et al., 1991].
In a study spanning a 4-vear period, Chariyalertsak et al demonstrated that HIV-1 - 
infected patients presenting with P. marneffei infection were more likely to be seen in the 
rainy season in each year; these investigators did not observe seasonal variation in the 
incidence of disseminated C. neoformans infections [Chariyalertsak et al., 1996]. The current 
study was conducted during the height of the Thailand dry season. Thus, the relatively low 
incidence of P. marneffei bloodstream infections in the Bangkok study patient population 
could have been a manifestation of seasonal variation in the occurrence of P. marneffei
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infections.
The mortality rate among study-patients with bloodstream infection was significantly 
higher than that of patients without bloodstream infection (mortality was particularly high 
among patients with bacteraemia or fungaemia versus those with mycobacteraemia). The 
blood culture system in the clinical microbiology laboratory of the study hospital had the 
capability of detecting Gram-positive or -negative bacteraemia, but was less sensitive for 
recovery of mycobacteria or fungi. Without comprehensive blood cultures, bloodstream 
infections in the patients that I studied would have gone undetected. The findings in the 
Thailand component suggest that the initial priority of other Thailand hospitals ought to be 
towards the development of microbiology services to diagnose bloodstream infection, and 
identification of the patient populations most at risk of having bloodstream infection through 
ascertainment of clinical predictors. By focussing available resources on obtaining blood 
cultures from high-risk patient populations using comprehensive methods to detect bacteria, 
mycobacteria, and fungi, clinicians could initiate directed (versus blind) empirical therapy later 
tailored to the results of cultures.
In many countries, limited resources may result in patients having no microbiology tests 
performed; or, where available, use of inadequate methods that include use of expired or 
inappropriate culture media or for optimal recovery of organisms, varying duration of 
incubation, or omission of essential quality control methods. The Western style inpatient- 
based culture methods cannot be established or sustained in such resource-poor settings. 
Cohort-based microbiologic surveillance studies focus on quality-controlled diagnostic testing 
over a finite period and are performed on patients with similar symptoms or signs, such as 
fever. Such studies could be conducted at sentinel hospitals that provide a natural gathering
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point to sample patients meeting these simple, objective entry criteria.
These cohort-based studies could be conducted in the form of periodic surveys of cohorts 
of patients meeting the aforementioned defined entry criteria using quality-controlled tests 
with a high positive predictive value for infection, such as cultures of blood, cerebrospinal 
fluid, or stool. A comprehensive cohort-based study conducted over a finite period may be 
more feasible and effective than individual patient-directed laboratory testing in providing 
useful clinical and public health information. Such studies may provide better estimates of 
true incidence and prevalence rates of emerging pathogens and antimicrobial resistance, and 
better determination of clinical predictors of infection. In addition, these studies would 
provide the opportunity to build capacity in basic clinical microbiology in sentinel regional 
hospitals or laboratories where there is inadequate critical public health infrastructure, or 
where full scale microbiologic services are unsustainable.
The results of the current study suggest that the HIV-1 pandemic has led to high rates of 
presentation of febrile adult patients with bloodstream infections to a large infectious disease 
hospital in Southeast Asia. The scope of clinical microbiology services offered by hospitals 
serving HIV-endemic areas in Thailand may need to be widened to include blood cultures for 
pyogenic bacteria, mycobacteria, and fungi. Development of algorithms based on clinical 
predictors of bloodstream infections may be a useful approach to more effectively use limited 
resources and improve patient care. Cohort-based microbiologic studies used for surveillance 
of emerging infections in sentinel hospitals may provide important clinical and public health 
information, such as clinical predictors of infection, identities of emerging pathogens and their 
antimicrobial susceptibility profiles of to commonly used antimicrobials, and prevalence rates 
of infections caused by these pathogens.
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The daunting task remains to define the role of new and emerging pathogens causing 
bloodstream infection in a variety of patient populations presenting to hospitals in Southeast
i
Asia and other less-developed countries. Continued recommendation of individual patient- 
directed culturing in less-developed countries is likely to fail because of insufficient laboratory 
personnel, resources, and expertise. The cohort-based methods used in the current study could 
be implemented at regional referral laboratories in less-developed countries. In this way, 
larger numbers of patients could be cultured using quality controlled methods. With the 
demonstrated utility of cohort-based microbiologic studies for the surveillance of emerging 
infections, there is hope that patient therapy can be improved and national and international 
surveillance of new and emerging pathogens and antimicrobial resistance can be enhanced.
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M a l a w i (D r y  s e a s o n )
The bloodstream infection prevalence rate in adult patients presenting with fever to a large 
general hospital in Central Malawi was 30%; the HIV-1 seroprevalence and malaria 
parasitaemia rates in this study cohort were 74% and 4%, respectively. The rates of positive 
blood cultures increased as the number of clinical predictors present increased, ranging from 
11% for patients with none of the independent clinical predictors of bloodstream infection to 
100% in patients with all three independent risk factors. The rate of bloodstream infection in 
the study population in Malawi was higher than the rates found in Nairobi (10%), Abidjan 
(17%), or Kampala (24 %) [Gilks et al., 1990a; Vugia et al., 1993; Ssali et al., 1998].
Although these differences in the prevalence of bloodstream infection may reflect different 
rates of HIV-1 infection or differences in the stage of HIV-1 infection when patients present to 
the hospital, they also reflect the sensitivity of various blood culture methods used in the 
Nairobi, Abidjan, and Kampala studies. In contrast, the Tanzania phase of the current study 
employed blood culture methods similar to those used in Malawi phase and an identical patient 
case definition (fever) for enrollment, and documented a bloodstream infection prevalence rate 
that was similar to that documented during the Malawi dry season (28% vs. 30%).
In the present study, S. pneumoniae was the most common pyogenic bloodstream 
pathogen. This finding, though similar to that in the Kenya and Uganda studies [Gilks et al., 
1990a; Ssali et al., 1998], contrasts with the findings in Tanzania, where culture techniques 
were similar to those used in Malawi, and with the findings in Cote d’Ivoire [Vugia et al., 
1993]. Although differences in the prevalence rates of S. pneumoniae may reflect differences 
in culture technique, other possible explanations for these differences in the rate of S. 
pneumoniae infection include geographic location (both Dar es Salaam and Abidjan are closer
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to seacoasts than is Nairobi or Lilongwe), seasonal variation, or exposure to antimicrobials, 
such as ampicillin. The prevalence rate of HIV-1 infection in the Malawi dry season study 
population is high and reflects several factors and potential biases, including the selection 
criteria used to enroll patients, socioeconomic factors in the population served by the hospital, 
and the dynamics of the HIV-1 epidemic in various regions of sub-Saharan Africa. The HIV-1 
infection rate (74%) in the Malawi patients was similar to that found in Uganda in 1998 [Ssali 
et al., 1998], but was higher than reported rates in Kenya (1989), Cote d’Ivoire (1991), and 
Tanzania (see Tanzania results in chapter 5). These differences in HIV-1 prevalence may 
relate to geographic location, year of the study, or unchecked progression of the HIV 
epidemic.
The relatively low prevalence rate (4%) of malaria parasitaemia in the Malawi dry 
season study cohort was not significantly different from the rate (7%) in a control group of 
healthy afebrile adults. Given that 49% of the patients in the current study were initially 
diagnosed with malaria and the common perception among the lay public and healthcare 
workers alike that malaria is a common cause of fever, one may conclude that during the dry 
season, adult patients presenting to LCH with fever were frequently over-diagnosed with 
malaria. It is possible, however, that study patients with negative malaria smears were already 
on antimalarial prophylaxis or therapy that could have been obtained from community clinics 
or bought over-the-counter and administered before presenting to LCH.
As was shown in Tanzania, the data from Malawi confirm that M. tuberculosis is a 
frequent cause of bloodstream infection in sub-Saharan African countries while M. avium 
complex is an uncommon cause of disseminated infection among HIV-1-infected patients. 
These findings are compatible with the results of other studies in sub-Saharan Africa [Gilks et
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al., 1995; Morrissey et al., 1992; Okello et al., 1990; Ssali et al., 1998; von Reyn et al., 1996]. 
In addition, some of these other researchers had come to the conclusion that disseminated M 
avium complex infection in HIV-infected patients was higher in developed than less-developed 
countries and was probably related to both differences in exposure and differences in 
immunity [von Reyn et al., 1996]. Only one patient in the current Malawi study had M. avium 
complex bloodstream infection, the fifth reported case of disseminated M. avium complex 
infection in an HIV-1-infected patient in sub-Saharan Africa (the previous cases were 
documented in the current Tanzania study [see results section] and Nairobi [Gilks et al., 1995].
The relative paucity of disseminated M. avium complex bloodstream infection is 
perplexing given the ubiquitous presence of M. avium complex in the environment of sub- 
Saharan Africa [Morrissey et al., 1992; von Reyn et al., 1993]. However, von Reyn and 
colleagues also found that isolation rates of M. avium complex in water supply systems were 
higher in the United States and Finland than they were in Kenya and Zaire (32% vs. 5%; P=
0.056), and that none of the water supply samples from hospitals in Kenya and Zaire tested 
positive for M. avium complex, while about 20% in the United States and 50% in Finland did 
von Reyn et al., 1993]. Thus, the most plausible explanation for the low occurrence of M. 
avium complex infection in sub-Saharan Africa might lie in the fact that M. avium complex 
infection is a condition associated with piped water, of which there is relatively less in Africa 
compared with developed countries in the Northern Hemisphere.
The findings in the current Malawi study indicate that HIV-1 infection is an independent 
risk factor for bloodstream infection in newly hospitalized, febrile adults. Therefore, 
knowledge of HIV-1 status in these patients should facilitate the decision to initiate empirical
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antimicrobial therapy. However, one cannot make a blanket recommendation that HIV-1 
testing should be done routinely in areas of high HIV-1 seroprevalence in order to make a 
decision about initial empirical therapy because many hospitals in Africa do not have the 
necessary financial or laboratory resources to test every patient suspected of having HIV-1 
infection. Even in institutions where HIV-1 testing services are available (e.g., LCH), it may 
take up to 5 days before test results become available to clinicians. Thus, HIV-1 serology test 
results cannot realistically be used to make clinical decisions for newly hospitalized febrile 
patients in HIV-1-endemic areas in less-developed countries. Notwithstanding these 
limitations, Malawian physicians have a low threshold of suspicion for HIV-1 infection and 
generally are able to suspect underlying HIV-1 infection from the history and physical 
examination alone.
The current Malawi data suggest that febrile patients with suspected or documented HIV- 
1 infection and clinical features, such as a history of chronic symptoms (fever, diarrhoea, 
weight loss, or cough), altered mental status, herpes zoster scars, pulmonary physical signs, or 
oral candidiasis should be suspected of having bloodstream infection (bacteraemia, 
mycobacteraemia, or fungaemia). The physician might wish to consider ancillary diagnostic 
tests, such as chest radiographs and/or sputum smear microscopy for bacteria and AFB, 
referral to the tuberculosis clinic, where appropriate, or initiation of empirical antibacterial or 
antituberculosis therapy. Febrile patients with signs of pulmonary consolidation alone are at 
increased risk of having a bacteraemia, probably caused by S. pneumoniae, and should be 
considered for bacterial blood cultures, if available, or treated with an appropriate empirical 
regimen. Since S. pneumoniae appears to be the most common bloodstream pathogen during 
the Malawi dry season, the spectrum of the empirical therapeutic regimen should be effective
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against this organism. The S. pneumoniae isolates were largely resistant to TMP/SMX and 
penicillin but susceptible to tetracycline, erythromycin, and chloramphenicol. Salmonella 
species were generally resistant to TMP/SMX and gentamicin but were susceptible to 
chloramphenicol. Thus, chloramphenicol, depending on availability, should be considered for 
empiric therapy in patients suspected of having a bloodstream infection.
The current data also suggest that during the dry season, newly admitted, febrile, adult 
patients with negative malaria blood smears are more likely to have bloodstream infection; 
patients with altered mental status are more likely to have bloodstream infections than cerebral 
malaria. Since patients frequently attend their local clinic or district community health centre 
for antimalarial treatment at the onset of fever or other malarial symptoms, those with a 
definite diagnosis of malaria would have responded to this therapy and therefore have no need 
to attend LCH. In contrast, patients who did not respond to initial antimalarial therapy would 
have been more likely to have an infection other than malaria and therefore would have been 
the ones most likely to present to LCH. This may explain why patients with negative blood 
smears were more likely to have a bloodstream infection. Studies, such as this, contribute to 
the global surveillance of emerging infectious diseases and antimicrobial resistance. M. simiae 
and possibly mycobacteria of the SAV-group represent emerging infections in HIV-1-infected 
patients of the developed world [Huminer et al., 1993; Wald et al., 1992; Floyd et al., 1996]. 
The finding of these agents in the bloodstream of patients who participated in the Thailand 
study, and now in Malawi, suggest the emergence of these pathogens in the less-developed 
world may be related to the HIV epidemic.
Documentation of decreased susceptibility to penicillin among S. pneumoniae, and to 
TMP/SMX and gentamicin among Salmonella species isolated from the bloodstream suggest
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that emerging antimicrobial resistance may be an increasing problem in sub-Saharan Africa. 
Followup studies may further characterize the diversity of infecting bloodstream pathogens 
and their clinical predictors; these data can be used to better target limited antimicrobials and 
improve patient outcomes in settings with limited resources.
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M a l a w i ( w e t  s e a s o n )
Whoever wishes to investigate medicine properly, should proceed thus: in the first place to 
consider the seasons o f the year, and what effects each o f them produces.
Hippocrates (460? -3 7 7  BC)
Despite this ancient admonition, little has been published about the seasonality of bloodstream 
infections in developed countries [Flournoy et al., 1983]. There is also a paucity of published 
data on the role of seasons in the occurrence of bacteraemia in less-developed countries where 
resources for diagnosis and treatment of life-threatening infections are limited. Mabey et al. 
were among the first to demonstrate seasonal variation in the occurrence of Salmonella 
septicaemia among paediatric patients in The Gambia [Mabey et al., 1987]. Data from 
published studies of bloodstream infection in hospitalized adults in various sub-Saharan 
African countries [Gilks et al., 1990; Vugia et al., 1993; Batchelor et al, 1996; Ssali et al.,
1998] and from the current studies in Tanzania, Thailand, and Malawi have demonstrated 
varying distributions in bloodstream infection pathogens. Moreover, as was documented in the 
introductory chapter of this thesis, most of the published studies of adult populations [Gilks et 
al., 1990; Vugia et al., 1993; Batchelor et al, 1996; Ssali et al., 1998] utilized limited 
laboratory methods, were conducted during one seasonal cycle, or included cumulative annual 
data that did not permit investigators to determine whether the distribution of bloodstream 
infection pathogens varied by season. In the previous chapter, it was established that the 
predominant pathogens causing bloodstream infection during the Malawi dry season are S. 
pneumoniae and M. tuberculosis.
The results from the wet season phase in Malawi confirmed that the overall bloodstream
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infection rate in a febrile, adult population hospitalized at the same Malawi District General 
Hospital during the 1998 rainy season was 28% and that the three most commonly isolated 
pathogens were non-typhi Salmonella species (41%), M. tuberculosis (19%), and C. 
neoformans (9%). The HIV-1 seroprevalence rate in the study population was high (73%), and 
the rates of pyogenic bacteraemia, mycobacteraemia, and fungaemia increased as the number 
of specific clinical predictors for each of these types of bloodstream infection increased. The 
previous study of a similar adult inpatient population at the same hospital during the 1997 dry 
season used the same case definition (fever), microbiologic methods, and blood culture 
inoculating volume, and showed similar bloodstream infection (28%) and HIV-1 
seroprevalence (76%) rates. In contrast, the bloodstream pathogens most commonly isolated 
in the dry season study were S. pneumoniae (33%) and M tuberculosis (26%).
Although seasonal variations in disease occurrence, especially for various infectious 
diseases, have been established by epidemiologists and clinicians over the years, very little 
data have been documented for seasonal variation in the incidence of bloodstream infections.
In 1983, Flournoy and colleagues observed a seasonal pattern for S. pneumoniae bloodstream 
infection in a United States institution—a monophasic pattern that peaked from December to 
April [Flournoy et al., 1983]. In a study of bloodstream infections in Gambian children during 
1979-1984, Mabey et al. found that the incidence of Salmonella septicaemia was more closely 
related to changes in transmission of malaria than to changes in the stool carriage rate of 
salmonellae, and that 74% of cases of non-typhi Salmonella septicaemia occurred during the 
rainy season in The Gambia [Mabey et al., 1987]. More recently, other researchers in Malawi 
established a seasonal pattern for bloodstream pathogens in febrile adult medical admissions to 
the largest hospital in the country: S. pneumoniae bacteraemia was more common in the cold
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dry months while non-typhi Salmonella spp. predominated following a rise in temperature 
[Gordon et al., 2001]. Suggested reasons for seasonal occurrence of bloodstream infections 
include variation in virulence of bacterial pathogens, host susceptibility, patient demographics 
and behaviour, environmental factors, such as weather, or occurrence of underlying diseases, 
such as HIV-1 infection [Flournoy et al., 1983; Mabey et al., 1987]. Mabey et al. suggested an 
explanation for the increased incidence rate of non -typhi Salmonella spp. in the hot months:
i.e., because raised levels of immune complexes persist in the serum for several weeks after an 
acute attack of P. falciparum malaria, the immune complexes might cause impairment of 
macrophage function throughout this phase and may render the patient susceptible to invasive 
Salmonella infections [Mabey et al., 1987].
Previous studies of bloodstream infections in sub-Saharan Africa either were conducted 
during one particular season, or combined data over seasonal cycles [Alausa et al., 1977; 
Batchelor et al., 1996; Gilks et al., 1990a; Ssali et al., 1998; Vugia et al., 1993]. The 
importance of season-specific surveillance is clearly illustrated by the different recovery rates 
despite similar culture methods for non-typhi Salmonella and S. pneumoniae in the wet and dry 
seasons. In more affluent settings, initial empirical therapy would be initiated to treat a broad 
spectrum of potential pathogens. Then, laboratory tests would be applied to focus treatment on 
a specific pathogen. In many less-developed countries, confirmatory laboratory tests are not 
available or the microbiologic methods (e.g., type of media available, duration of incubation, 
requirements for quality control) may be inadequate. Where cost or availability prohibits the 
use of multiple antimicrobials, the clinician often is compelled to choose one empiric regimen. 
Thus, the patient’s survival may depend on the clinician’s awareness of the distribution of 
bloodstream infection pathogens that he is potentially dealing with.
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To improve patient outcomes and enhance rational use of antimicrobials, hospitals in 
less-developed countries with limited laboratory resources may need to improve the accuracy 
of probable diagnoses and choice of antimicrobials used for initial empiric therapy. 
Establishing comprehensive microbiology laboratories at all hospitals in these settings may be 
inappropriate or unrealistic. A better approach would be identification of regional or sentinel 
microbiology laboratories and utilization of resources in these laboratories to conduct cohort- 
based studies. Such studies are conducted as periodic surveys of patients who meet simple, 
objective entry criteria, such as symptoms, signs (e.g., fever, diarrhoea, rashes, or altered 
mental status), or syndromes. Cohort-based microbiologic sample surveillance studies, such 
as these series of blood culture surveys, focus on quality-controlled diagnostic testing with a 
relatively high positive predictive value for infection, such as cultures of blood, cerebrospinal 
fluid, or stool, and may be more feasible and effective than continuous, individual, patient- 
directed laboratory testing in providing useful clinical information. In this way, the 
distribution of pathogens associated with various infections, and their susceptibilities to 
available antimicrobials would be determined. These data could then be used to facilitate 
selection of the most appropriate agents for empirical therapy between study periods. In 
addition, these studies provide the opportunity7 to enhance basic clinical microbiology capacity 
in sentinel regional hospitals or laboratories in need of critical public health infrastructure. In 
the current study, available resources were focussed on obtaining blood cultures in a high-risk 
patient population using comprehensive methods to detect bacteria, mycobacteria, and fungi 
onsite. These methods include relatively simple but highly efficient blood culture techniques 
that can be effectively applied even in an underdeveloped setting.
Another cost-effective approach to the use of limited microbiology resources would be to
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obtain blood cultures or initiate empirical therapy on clinical predictors or syndromes. The 
data from the present study suggest that although the predictive value positive of clinical 
correlates of bacteraemia, mycobacteraemia, or fungaemia are limited in scope, they are 
potentially useful for the development of therapeutic or diagnostic algorithms. For example, 
patients presenting with acute diarrhoea, vomiting, jaundice and a high fever may be 
considered to be at increased risk of acquiring a bloodstream infection, probably caused by 
non-typhi Salmonella species, and ought to be considered for bacterial blood cultures, where 
these services are available, or treated with an appropriate empirical regimen. Febrile, adult 
patients with a history of chronic cough and a family history of cough may be considered at 
risk of acquiring disseminated M. tuberculosis and should be examined with a chest radiograph 
and sputum smear at the very least.
Although differences in the prevalence of bloodstream infection may reflect different 
rates of HIV-1 infection or differences in the stage of HIV-1 infection when patients present to 
the hospital, they also reflect the sensitivity of various blood culture methods used in these 
studies, especially for isolation of mycobacteria. Although the contribution of 
mycobacteraemia to acute morbidity may be small, it may be necessary to assess whether the 
relatively large number of patients with M. tuberculosis bloodstream infection poses a 
significant infectious risk to others in the hospital and in their communities.
The issue of hospitalized patients who do not have symptoms or signs of M. tuberculosis 
infection but have disseminated tuberculosis as evidenced by mycobacteraemia (occult 
mycobacteraemia) at the time of admission was observed in the first phase of the study in 
Tanzania, but requires further study. Identification of clinical predictors of M. tuberculosis 
bloodstream infection may provide an early opportunity to determine which patients have a
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high probability of disseminated tuberculosis and therefore should be screened early on with 
chest radiographs and sputum smears.
Febrile illnesses are responsible for a significant number of hospital admissions in the 
countries where the current series of studies were executed, and in other parts of sub-Saharan 
Africa [Ngaly and Ryder, 1988]. Moreover, such febrile illnesses often are attributed to 
malaria [Nwanyanwu et al., 1997]. Although the rate of malaria parasitaemia was significantly 
higher during the wet season study-patients compared to those in the dry season study-cohort 
(31% vs. 4%; P <0.001), clinical malaria was markedly overdiagnosed in both seasons. In the 
wet season, 56% of the study-patients diagnosed with malaria were incorrectly diagnosed. Of 
those patients incorrectly diagnosed and treated for malaria, 34% had bloodstream infections 
caused almost exclusively by Gram-negative pathogens.
Although malaria is an illness of well-known seasonality, treatment algorithms often fail 
to reflect this [Aniedu, 1997; Hay et al., 1998]. Resources may be unnecessarily spent on 
providing empiric therapy at constant levels throughout the year for an infection whose 
etiologic agent varies seasonally. Taking seasonal variations in disease prevalence into 
consideration could strengthen therapeutic algorithms for hospitalized patients with fever.
In developed countries, confirmation of HIV-1 serologic tests with Western blot 
molecular technique is standard in many laboratories. In contrast, there is continuing debate 
about the usefulness of expensive HTV-1 confirmatory tests in less-developed countries where 
the Western blot often is not used because of its complexity and high cost. In hospitals in sub- 
Saharan Africa and Southeast Asia, where 50-75% of adults who present to hospitals with 
fever may be HIV-1-infected [Batchelor et al., 1996; Gilks et al., 1990a; Ssali et al., 1998], it 
may not be economically feasible to conduct HIV-1 confirmatory testing, though a number of
Chapter 8: Page 122
false HIV-positive test results would, of course, be expected. Ittiravivongs et al in Thailand, 
and Urassa et al in Tanzania showed that use of two ELISA tests to confirm the presence of 
HIV-1 antibodies produces results comparable to those of the Western blot [Ittiravivongs et al., 
1996; Urassa et al., 1992]. In the current series of studies in Tanzania, Thailand, and Malawi, 
there was 100% concordance between the final results of two ELISA antibody tests and 
Western blot..
Variation in the data from the studies show that results cannot be extrapolated to other 
regions or countries. Rather, the approach of regional, season-specific, surveillance studies is 
offered as a model for optimizing patient care where routine laboratory testing is not available. 
Selective application of diagnostic laboratory resources can provide answers to clinical 
questions that can be generalized within a region, greatly extending the effects of limited 
resources, improving patient care, and enhancing the recognition of emerging pathogens or 
antimicrobial resistance.
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U n r e c o g n is e d  (O c c u l t ) m y c o b a c t e r a e m ia
Much current emphasis on controlling the global increase in tuberculosis is placed on 
promoting directly observed treatment, short course (DOTS). The main objective of this 
prevention effort, led by the World Health Organization [World Health Organization, 1998], is 
to achieve increased cure rates through greater compliance with antimicrobial therapy. This 
emphasis is appropriate given that both HIV-1-infected and noninfected patients may be 
rendered non-infectious for tuberculosis through treatment, and that the emergence of 
multidrug resistance in M. tuberculosis is mainly a result of non-compliance with therapy.
Primary prevention of M. tuberculosis infection, however, is another important part of 
controlling the worldwide increase in tuberculosis. The hospital setting is an epicentre for the 
spread of tuberculosis particularly in less-developed countries where M. tuberculosis and HIV 
infection are prevalent. In such healthcare settings, highly susceptible patients, many with 
advanced HIV infection, are in close proximity to others with active tuberculosis. Although 
transmission of M. tuberculosis in such settings may appear inevitable, even simple infection 
control efforts, such as early diagnosis and treatment, or the isolation of groups of patients 
with active disease, may have a major impact on nosocomial transmission rates.
The current studies show that about 10% of patients with fever, admitted to an infectious 
disease hospital in Thailand and a general hospital in Malawi had bloodstream infections 
caused by M. tuberculosis:; 30% of patients in the infectious disease hospital and 71% of 
patients in the general hospital were not thought to have active tuberculosis disease because 
they had not received previous antituberculosis therapy, chest radiography, or sputum smear 
results at the time of admission. The greater recognition of active disease in the infectious 
disease hospital was associated with greater overall availability or use of antituberculosis
Chapter 8: Page 124 
therapy, chest radiographs, and sputum smears. The greater availability or use of 
antituberculosis drugs at the infectious disease hospital was associated with higher rates of 
drug resistance among M. tuberculosis isolates.
The failure to identify M. tuberculosis in blood often is in many cases the result of use of 
inappropriate culture media, insufficient incubation of cultures, or failure to obtain blood 
cultures for mycobacteria. Important for the execution of this study was the availability of 
simple and effective means to isolate mycobacteria from blood [Reimer, 1994]. Although the 
current study incorporated a commercial system to lyse white blood cells in blood culture 
specimens before inoculating onto commercial liquid and solid media, noncommercial systems 
have been devised for the effective recovery of mycobacteria from the blood [Fandinho et al., 
1997]. Inoculation of the lysis-centrifugation pellet into liquid or biphasic media may result in 
inhibition of mycobacterial growth [Wasilauskas & Morrell, 1994]. This inhibition was 
overcome by inoculating only 0.5 ml of the pellet into the biphasic media broth [Doem & 
Westerling, 1994] and inoculating part of the pellet directly onto Middlebrook 7H11 agar 
slants.
HTV-1-infected patients are more likely to have extrapulmonary disease than are HTV-1- 
negative individuals; chest radiographs were not done routinely in the study populations in 
Malawi. Therefore, it was not possible to ascertain with certainty whether all patients with M. 
tuberculosis bloodstream infection had pulmonary involvement. However, in a previous study 
of HIV-1-infected patients selected on the basis of having extrapulmonary disease, many were 
found to have viable M. tuberculosis in their sputum [Shafer et al., 1991]. In other studies, 
lung involvement was found in most patients with M. tuberculosis bacteraemia, who were 
assessed with chest radiographs [Barber et al., 1990; Bouza et al., 1993; Grinsztejn, 1997]. In
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addition, the fact that most patients in the current study with unrecognised tuberculosis 
infection had symptoms of acute or chronic cough is of concern. Even if the bacterial load in 
the sputum of such patients is low at the time of admission, one must expect increased 
infectivity while the patient is in hospital unless active disease is recognised and therapy 
promptly initiated.
The proportion of all infectious patients (i.e., those admitted to the hospital with active 
tuberculosis) detected by these surveys is unclear. In retrospective studies of HIV-1-infected 
and non-infected patients with active tuberculosis only 14% -15% of those tested had 
mycobacteraemia [Bouza et al., 1993; Shafer et al., 1989]. However, in a prospective survey 
of 33 HIV-1-infected patients with active tuberculosis that used the lysis centrifugation 
technique for blood culture, Grinsztejn and colleagues found mycobacteraemia in 60% of 
patients; in five (15%) patients, blood was the only specimen that yielded M. tuberculosis 
[Grinsztejn et al., 1997]. In another study of 11 AIDS patients with pulmonary tuberculosis, 
all had mycobacteraemia by the lysis-centrifugation technique [Mattar et al., 1992]. Although 
as many as one-third of patients who present to hospitals with active tuberculosis may be 
afebrile, the proportion is probably much smaller among HIV-1-infected patients [Shafer et al.,
1991]. Therefore, although the present study studies were limited to a blood culture evaluation 
of febrile patients, available data suggest that most patients with advanced HIV-1 infection and 
active tuberculosis were ascertained [Shafer et al., 1989; Mattar et al., 1992; Nunn et al..
1992].
Patients with unrecognised active tuberculosis were defined on the basis of the absence 
of previous therapy or abnormal chest radiograph, or positive AFB sputum smear results from 
a test carried out on or before the day of admission. The under-recognition of active disease
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was associated with lower rates of previous therapy and diagnostic testing. Although some 
clinicians advocate analysis of medical records as a means of assessing whether active 
tuberculosis is present in patients, the criteria used to define these patients in the present blood 
culture surveys offer more objective evidence as to whether tuberculosis was seriously 
suspected by the admitting clinicians. Evaluation of an old test, the chest radiograph, supports 
its role in the diagnosis of tuberculosis [Barnes et al., 1988]. AFB sputum smears have an 
established role in diagnosing active disease [Kramer et al., 1990; Modilevsky et al., 1989; 
World Health Organization, 1998] and are important for determining infectivity for infection 
control purposes [Centres for Disease Control and Prevention, 1994]. Traditionally, the 
diagnosis of active tuberculosis could be achieved with a fair degree of accuracy without the 
aid of additional diagnostic tests. In the HIV era, however, this is no longer true [Elliott et al., 
1993; Gilks et al., 1990b; Kramer et al., 1990; Modilevsky et al., 1989; Shafer et al., 1991].
The challenges faced in the global battle against tuberculosis are tremendous. Results 
from this study emphasize these challenges and the overwhelming nature of the problem. One 
encouraging finding, however, is the association of a lower rate of antimicrobial resistance 
with the under-recognition of active disease.
Nonetheless, global tuberculosis-control efforts should also focus on primary prevention 
by improving the availability and use of chest radiographs and sputum smears to diagnose 
active disease. The problem is that when chest radiographs have not been obtained, one does 
not know if they would have been abnormal. Thus, initiating empirical therapy in patients 
with suspected active tuberculosis is more important. The findings of the present study 
suggest that these tests should be carried out at hospitals in less-developed countries on all 
febrile adult patients with oral thrush, chronic cough, fever, or weight loss. In less-developed
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countries even with clinical microbiology facilities, testing every febrile patient admitted to 
hospital for mycobacteraemia using blood cultures may be costly, unsustainable, or an 
inappropriate use of available resources. Development of simple clinical algorithms for 
identifying high-risk patients who would benefit from sputum smears for AFB, chest 
radiographs, or from empirical antituberculous therapy might be a better use of resources. For 
example, HIV-1-infected patients who present with oral thrush, chronic fever, cough or weight 
loss have a high risk of mycobacteraemia and would benefit from empirical antituberculous 
therapy and sputum or blood cultures for M. tuberculosis.
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COMPARISON OF BLOOD CULTURE METHODS
Although the methodologies used for detecting organisms at each of the three study sites were 
sensitive for recovery of these bacteria, mycobacteria, and fungi, total volumes of blood 
required for comprehensive cultures were high (20-30 ml), and processing of the Isolator tubes 
followed by inoculation of the concentrate into Middlebrook broth and onto solid media 
required additional laboratory steps that are not otherwise necessary during inoculation and 
processing of blood culture bottles. These additional steps required multiple kinds of culture 
media and additional laboratory time. Moreover, because of subculture steps, the risk of 
contamination with environmental organisms is increased using the Isolator tube and lysis- 
centrifiigation system [Campos & Spainhour, 1985; Carey, 1984; Eisenach et al., 1992]. In 
less-developed countries with limited resources, such added costs are not sustainable. In 
addition, where clinical microbiology facilities exist for processing mycobacteria blood 
cultures, testing every patient admitted to hospital may be costly, or require inappropriate use 
of already scarce microbiology resources. Other factors that preclude the processing of 
mycobacteria blood cultures in these laboratories include the need for a dedicated carbon 
dioxide incubator and limited refrigerated facilities for the storage of several kinds of media.
Previous comparative studies have demonstrated that the SC-B system is able to detect 
more bacterial microorganisms associated with sepsis than conventional broth cultures 
[Weinstein et al., 1985], and a similar number of bacterial pathogens compared with the 
BACTEC radiometric system [Weinstein et al., 1986]. Lysis-centrifugation using the Isolator 
tube has been shown to detect microbiologically proven bacteraemias or fungaemias in 
significantly greater numbers than either conventional tryptic soy broth bottles with C 02, or a 
biphasic bacterial blood culture bottle [Henry et al., 1983]. Direct inoculation of Middlebrook
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7H11 conventional solid media or broth media with Isolator concentrate remain two of the 
most widely used methods for recovery of mycobacteria from blood [Askgaard et al., 1991; 
Reimer, 1994]. During the conduct of the Tanzania, Thailand, and Malawi studies, inoculating 
the Isolator concentrate into the SC-AFB biphasic bottle containing Middlebrook 7H9 broth 
was noted to be more sensitive for recovery of mycobacteria than inoculating the Isolator 
pellet onto solid Middlebrook 7H11 agar.
For any of the methods presented, culturing blood comprehensively for bacteria, 
mycobacteria, and fungi requires drawing at least 20-30 ml of blood from adult patients. For 
cultural reasons, patients in various countries are loathe to part with seemingly large volumes 
of blood. The data from the Malawi studies indicate that the MFL bottle inoculated with just 5 
ml blood is (i) superior to the SC-B bottle inoculated with 10 ml blood, and similar to lysis- 
centrifugation for detection of bacteraemia and fungaemia; and (ii) superior or similar to 
Isolator concentrate inoculated on solid media or in Middlebrook broth, respectively, for 
detection of mycobacteria.
The Malawi study was conducted in a region where nearly three-quarters of febrile 
adults presenting to the regional general hospital are HIV-1-infected (see Malawi results). 
During processing, the Isolator/lysis-centrifugation system requires several manipulations that 
potentially could result in needle stick injury, cuts from broken Isolator tubes, or aerosol 
exposure to Isolator tube contents. Thus, for laboratory personnel in HIV-1-endemic regions, 
using the Isolator system increases risk of exposure to the HIV-1 virus. For less-developed 
world settings, where blood cultures either are or should be part of the microbiology service 
repertoire, the MFL blood culture system has several advantages: one bottle will yield growth 
of bacteria, mycobacteria, or fungi, it does not require a carbon dioxide incubator, it is
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compact and easily stored, and it is easily read by manually shining an ultraviolet light on the 
bottom of the bottle. These data demonstrate that comprehensive culture for the three groups 
of pathogens could be achieved by inoculating just 5 ml of blood into one blood culture bottle 
rather than inoculating aliquots of blood into various bottles, tubes, or culture media. Ease of a 
single inoculation into one blood culture bottle circumvents the necessity of multiple 
inoculations, processing steps, and sub-culturing onto various culture media, thereby reducing 
rates of contamination, the amount of technician time required for processing, and the risk of 
needle stick injuries.
The rate of blood culture contamination in Malawi was low (1.6% overall and 0.8% 
when contamination of Middlebrook 7H11 agar slants were excluded). These low rates were 
achieved by ensuring that high aseptic standards were maintained before and during the blood 
draw, using both 70% alcohol and iodine tincture for skin cleansing and allowing the skin to 
dry properly before venesection, and scrupulous cleaning of the rubber diaphragms of blood 
culture bottles and Isolator tubes with isopropyl alcohol before inoculation with blood, and 
before accessing with needle and syringe during microbiologic processing of blood culture 
bottles and Isolator tubes. Of note, the overall blood culture contamination rate (1.3%) 
achieved when using alcohol followed by povidone-iodine was similar to the contamination 
rate (1.6%) observed when skin disinfection was carrried out with alcohol and iodine tincture.
In the United States, the MFL bottle with the BACTEC 9000 series automated machines 
is marketed as a system for the growth and detection of mycobacteria. Because the MFL 
blood culture media is not selective and will support the growth of aerobic organisms, such as 
mycobacteria, bacteria, yeasts, and fungi, the presence of other organisms in the blood may 
inhibit growth of mycobacteria in the MFL medium. While this might constitute a limitation
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in the United States, it is this property that renders the MFL medium, in combination with a 
hand-held ultraviolet lamp, an excellent system for the comprehensive detection of 
mycobacteraemia, bacteraemia, or fungaemia in less-developed countries.
In conclusion, one MFL blood culture bottle, inoculated with just 5 ml of blood, was as 
efficient as the SC-B, SC-AFB, or Isolator blood culture systems in detecting bacteraemia, 
mycobacteraemia, and fungaemia in a febrile adult population in an HIV-1-endemic region. 
Moreover, growth in an MFL bottle was easily detected by shining an ultraviolet lamp on the 
indicator located in the base of the bottle. Such lamps are readily obtained at relatively cheap 
prices at general electronic stores. The MFL system provides a sensitive and uncomplicated 
method for comprehensive detection of bloodstream infection in less-developed countries.
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UTILITY OF NUMBER OF MFL BLOOD CULTURE BOTTLES IN PATHOGEN RECOVERY 
The data in the previous chapter demonstrate that the MFL bottle compares with the gold 
standard set by the lysis-centrifugation method for detecting bacteraemia, mycobacteraemia, 
and fungaemia [Henry et al., 1983]. In the present analysis, the data suggest that since nearly 
all (91%) pairs of bottles had positive cultures following sequential inoculation with blood 
from a single venipuncture, the culture of a second MFL bottle does not add incrementally to 
the recovery rate established by inoculation of the first bottle. In fact, the bloodstream 
infections in 11 (92%) of the 12 patients with mycobacteraemia and 38 (92%) of the 41 
patients with bacteraemia would have been detected anyway had only one MFL bottle been 
inoculated (Table 18). The overall median time to detect bacteria and fungi in the MFL bottles 
was 1 day (range: 1-4 days). A comparison of the time of recovery for mycobacteria could not 
be realistically conducted for the two MFL bottles because it was not feasible to determine 
growth during shipment of the bottles to the United States.
Published recommendations for culture of blood drawn from febrile patients include 
retrieval of two blood samples, each a minimum of 10 ml, drawn separately and as close as 
possible to the febrile episode [Reller et al., 1982; Washington, 1986]. These are based on 
studies conducted in the United States where rates of bloodstream infections are relatively low 
compared with HIV-endemic settings where bloodstream infection rates among febrile 
inpatients range from 28% to 48% [see previous thesis chapters]. In the Malawi study, blood 
from a single venesection was inoculated consecutively into two MFL bottles; the main issue 
examined in the present analysis was the adequacy of blood volume in a single blood draw for 
detecting bloodstream infections. The design of the study did not enable ascertainment of the 
the utility of inoculating blood from two separate blood draws (i.e., two sets) into respective
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MFL bottles for bacterial, mycobacterial, or fungal cultures.
Although the practice of obtaining paired bacterial blood cultures from single and 
separate blood draws has been extended to obtaining mycobacterial blood cultures, there are 
no published data that critically evaluate these practices. The prevalence rate of bloodstream 
infections in the Malawi study setting was 25% (95% confidence interval: 19%, 31%).
As outlined in the previous chapter, the MFL bottle is designed for use in the BACTEC 
9000 series automated blood culture machines and is licensed and marketed as a system for the 
growth and detection of mycobacteria [Waite & Woods, 1998]. The MFL blood culture media 
is not selective and will support the growth of aerobic organisms, such as mycobacteria, 
bacteria, and yeasts. Microorganisms (e.g., mycobacteria and certain fungi) that grow 
relatively slowly are less likely to be detected during the first week of incubation. However, 
since the MFL bottles were kept incubated for a total of 8 weeks, presence of any such 
pathogens should have been detected. Thus, it is plausible that the predominance of one type 
of microorganism might have interfered with the recovery of other types and therefore prevent 
detection of polymicrobial (i.e., >1 pathogen) bloodstream infections. This may explain why 
none of the MFL pairs exhibited any evidence of polymicrobial bloodstream infections.
In summary, aseptic inoculation of 5 ml of blood into one MFL bottle will detect about 
92% of cases of bacteraemia and mycobacteraemia. In addition, the data suggest that the MFL 
bottle serves as a useful, multipurpose tool for the detection and characterization of 
bloodstream infections in settings of HIV endemicity in less-developed countries and that 
inoculation of blood obtained in a single blood draw into a single MFL bottle is acceptable for 
detecting bacteraemia and mycobacteraemia. A second MFL bottle does not significantly 
increase the sensitivity of detection of these pathogens.
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E m e r g in g  p a t h o g e n s : SAV G r o u p  m y c o b a c t e r ia
Advances in laboratory methodology have enabled more rapid and reliable differentiation of 
mycobacterial species more commonly associated with clinical illness (e.g., M. tuberculosis 
and Mycobacterium avium complex), and the identification of new or emerging species (e.g., 
M triplex) [Hale et al., 2001]. However, ambiguities in determining specific mycobacteria 
species remain, and methods for identification and susceptibility testing are not standardized 
for many species. The mycobacterial isolates obtained from the four patients with SAV Group 
mycobacteraemia were tested using similar methods by two different References Laboratories 
with extensive experience in working with mycobacteria. Standard susceptibility testing 
panels have not yet been established for these microorganisms.
These features may lead to difficulties in the clinical management of patients with 
disseminated mycobacterial infection. The clinical manifestations of such infection are 
relatively nonspecific and not indicative of the infecting species. The four patients with SAV 
Group mycobacteraemia had presented with typical, nonspecific clinical features, such as 
fever, lymphadenopathy, and cachexia that also are commonly seen in patients with 
disseminated mycobacterial infections caused by Mycobacterium avium complex or M. 
tuberculosis. There were no distinctive clinical findings among these patients that would aid 
in making a specific diagnosis of M. simiae or SAV mycobacterial infection. Thus, as with 
other mycobacterial infections, diagnosis and specific therapy is ideally guided by laboratory 
testing, including species identification and susceptibility testing, rather than clinical findings 
alone.
Because the primary focus of these studies was bloodstream infections in general rather 
than bloodstream infections in HIV-1-infected patients specifically, neither CD4 lymphocyte
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nor HIV-1 viral load data were obtained from patients in these studies. However, since each of 
the four patients had a marker of symptomatic HTV-1 infection (oral candidiasis, Kaposi’s 
sarcoma, or positive cerebrospinal fluid cryptococcal antigen), it can be assumed that all had at 
least moderately advanced disease. In addition, because these patients had at least moderately 
advanced HIV-1 infection and clinical evidence of probable other opportunistic infection, and 
because the symptoms and physical findings were nonspecific, one could not be certain that M. 
simiae or SAV mycobacteria were the cause of their symptoms. Further study and 
characterization of SAV mycobacteria and of the clinical illness with which it is associated are 
required to better ascertain the frequency and clinical significance of these mycobacterial 
infections. No data on treatment or post-discharge outcome for these patients were available.
Awareness of M  simiae and SAV mycobacteria as potential causes of disseminated 
infection in patients with AIDS is of public health importance for several reasons. Because of 
their phenotypic similarity to each other and to other mycobacterial species, patients infected 
with M. simiae or SAV mycobacteria may go unrecognised and presumed to be infected with 
other mycobacterial species, particularly M. tuberculosis, in resource-poor settings without 
access to adequate laboratory testing. This may lead to ineffective treatment, as not all species 
are susceptible to all agents (testing of three isolates using the methods established for M. 
tuberculosis suggests resistance to many antituberculosis drugs). Lastly, had it been assumed 
that these SAV mycobacteria were M. tuberculosis, the presence of MDRTB would have been 
overestimated. Because of the lack of data and clinical experience with M. simiae and SAV 
group infections, the best definitive treatment has yet to be determined. Infections with other 
mycobacteria, particularly M. tuberculosis, require treatment with multiple agents to which the 
organisms are susceptible for prolonged periods. Not adhering to these principles may
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promote the development of drug-resistance. It is unknown at present whether similar hazards 
exist when SAV mycobacteria are treated with ineffective agents or otherwise suboptimal 
therapy.
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CHAPTER 9 
LIMITATIONS
Only one set of blood culture (i.e., blood from one venipuncture) was drawn from each study 
patient; two blood cultures would probably have yielded a larger number of organisms 
[Weinstein et al., 1983]. It follows that the true rates of bloodstream infections in the study 
populations were probably higher than the observed rate of 28% in Tanzania, 48% in Thailand, 
and 28% in Malawi.
Blood cultures could not be repeated in some patients in whom S. epidermidis, 
Micrococcus spp, and Bacillus species were isolated because the patients died before the 
organisms were identified in the laboratory. The decision to treat these organisms as 
contaminants was based on the results of studies work completed in the United States that 
suggest the presence of these organisms in the blood does not correlate with presentation and 
clinical state [Weinstein et al., 1983].
The predominance of one organism in the blood may interfere with the recovery of other 
types and therefore prevent the detection of polymicrobial bloodstream infection.
HIV-1 ELISA results were not confirmed by secondary tests. Data from Tanzania and 
Thailand have shown that the use of two ELISA tests to confirm the presence of HIV-1 
a antibodies produces results comparable to those of the Western blot [Urassa et al., 1992;
Ittiravivongs et al., 1996]. Thus, in a country with a high prevalence rate of HIV-1 infection 
and limited financial resources, Western blot analysis is neither customary nor necessary, 
though second less sensitive, more specific immunoassays are recommended for confirmation 
in Western countries.
Different body sites and fluids were not cultured for pathogens. It was therefore not
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possible to correlate the presence of a bloodstream infection with a concurrent positive culture 
for the same organism from another anatomic site.
Although the HIV test kits used in these series of studies were able to detect HIV-2 
antibody, the design of the study did not enable ascertainment of specific patients with HIV-2 
antibody. To date, however, no HIV-2 infection has been found in Tanzania or Malawi despite 
continuous search by researchers.
The patient populations under study had remarkably high HIV-1 seroprevalence rates. 
This underscores the potential pitfalls in applying these results to other populations that may 
have a relatively lower HIV-1 seroprevalence rate, and the need for region-specific studies.
The results of a two-month survey from one hospital are not representative of other regions for 
any of the countries where the studies were conducted because the aetiology of bloodstream 
infections and the clinical predictors of bloodstream infection using logistic regression were 
highly variable. This may be due to seasons, geography, the environment, available diagnostic 
microbiology resources, and the susceptibility of the patient population. For clinical predictors 
to be useful, they would have to be assessed for the area in which they would potentially be 
used. One cannot extrapolate the results of a four week study in Lilongwe, Malawi to other 
regions in sub-Saharan Africa, or to other countries. Thus, the predictors that were ascertained 
through multivariate analysis are useful primarily as an example. Appropriate clinical 
algorithms would have to be developed from studies conducted in the respective regions. For 
clinical predictors to be useful, they would have to be determined for patient populations in 
regions where they would be used.
The Malawi studies were conducted during the height of the Malawi dry and wet seasons 
and confirmed seasonal variation in the occurrence of salmonella and pneumococcal
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bloodstream infections and malaria. In contrast, the studies in Tanzania and Thailand were 
conducted during only one cycle of seasons. Thus, the data from Tanzania and Thailand do 
not enable similar ascertainment of the role of seasons on the nature and occurrence of 
bloodstream infections. Confirmatory assessments of seasonal variations in the aetiology of 
bloodstream infection in hospitalized populations may need to be determined over several 
seasonal cycles in some countries.
High rates of malnutrition and HIV-1 infection (both of which may suppress the febrile 
response) were documented for the study populations in Tanzania, Thailand and Malawi.
Thus, using fever as the case definition for patient enrollment might have excluded a 
significant number of afebrile, HIV-1-infected patients who had bloodstream infections.
The type of antimicrobials used by some study-patients before presentation to hospital 
and the duration of such therapy were often uncertain. Moreover, the study populations had 
relatively high rates of pre-admission antimicrobial exposure. In Malawi, antimicrobial 
exposure during the wet season was lower than in the dry season rate (35% wet season vs. 48% 
dry season; P <0.01). However, this significant seasonal difference in antibacterial exposure 
preceding hospital admission did not appear to significantly affect the percentage recovery of 
bloodstream infection pathogens (29% wet season vs 28% dry season; P = NS). Although the 
data suggest that exposure to antimicrobials before hospital admission was not associated with 
the presence or absence of bloodstream infection, there was documentation of resistance 
among the non-typhi Salmonellae isolates to two antimicrobial agents that are commonly 
prescribed at the Malawi study site. Thus, these data further emphasize the need to control 
unrestricted antimicrobial use in international settings if emerging antimicrobial resistance is 
to be prevented.
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There were limitations to the analysis of the blood culture methods. For example, while 
the MFL blood culture system was as sensitive as the Isolator concentrate inoculated on IMA 
in detecting fungi, the numbers of these isolates (11 C. neoformans, one Ciyptococcus 
laurentii, and one Candida tropicalis) were too small to enable a valid assessment of overall 
sensitivity of fungi. For similar reasons, Waite et al also were not able to make any general 
inferences about the reliability of the MFL bottle for the recovery of fungi [Waite et al., 1998]. 
Moreover, the numbers of fungal bloodstream infections were too small to enable a valid 
assessment of one versus two MFL bottles in detecting fungaemia
It was demonstrated that the MFL bottle’s ability to recover bacteria, mycobacteria, and 
fungi was comparable to the lysis-centrifugation method. However, comparison of the MFL 
bottle with other bottles, such as the BACTEC™ bottles containing large volumes of resin, has 
not been conducted in similar settings with high rates of HIV-1 and bacteraemia.
Because the MFL and SC-AFB bottles and the Middlebrook 7H11 agar slants were 
shipped to the United States for further processing, assessment and comparison of relative 
times of detection of mycobacteria by these respective recovery methods were not possible.
As expected for most comparative studies of this type, there was a bias as regards the volume 
of blood inoculated into the various media. Ten ml of blood were inoculated into each of the 
SC-B bottle and Isolator tube; 5 ml were inoculated into the MFL bottle as recommended by 
the manufacturer. Thus, it is likely that the recovery rate of pathogens from the MFL system 
might have been higher had the inoculating volume of blood into MFL bottles been >5 ml.
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CHAPTER 10 
CONCLUSION
I n s ig h t s  in t o  e f f e c t iv e  d e v e l o p m e n t  a n d  u s e  o f  m i c r o b io l o g y  l a b o r a t o r y
DIAGNOSTICS IN DEVELOPING COUNTRIES
Using the experience of the approach that was used to study bloodstream infections in 
Tanzania, Thailand, and Malawi, the issue of limited microbiology resources in developing 
countries was reviewed. This conclusion includes a discussion of the feasibility and utility of 
the cohort-based approach to integrate microbiology, epidemiology, and clinical medicine to 
survey emerging bloodstream infections in these countries, and the role of sentinel hospitals in 
carrying out these endeavours.
In industrialized countries, it is the best of times for microbiologic diagnosis and 
treatment of infections. In some developing countries, progress is also apparent. Ministries of 
health are building hospital intensive care units (ICUs) with increasing use of sophisticated 
medical devices, and invasive diagnostic and therapeutic procedures and interventions. 
Increasing numbers of infants and adults are being admitted to, and benefiting from, these 
units. More patients with conditions such as chronic renal failure or hematologic disorders are 
being treated in specialized units. The Internet has made physicians generally more 
knowledgeable than before.
Nevertheless, it is the worst of times for hospitals in other developing countries, where 
infectious diseases remain the leading cause of death [Hinman, 1998; Mabey et al., 2004]. 
Many sentinel hospitals have less than basic microbiology laboratory facilities; there is no end 
in sight to the HIV epidemic, and the rate of tuberculosis is increasing in parallel with it;
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hospital infections, especially surgical site infections, have become important causes of illness 
and death in certain hospitals in sub-Saharan Africa (unpublished data); and invasive medical 
devices and procedures are increasingly being introduced into ICUs and operating theatres 
without the necessary infection control procedures. In some developing countries, some 
institutions have all the needed microbiologic resources, while others have none; some hospital 
laboratories have instruments and reagents yet have no technical staff to use them; others may 
be able to amplify genomes yet cannot report the results of a simple Gram stain in a timely 
manner. For all these reasons, the causes of many infections among inpatients in Africa, 
Southeast Asia, the Indian subcontinent, and parts of the Americas remain largely unknown or 
uncharacterised.
In sub-Saharan Africa and Southeast Asia, antimicrobial-drug resistance is being 
increasingly recognised in pathogens that commonly cause infections in health-care settings, 
rendering available antimicrobial agents ineffective and further shortening the list of already 
scarce effective agents [Hart & Kariuki, 1998]. Thus, to diagnose and treat infections 
appropriately and to fully characterize emerging infections in developing countries, enhanced 
clinical microbiology services should be a priority. The clinical microbiology laboratory in 
developing countries should be patient directed and guided by clinical reality and not by high 
technology or outside interests.
Two other factors have had a marked effect on the role of clinical microbiology in 
developing countries, the HIV and tuberculosis epidemics. Most (95% of the global total) 
people with HIV infection live in the developing world [Grant & De Cock, 1998; World 
Health Organization, 1999]. In almost 6 million of the 34 million adults and children with 
HIV or AIDS, HIV infection was acquired during 1999 [World Health Organization, 1999];
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3.8 million cases occurred in sub-Saharan Africa and 1.3 million in South and Southeast Asia. 
Of the approximately 40 million Tuberculosis cases globally, 73% are projected to have 
occurred in Southeast Asia and sub-Saharan Africa [World Health Organization, 2000]. 
Tuberculosis, which accounts for almost one third of the AIDS deaths worldwide, and other 
opportunistic bacterial, fungal, and protozoal infections are leading causes of death among 
HIV-infected patients [Grant & De Cock, 1998; World Health Organization, 1999; World 
Health Organization, 2000]. In consequence, HIV infection, tuberculosis, and HIV-related 
opportunistic infections have overwhelmed existing resources in hospital microbiology 
laboratories in most developing nations.
At CDC, a main objective of the strategy for preventing and controlling emerging 
infectious diseases in developing countries is establishing more effective international 
surveillance networks [Centres for Disease Control and Prevention, 1994]. In the 
industrialized world, infection control relies on results from individual patient-directed 
diagnostic microbiology laboratory tests. However, basic clinical microbiology has not been 
recognised as a priority by donor or governmental agencies in industrialized countries or by 
the developing countries themselves. The problem often has been compounded by lack of 
trained laboratory personnel or prohibitive costs associated with maintaining a laboratory. 
Where resources are available, they may be used inappropriately (e.g., nonessential stool, 
urine, or sputum cultures; antimicrobial susceptibility testing of microorganisms without 
quality assurance; or complete laboratory characterization and antimicrobial susceptibility 
testing of bacterial isolates that are not clinically relevant).
Prohibitive costs and doubtful cost-effectiveness of specific tests are commonly cited as 
reasons for the unavailability of microbiology tests. The first steps in achieving cost-effective
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use of resources include assessing whether or not a test has sufficient diagnostic value to be 
used and establishing criteria to limit processing to those organisms most likely to be clinically 
relevant [Robinson, 1994]. The concept of clinical value encompasses several issues 
[Spencely et al., 1979]: why was the test requested? Will the result help or alter patient 
management? Would a simpler test do? Will the use of a test increase knowledge? Can we 
do without it? Is the test of public health or clinical importance? For example, hospitals in 
developing countries still routinely obtain and process anaerobic blood cultures, despite that a 
positive anaerobic blood culture often reflects an underlying anaerobic infection (e.g., 
intraabdominal sepsis or female genital tract infection) that already is clinically apparent or 
discernible [Ortiz & Sande, 2000; Bartlett & Dick, 2000]. The counter argument is that while 
such data may reflect reality for a microbiology issue in industrialized nations, they may not 
be applicable for developing settings—all the more reason for important questions about 
diagnostic clinical microbiology in developing countries to be addressed through 
evidence-based clinical studies.
The importance of integrating epidemiology and microbiology is exemplified by studies 
that ascertained the usefulness of expensive HTV confirmatory tests in developing countries.
In industrialized countries, confirmation of HIV serologic tests with the Western blot 
molecular technique is standard practice. In developing countries, the Western blot often is 
not routinely used because of its complexity and high cost. Studies with epidemiologic, 
clinical, and microbiologic components that were conducted in Thailand and Tanzania have 
shown that the use of two ELISA assays to confirm the presence of HIV antibodies produces 
results comparable with those of the Western blot [Urassa et al., 1992; Ittiravivongs et al., 
1996]. This approach was effectively used to confirm HIV status of patients in the present
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study protocol in HIV-endemic regions in Tanzania, Thailand, and Malawi. Thus, in a country 
with a high prevalence rate of HIV infection, limited financial resources, and inadequate 
laboratory infrastructure, Western blot analysis for confirmation of HIV infection is not 
essential.
Medical services in industrialized nations rely on results from individual, 
patient-directed, diagnostic microbiology laboratory tests ordered by clinicians. This system 
appears effective for industrialized settings and is generally sustainable. Not surprisingly, 
diagnostic microbiology services in some developing countries have been modelled on these 
practices in industrialized countries. However, such routine laboratory testing may be 
impossible in developing settings because of lack of microbiology services, or, where these 
services are available, tests may be unreliable if performed improperly or without adequate 
quality control. Further, the tests may well be inappropriate, irrelevant, or redundant. For 
example, antimicrobial susceptibility testing without quality controls may lead to invalid or 
distorted data that give rise to bias and inaccuracy in reports being used for clinical and public 
health decision making.
H o s p it a l  c o h o r t - b a s e d  s t u d ie s
The study protocol for the present thesis is, in fact, a series of hospital, cohort-based, 
epidemiologic and microbiologic surveys. Such surveys are conducted with a cohort of 
patients who meet simple, objective entry criteria or case definitions (e.g., fever, diarrhoea, 
cellulitis, or specific syndromes). Detailed clinical and epidemiologic data are collected for 
later analyses, and cultures with a high positive predictive value for infection (e.g., blood, 
cerebrospinal fluid, other sterile sites, or stool for enteric pathogens) are obtained. The
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emphasis is on performing quality-controlled laboratory testing for a finite period rather than 
long-term, routine diagnostic testing. These surveys are best conducted in selected hospitals or 
laboratories that provide a natural gathering point to sample patients meeting these entry 
criteria. A cohort-based study carried out during a finite time period may be more effective 
than long-term individual patient-directed laboratory testing in providing useful clinical and 
public health information, in determining the true incidence and prevalence rates of emerging 
pathogens and antimicrobial-drug resistance, and in yielding clinical predictors for various 
infections in defined patient cohorts. In addition, cohort-based studies provide the opportunity 
to establish diagnostic capability in basic clinical microbiology in sentinel hospitals or 
laboratories and promote surveillance activities in regions where critical public health 
infrastructures have been neglected.
C o h o r t  s t u d i e s  o f  b l o o d s t r e a m  in f e c t io n
Using the cohort-based approach to clinical microbiology and epidemiology, studies of 
bloodstream infections among inpatients in sub-Saharan Africa and Southeast Asia were 
executed and completed. Fever was chosen as the case definition because it may be attributed 
to HTV infection, diarrhoea, pneumonia, tuberculosis, or, in sub-Saharan Africa, malaria.
Blood cultures were obtained because of their high positive predictive value for presence of 
bloodstream infections in febrile patients.
In Thailand, about half of consecutive febrile adults admitted to a sentinel teaching 
hospital for infectious diseases had bloodstream infections; in similar patient cohorts in 
Tanzania and Malawi teaching hospitals, over one quarter of patients had a bloodstream 
infection. For these three countries, M. tuberculosis, S. pneumoniae, and Salmonella species
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were the predominant causes of bloodstream infections in these patients. Data from these 
studies also included clinical predictors for bloodstream infections and antimicrobial 
susceptibility profiles of clinically important isolates, including M tuberculosis isolates. Both 
the predictors and susceptibility profiles were potentially useful for developing algorithms for 
empiric treatment of febrile inpatients and for helping clinicians decide which patients would 
most benefit from limited blood culture services, where these were available.
The cohort-based studies in Malawi during the dry and wet seasons demonstrated 
seasonal variation in the prevalence of bloodstream infections: S. pneumoniae and M 
tuberculosis were the predominant bloodstream pathogens during the dry season, whereas 
Salmonella species were the predominant bacteria isolated during the wet season. In addition, 
the Malawi data confirmed that malaria was overdiagnosed in both the wet and dry seasons in 
Malawi and that empirical therapeutic decisions had to reflect this reality.
The cohort-based studies in Tanzania, Thailand, and Malawi demonstrated the 
occurrence of occult mycobacteraemia and new emerging pathogens. For example, 42% of 
patients with M. tuberculosis bloodstream infections had neither symptoms nor signs of 
pulmonary tuberculosis. These results highlighted the importance of maintaining a low 
threshold of suspicion for active tuberculosis; the need for strengthening each hospital's 
microbiology capabilities to examine and report on sputum smears for AFB; and the potential 
for intrahospital tuberculosis transmission from seemingly noninfectious patients.
The public health implications of the cohort-based approach are enormous. Conducting 
similar studies in other countries would improve microbiology services by encouraging 
appropriate use of limited resources in sentinel hospital laboratories and focussing on 
clinically relevant problems (e.g., bloodstream infections, meningitis, pneumonia, febrile
Chapter 10: Page 148
diarrhoea, and surgical wounds). Moreover, laboratory personnel would benefit from training 
in the conduct of quality-controlled tests, such as antimicrobial-drug susceptibility testing. 
Prevalence rates of common infections, HIV infection, or resistance of common hospital 
pathogens to available antimicrobial agents would be available for clinical and public health 
decision making. Updated lists of probable diagnoses, clinical predictors for specific 
infections, and development of clinical algorithms and antimicrobial-drug susceptibility 
profiles based on these objective data would enhance patient care through rational diagnosis 
and prescribing policies.
Although it may not be economically feasible to obtain cultures for all patients who 
might benefit from microbiologic tests in developing countries, cohort-based studies could be 
applied to establish the causes and clinical predictors for these infections and thereby facilitate 
directed rather than blind empirical therapy. Data from cohort-based studies in one region or 
country may not be suitable for direct extrapolation to other regions or countries. Rather, 
regional, season-specific surveillance studies can be tools for optimizing patient care where 
routine laboratory testing is not available. The data from Thailand and Malawi also included 
documentation of bloodstream infections caused by a new emerging pathogen: SAV Group 
mycobacteria. The task remains to define the role of other new and emerging pathogens in 
various patient populations at hospitals in developing countries, using the cohort-based 
approach.
T h e  R o l e  o f  S e n t in e l  H o s p it a l s
The cohort-based approach to collaborative global endeavours in the characterization of 
emerging infections has included identifying sentinel hospitals and then enhancing their
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clinical microbiology laboratory capacity by assessments, training of personnel, and initiating 
projects that answer questions of clinical and public health significance. In developing 
countries, where limited resources and infrastructure may preclude comprehensive medical, 
surgical, and laboratory services for every region or province, centralization of available 
resources in a few selected centres is one way of optimizing resources. This paradigm is 
evident in many countries in Southeast Asia, Africa, Latin America, and the Caribbean, where 
a few institutions have evolved into sentinel centres of paramount importance for providing 
such services.
Sentinel hospitals tend to be large institutions (usually >500 beds) that are the main 
teaching centres for medicine, surgery, nursing, and laboratory science; they commonly house 
specialized ICES, surgery, haemodialysis, or invasive medical procedures; they have problems 
with hospital infections and antimicrobial-drug resistance; they are associated with 
microbiology laboratories that are often reference centres with the ability and capacity to 
conduct various microbiologic tests using scrupulous, quality-controlled methods; and they 
usually are government affiliated and have very close links with the respective ministry of 
health. The last attribute is important since governmental agencies from industrialized 
countries (e.g., WHO, United States Agency for International Development) generally prefer 
to maintain collaborative endeavours with sentinel centres for reasons that include adequate 
infrastructure, trained personnel, and access to the ministry of health.
A high priority for future global consortiums of epidemiology and biomedical research 
centres will be to initiate or build upon existing systems in sentinel hospitals in developing 
countries for the international monitoring and reporting of antimicrobial susceptibility data. 
Two systems that offer a foundation of international linkages are CDC's International
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Nosocomial Surveillance Program for Emerging Antimicrobial Resistance and the WHO 
Antimicrobial Resistance Monitoring Program. The international and national objectives of 
these programs depend on conducting proper, quality-controlled, antimicrobial susceptibility 
testing and promoting the use of resistance data to guide antimicrobial therapy. These results, 
when integrated with clinical and epidemiologic data on opportunistic and hospital infections, 
may lead to substantial improvement in patient outcomes.
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APPENDIX D
Data Entry
Study Number [ ][ ][ ] Ward NO [ ] WD [ ]
Admission Date / / Hospital number
Gender [1] Male [2] Female Age GEN [ ] AGE [ ]
Occupation Family size OCC [ ] FAM [ ]
No. rooms in house ROOMS [ ]
L  History
Presentation ADMDX [ ]
Date of onset / / ONSET [ ]
Temperature °C °F BTC [ ] BTF [ ]
Respiratory rate /min RR [ ]
Pulse /min BP: / P [ ] BP [ ]
2. Acute Symptoms SFEV [ ]
1) Fever [ ] Yes [2] No SCHI [ ]
2) Cold/clammy (chills) [ ] Yes [2] No SCOU [ ]
3) Cough [ ] Yes [2] No SSOB [ ]
4) Shortness of breath [ ] Yes [2] No SDIA [ ]
5) Diarrhoea [ ] Yes [2] No SVOM [ ]
6) Vomiting [ ] Yes [2] No SCONV [ ]
7) Convulsions/LOC [ ] Yes [2] No HEADACHE [ ]
8) Headache [ ] Yes [2] No NECKSTIF [ ]
9) Neck stiffness [ ] Yes [2] No SKINLES [ ]
10) Infected Skin Lesion(s) [ ] Yes [2] No JAUND [ ]
11) Jaundice [ ] Yes [2] No GENULCER [ ]
12) Genital ulcers [ ] Yes [2] No URIN [ ]
13) Urinary symptoms [ ] Yes [2] No RASH [ ]
14) Rash [ ] Yes [2] No FAMCOUGH [ ]
Family history of cough [ ] Yes [2] No PMH [ ]
Past medical history (PMH).... ..................[ ]
3. Chronic Symptoms (over one month) [1] Yes [2] No CSYM [ ]
1 )Fever [ ] Yes [2] No CFEV [ ]
2) Cough [ ] Yes [2] No CCOU [ ]
3) Diarrhoea [ ] Yes [2] No CDIA [ ]
4) Weight loss [ ] Yes [2] No CAC [ ]
5) Chronic Skin Lesion(s) [ ] Yes [2] No CSL [ ]
6) Vomiting [ ] Yes [2] No CVOM [ ]
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APPENDIX D (continued)
4. Physical Examination ORAC [ ]
1) Oral candidiasis [1] Yes [2] No LEUKO [ ]
2) Oral leukoplakia [1] Yes [2] No KAP t ]
3) Kaposi sarcoma [1] Oral [2] No [3] Both [4] Skin ADENOP [ ]
4) Lymphadenopathy [1] Yes [2] No HEPENL t ]
5) Hepatomegaly [ 1 ] Yes [2] No SPLEENL [ ]
6) Splenomegaly [1] Yes [2] No BCGSCA [ ]
7) BCG scar [1] Yes [2] No ZOSCAR [ ]
8) Zoster scar [1] Yes [2] No CRACK [ ]
9) Chest: i)Crackles [1] Yes [2] No EFFUS t ]
ii) Effusion [1] Yes [2] No CONSOL [ ]
iii) Consolidation [1] Yes [2] No SIMPLEX [ ]
10) Herpes simplex [1] Acute [2] No [3] Chronic NECKRIGf ]
12) Neck rigidity [1] Yes [2] No CNS t ]
10) Central nervous system [1] Confused [2] Alert
[3] Unconscious RASH [ ]
11) Rash [1] Yes [2] No
5. Medications (pre-admission)
1) Antibiotics [ 1 ] Yes [2] No ABX t ]
2) Antifungals [1] Yes [2] No AFG t ]
3) Antimalarials [1] Yes [2] No AMAL t ]
4) Anti TB drugs [1] Yes [2] No ATUB t ]
6. Laboratory
1) Hb HB [ ]
2) WBC WBC [ ]
3) Malaria smear [1] Positive [2] Negative [3] Not done MAL t ]
4) Chest X-ray [1] Abnormal [2] Normal [3] Not done CXR t ]
5) Sputum AFB [1] Positive [2] Negative [3] Not done SAFB t ]
6) CSF results [1] Abnormal [2] Normal [3] Not done CSF t ]
7) HIV status [1] Positive [2] Negative HIV t ]
7. Discharge Date / / DD [ ]
DDIAGNOSIS DIAG [ ]
2) Outcome [1] Discharged [2] Died [3] Still Inpatient OUTC t ]
[4] Absconded
3) Length of hospital stay days LOS [ ]
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APPENDIX E 
C o n s e n t  f o r m  f o r  a d u l t  p a t ie n t s  w i t h  f e v e r  
You are being asked to be in a research study of bloodstream infections. Bloodstream 
infections mean that microorganisms, or germs, have gotten into the blood. These germs 
should not be there and these infections are serious. People often get a fever with the 
infection. Research studies already done in Africa, Southeast Asia, Europe and the United 
States have shown that in people admitted to hospital with fever, bloodstream infections are 
more common than we thought. Also, the germ which causes Tuberculosis has been found to 
be a common cause of bloodstream infections in people with fever who are infected with the 
AIDS virus. We are trying to find out how many people in Tanzania, Malawi, and Thailand 
who come to hospital and have a fever, have a bloodstream infection. We are asking people 
at Muhimbili Medical Centre (Tanzania), Bamrasnaradura Hospital (Thailand), and Lilongwe 
Central Hospital (Malawi) to be in this study. The Ministry of Health in these three countries, 
a public health organization from the United States, the Centres for Disease Control and 
Prevention (CDC), and Duke University Medical Center in the United States are doing the 
study.
We are asking you to be in this study because you have been admitted to hospital and you 
have a fever. If you decide to be in this study, you will be asked a few questions about your 
illness, and then you will have a physical examination. After this, we will take about 25 ml of 
blood (5 teaspoonfuls) from you: 10 ml will be cultured for germs, including Mycobacterium 
tuberculosis, the organism which causes tuberculosis; 5 ml will be used for checking your 
blood count and for malaria; 5 ml will used for testing of HIV-1, the virus that causes AIDS; 
and 5 ml will be used to test how well your body fights infections by testing your immune
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response to germs that might be in the blood. These are all tests routinely performed on 
patients with a fever in the United States who might have been infected with the AIDS virus. 
What follows is more detail on each part of this study. There are four parts:
Part #1
Blood cultures. Taking blood by needle puncture so that we can try to grow germs from it 
(we call this “culture”) is a routine medical procedure. Doctors usually give patients with a 
fever, like you, antibiotics. The choice of antibiotics which you receive depends on which 
germs are in the blood. Identifying germs in your blood and sharing this information with 
your doctor will allow the doctors taking care of you to make better choices of antibiotics to 
treat an infection, if you have one. If blood cultures are not done, a bloodstream infection will 
not be found and you may not receive the right therapy. These germs will also be sent to 
Duke University in the United States, to see if they get the same results we do here.
Part #2
HIV tests. Doctors would like to know if patients with fever, who have germs in their blood, 
are infected with the AIDS virus. Also, this information will help in planning your medical 
treatment. The blood test that is used in this hospital to tell whether a person is infected with 
the AIDS virus is called the HTV antibody test. Antibodies are substances made by the blood 
to fight infection. When a person is infected with the AIDS virus, the body produces 
antibodies against HIV. If antibodies are present in the blood, which is then tested by the HIV 
antibody test, the test will be positive. If there are no antibodies in the blood, the test will be 
negative. If there are antibodies in the blood, tests may be done to measure how much HIV
vims is in the blood. A positive HIV antibody test means that a person is infected with the 
AIDS vims. It also means that this person can give the AIDS vims to other people. The 
AIDS vims is found in the blood, semen, and vaginal fluids. A person can get the AIDS vims 
by having sex with someone who is infected. Women who are pregnant can also give the 
AIDS vims to their unborn babies. A person cannot get the AIDS vims by holding hands, 
hugging, drinking from the same glass, or being in the same room with someone who has the 
AIDS vims. A person recently infected with the AIDS vims may not yet have a positive HIV 
antibody test since it sometimes takes 3-6 months after infection for antibodies against the 
AIDS vims to show up in a blood test. However, during this early period, when the test is not 
yet positive, the recently infected person can still infect others with the AIDS vims. In 
addition, having a negative AIDS test now does not protect against having infection with the 
AIDS vims in the future. The HIV test can provide information that can help your doctor 
treat you and help you stay healthy and avoid giving the HIV vims to others. For this reason, 
doctors and nurses recommend the test to patients like you whose illnesses suggest the 
possibility of AIDS.
As recommended by the Ministry of Health, blood will be tested for HIV only after you 
have received counselling about the test and about what it means to be infected, or not 
infected. You will also receive counselling once the HIV test results are done, whether the 
test is positive or negative. Counselling will be carried out by permanent staff counsellors 
from the adult medical wards.
Part #3
Other blood tests. Your blood will be tested for malaria which also causes of fever.
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Part #4
Leftover serum samples. After all the above tests have been done, leftover serum will be 
stored in freezers in Dar es Salaam, Bangkok, and Lilongwe. Should the results of all your 
tests prove negative, having the stored serum will enable us to check for other agents (e.g., 
influenza virus) that could have been responsible for your fever. These results will be under 
the authority of the doctor who was responsible for your care during your hospitalization. 
Your name will be removed from all data collection forms. The tube with your blood will 
have a code number so that your identity will not be revealed. No individual identities of 
patients will be forwarded to CDC or Duke University Medical Center.
Confidentiality
We will keep the information we get from you as private as we can. Your name will not be 
on your test results-we will use a number instead of your name. The results of your blood 
culture, HIV antibody test, and other blood tests will be told only to your doctor. These results 
will be under the authority and supervision of the doctor responsible for your inpatient care. 
Your doctor will discuss these results with you. Your doctor might write the results of your 
HIV test in your medical notes. All this information will be kept confidential in your medical 
records to the extent legally possible. Your name will not be mentioned in any papers or 
speeches about the study.
Risks
There are several possible risks to you from being in this study. First, taking blood by needle 
will hurt for a moment, and may leave a bruise. Second, having an HIV test might cause you
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some anxiety and, if your test is positive, this will likely change the way you think about the 
future. Third, there is the chance that someone outside the hospital may find out that you 
have been tested for HIV infection or may find out the results of your HIV test, although we 
think this is a small chance.
Benefits
There are several benefits to you from being in this study. First, if you have a bloodstream 
infection, your doctor will better be able to treat your infection. Second, if you have a low 
blood count, your doctors might decide to offer you a transfusion. Third, many people want 
to have an HIV test, because it helps them plan for the future and, if it is positive, help keep 
them from infecting others. If your test is positive, your doctors will be better able to manage 
your illness, also. Last, you will be helping other people in the future, because the results of 
this study will allow doctors to better treat people who have illnesses like you.
Costs
There will be no cost to you.
Refusal to participate
You may refuse to be in one or all parts of the study. If you do not want to be in the study or 
to have an HIV antibody test, that decision will not in any way interfere with your ability to 
receive proper medical care or attention. If you do have a bloodstream infection but choose 
not to be in the study, it is highly likely that this bloodstream infection will not be detected. 
Because you are ill, your doctor might still treat you with antibiotics but may not select the
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correct one to treat the germ that is making you ill. Should you choose to not be in the study 
but your doctor asks that the research investigators get blood cultures from you on the 
grounds that the information will help him/her decide the course of your medical management 
and therapy, we would be very happy to do so with your consent.
Contact information
1) If you have questions about the study, please contact:
Telephone number:..........................................................................................
(2) If you have questions about your rights as a participant of this study please contact:
Nam e:................................................................................................................
Telephone number:...........................................................................................
(3) If you sustain any complications as a result of venipuncture please contact:
Telephone number:.........................................................................................
Summary statement
I have been told that my being in the study is up to me, that I choose to be in only part of it, 
and that I can stop being in the study at any time without any change in the medical care I 
would get if I were not a participant in the study. The doctor has told me about blood 
cultures, HIV antibody testing, and has explained the other blood tests. I have been able to 
ask questions about blood cultures, the clinical importance of bloodstream infections, HIV 
testing, and other immunologic testing.
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Do you:
Agree to blood cultures (Part 1): Yes. No
Agree to HIV testing (Part 2): Yes No,
Agree to other blood tests (Parts 3 and 4) Yes No
Name of patient.........................................................................................
Relative or person to contact if there is a complication:................................................
Signature of patient...........................................................................................................
Name of physician advising patient.................................................................................
Signature of physician......................................................................................................
Witness for oral consent...................................................................................................
By signing below, I attest that the consent form was accurately read to the participant 
Signature of witness for oral consent...............................................................................
Date
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